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Deutsche Zusammenfassung
0.1 Motivation & Einleitung
Proteine und ihre Wechselwirkungen in wa¨ssriger Lo¨sung spielen eine zentrale
Rolle fu¨r die biologischen Funktionen in jedem Lebewesen. Diese Arbeit bescha¨ftigt
sich mit der Beeinflussung dieser Wechselwirkungen durch A¨ndern von Kontrollpa-
rametern wie der Salzkonzentration oder der Temperatur, um das Phasenverhalten
gezielt zu beeinflussen und Proteine zur Kristallisation zu bringen.
Die unerwu¨nschte Aggregation oder Kristallisation von Proteinen spielt eine
Schlu¨sselrolle fu¨r viele Krankheiten. Beispiele sind Sichelzellana¨mie, die durch
Fasern aus sichelfo¨rmigen Ha¨moglobinmoleku¨len ausgelo¨st wird oder auch durch
die Aggregation des Proteins γ-Kristallin im Glasko¨rper des Auges verursachter,
altersbedingter grauer Star [70]. Einige neurodegenerative Erkrankungen wie etwa
Alzheimer, Parkinson, die Creutzfeldt-Jakob-Krankheit, amyotrophe Lateralskle-
rose und Chorea Huntington ru¨hren von einer irreversiblen Bildung von Pro-
teinaggregaten, u¨blicherweise Fasern aus fehlerhaft gefaltetem Eiweiß, her [3,121,155].
Nachweislich ko¨nnen Salze die Faserbildung beeinflussen, wobei sowohl die Io-
nensta¨rke als auch die Art des Anions eine Rolle spielen [84].
Seit der ersten Ha¨lfte des 20. Jahrhunderts wird Proteinkristallisation zur Auf-
reinigung von Proteinen eingesetzt. Beispiele sind eine Vielzahl an Serum-Albumi-
nen, Enzyme und viele andere [62]. Die große Bedeutung von Salzen, Lo¨sungsmit-
teln, dem pH-Wert und der Temperatur wurden schnell bemerkt und die Hofmeis-
terreihe dazu eingesetzt, um eine U¨bersa¨ttigung der Lo¨sung zu erreichen. Die
Wichtigkeit von Metallionen fu¨r die Proteinkristallisation wurde entdeckt, ins-
besondere an der Kristallisation von Insulin, die nur durch Zugabe von Zn2+ er-
reicht werden konnte [2,62]. Zudem enthalten u¨ber 90% aller pharmazeutischen
Produkte bioaktive Wirkstoffe in kristalliner Form, in erster Linie, um Stabilita¨t
zu gewa¨hrleisten [47]. Sich langsam im Ko¨rper auflo¨sende Kristalle ermo¨glichen
eine kontinuierliche Bereitstellung des Wirkstoffes und stellen damit eine weitere
Einsatzmo¨glichkeit von Proteinkristallen im medizinischen Bereich dar [70,204].
Ihre hauptsa¨chliche Anwendung finden sie jedoch in der Strukturbiologie: Die
dreidimensionale Struktur von Proteinen ist eng verknu¨pft mit ihrer biochemi-
schen Funktion [127]. Daher ist die genaue Kenntnis von Proteinstrukturen essen-
ziell fu¨r das Versta¨ndnis von grundlegenden physiologischen Prozessen und die
gezielte Entwicklung von Medikamenten [124,127]. Gerade das Humangenomprojekt
hat durch die Sequenzierung des menschlichen Genoms enorme Mo¨glichkeiten fu¨r
das Versta¨ndnis von durch Fehlfunktionen der Zelle verursachte Krankheiten und
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fu¨r die Entwicklung neuer medikamento¨ser Therapien ero¨ffnet. Die entsprechende
Proteinstruktur zu allen kodierenden DNS-Regionen zu bestimmen ist daher eine
große Herausforderung [29].
Weitere Mo¨glichkeiten, Informationen u¨ber die Proteinstruktur zu gewinnen,
sind Kernspinresonanz (nuclear magnetic resonance, NMR), Massenspektrometrie
und Mikrokalorimetrie. Die universellste und erfolgreichste Methode zur Struk-
turbestimmung bleibt jedoch Ro¨ntgenbeugung. Am ehesten stellt NMR eine Al-
ternative dar, sie ist jedoch auf kleine Makromoleku¨le mit weniger als 70 kDa
beschra¨nkt [127]. Zu den Anforderungen der Ro¨ntgenbeugungsmethode geho¨ren
dagegen relativ große und hochqualitative Einkristalle. Aus neu exprimierten Pro-
teinen solche hochqualitativen Kristalle zu zu¨chten ist jedoch keine einfache Auf-
gabe und stellt nach wie vor den hauptsa¨chlichen Flaschenhals der Proteinstruk-
turbestimmung dar [127]. Die vielfa¨ltigen (teils durch die inhomogene Ladungsver-
teilung und die unregelma¨ßige Form der Proteine meist anisotropen) Wechsel-
wirkungen von Proteinen untereinander und mit ihrer Umgebung, wie Wasser-
stoffbru¨ckenbindungen, elektrostatische Wechselwirkungen oder Van-der-Waals-
Kra¨fte, spielen eine entscheidende Rolle fu¨r die Proteinkristallisation [43,127] und
machen es schwierig, diesen Prozess mit einfachen Modellen zu beschreiben. Ein
weiterer wichtiger Punkt ist, dass die Neigung zur Kristallisation bei den meisten
Proteinen die evolutiona¨re Fitness des Organismus beeintra¨chtigt. Zwar existieren
Ausnahmen, in denen die Kristallisation von Proteinen vorteilhaft ist, in der Regel
schadet dies jedoch dem U¨berleben der Zelle [41,42]. Daher haben sich die meisten
Proteine im Laufe der Evolution dahingehend entwickelt, zumindest unter physi-
ologischen Bedingungen schwer kristallisierbar zu sein [41].
In den letzten Jahren wurde in unserer Arbeitsgruppe entdeckt, dass die Wech-
selwirkungen zwischen Proteinen in Lo¨sung durch “reentrant condensation” (RC)
bei der Zugabe von Salzen angepasst werden ko¨nnen und weiteres vielfa¨ltiges
Phasenverhalten wie flu¨ssig–flu¨ssig Phasenauftrennung (liquid–liquid phase sepa-
ration, LLPS) oder Kristallisation ausgelo¨st werden kann [86,151,157,220,222,223,226,227]:
Bei steigender Salzkonzentration tritt eine erste Grenze c* auf, an der ein U¨bergang
von einer klaren Lo¨sung bei kleinen Salzkonzentrationen (Regime I) zu einer
tru¨ben Probe mit durch attraktivere Wechselwirkungen gebildeten Aggregaten
auf (Regime II). Bei weiter steigender Salzkonzentration tritt eine zweite Grenze
c** auf, ab der die Proben wieder vollsta¨ndig klar sind (Regime III). Diese Meth-
ode wird in dieser Arbeit weiterverfolgt, um die Bedingungen fu¨r Kristallisation
zu optimieren. Ein wesentlicher Bestandteil der Arbeit besteht darin, die Kristal-
lkeimbildung genauer zu beschreiben und unterschiedliche Mechanismen zu un-
terscheiden. Dies kann durch die schlechte Zuga¨nglichkeit eines Keims oft nur
indirekt geschehen. Die hier vorgestellte Arbeit liefert ein tieferes Versta¨ndnis
dieser Prozesse in den untersuchten Modellsystemen. Die Mo¨glichkeiten zur An-
wendung in anderen Systemen werden diskutiert.
0.2 Ergebnisse 11
0.2 Ergebnisse
In diesem Abschnitt werden die Ergebnisse der Publikationen A-D zusammenge-
fasst, die in wissenschaftlichen Zeitschriften erschienen oder erscheinen sollen
(Publikation D). Sie entsprechen den Kapiteln 3-6. Abschnitt 0.2.5 fasst die Un-
tersuchungen zur U¨bertragbarkeit auf andere Systeme aus Kapitel 7 zusammen.
0.2.1 Publikation A: Nicht-klassische Proteinkristallisation
mit mehrwertigen Metallionen
In Publikation A wurde das Kristallisationsverhalten des Proteins Beta-Lactoglo-
bulin (BLG) in Lo¨sung mit Yttriumchlorid (YCl3) oder Zinkchlorid (ZnCl2) un-
tersucht. Durch ZnCl2 (oder auch durch das ebenfalls zweiwertige Salz Cadmium-
chlorid (CdCl2) kann eine erste Grenze c* ausgelo¨st werden. Bei hohen Salzkonzen-
trationen kommt es jedoch nur zu einem teilweisen Wiederaufklaren ab einer
als Pseudo-c** bezeichneten Konzentration. Mittels Kleinwinkelro¨ntgenstreuung
(SAXS) wurde gezeigt, dass die effektiven Wechselwirkungen sich bei steigender
Salzkonzentration von repulsiv im ersten Regime zu attraktiv vera¨ndern. Attrak-
tive Wechselwirkungen dominieren auch im Bereich von Pseudo-c**.
Die besten Bedingungen fu¨r Proteinkristalle hoher Qualita¨t wurden nahe c*
und c** (im Fall von YCl3) bzw. Pseudo-c** (im Fall von ZnCl2) gefunden. An-
ders als fu¨r HSA beobachtet [223], findet Kristallisation zwar im gesamten zweiten
Regime statt, die Kristallqualita¨t nimmt weiter von den Grenzen entfernt jedoch
deutlich ab. Unsere Strukturuntersuchungen zeigen auch, dass die Metallionen ein
integraler Bestandteil des Kristallgitters sind. Sowohl Zn2+ als auch Y3+ ko¨nnen
neue Proteinkontakte im Gitter durch Ionenbru¨cken erzeugen, wobei Yttrium im
Vergleich zu Zink eine gro¨ßere Zahl solcher Kontakte bildet.
Wa¨hrend nahe der unteren Grenze c* die Kristallisation vermutlich klassisch
abla¨uft, d.h. direkt aus der Lo¨sung und ohne weitere Zwischenphasen, tritt nahe
(Pseudo-)c** vor der Kristallisation eine weitere Phase auf. Die Morphologie
dieser Phase ha¨ngt stark von der Kristallisationstemperatur ab: Oberhalb einer
U¨bergangstemperatur Ttr sind die betreffenden Proben klar und kristallisieren
nicht [227]. Nahe Ttr besteht die Zwischenphase aus Proteinclustern. Deutlich un-
terhalb Ttr werden diese zu makroskopischen Aggregaten, die sich nach einiger
Zeit zu einer dichten flu¨ssigen Phase umwandeln. Kristallisation wird schließlich
an der Grenzfla¨che zwischen dieser dichten und der umgebenden du¨nnen flu¨ssigen
Phase beobachtet. Unsere Beobachtungen mittels optischer Mikroskopie ko¨nnen
jedoch nicht beantworten, ob es sich bei der Kristallkeimbildung um einen zwei-
schrittigen Prozess handelt, bei dem die dichte Phase einen direkten Vorla¨ufer
des Kristalls darstellt oder ob nicht vielmehr heterogene Keimbildung der du¨nnen
Phase an der Tropfenoberfla¨che stattfindet. Mo¨gliche Szenarien werden anhand
von Phasendiagrammen kolloidaler Systeme diskutiert.
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0.2.2 Publikation B: Echtzeit-Beobachtung der Kinetik
von nicht-klassischer Proteinkristallisation
(Dieser Abschnitt entha¨lt u¨bersetzte Auszu¨ge eines fu¨r GIT Labor Fachzeitschrift
geschriebenen Artikels)
In Publikation B wurde BLG in Lo¨sung mit CdCl2 untersucht. Wie im System
mit ZnCl2 wurde Kristallisation im gesamten zweiten Regime und etwas u¨ber die
Grenzen hinaus beobachtet. Fu¨r die Strukturbestimmung gut geeignete Qualita¨t
hatten jedoch nur Kristalle, die aus Proben nahe der Grenzen c* oder Pseudo-c**
gezu¨chtet wurden.
Direkt unterhalb c*, wo die gesamte Probe klar ist oder etwas daru¨ber, wo nach
Zentrifugation ein klarer U¨berstand zuru¨ckbleibt, kann Kristallisation direkt aus
der Lo¨sung beobachtet werden. Im Bereich von Pseudo-c** sind Proben tru¨b
und unter dem Lichtmikroskop sind Proteinaggregate zu sehen (im Gegensatz
zu Proben nahe c*, bei denen auch in tru¨bem Zustand die Aggregate zu klein fu¨r
die Beobachtung sind). Unsere Beobachtungen und die Analyse des Kristallwachs-
tums deuten darauf hin, dass die Aggregate eine entscheidende Rolle fu¨r die Keim-
bildung spielen.
Aufgrund der geringen Auflo¨sung und Statistik der Beobachtung mit Licht-
mikroskopie wird SAXS eingesetzt, um die strukturelle Entwicklung der Proben
zu charakterisieren. Nahe c* a¨hneln die Messkurven dem Formfaktor von BLG.
Nach einiger Zeit tauchen Bragg-Peaks auf und zeigen die Kristallisation der Probe
an. Es wurden keine Anzeichen fu¨r andere Strukturen als Lo¨sung und Kristall
gefunden. Im Bereich von Pseudo-c** weichen die Messkurven stark vom Form-
faktor ab. Es tritt zudem ein breiter Peak bei mittleren q-Werten auf, der mit
zunehmender Zeit in seiner Intensita¨t anwa¨chst. Dies kann durch die Bildung
von Proteinaggregaten mit einer bestimmten inneren Struktur erkla¨rt werden.
Zusa¨tzliche Bragg-Peaks treten auf, deren Intensita¨t zunimmt, wa¨hrend der brei-
te Peak schließlich kleiner wird und verschwindet.
Um die Beziehung zwischen Aggregaten und Kristallen zu quantifizieren, wird
die Fla¨che unter dem breiten Peak und die unter den Bragg-Peaks ausgewertet
und als Funktion der Zeit aufgetragen. Es ko¨nnen zwei interessante Eigenschaften
der Kristallisationskinetik beobachtet werden: Erstens fa¨llt das Maximum in der
Fla¨che unter dem breiten Peak mit einem lokalen Maximum der Kristallisations-
rate (erste Zeitableitung der Fla¨che unter den Bragg-Peaks) zusammen. Dies ist
charakteristisch fu¨r einen zweischrittigen Prozess, bei dem die Keimbildung aus
einer Zwischenphase stattfindet und daher proportional zur Menge des Proteins
in der Zwischenphase ist. Zweitens tritt, wenn der Großteil der Zwischenphase
konsumiert wurde, eine starke Zunahme der Bragg-Peak-Fla¨che auf. Wir inter-
pretieren dies als Wachstum der Kristalle in Kontakt mit der Lo¨sung, in der zwar
die Keimbildung weniger wahrscheinlich, aber das Wachstum der Kristalle durch
die schnellere Diffusion, verglichen mit der in den Aggregaten, begu¨nstigt sein
ko¨nnte.
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Wir verwenden Ratengleichungen basierend auf Prozessen mit klarer physikali-
scher Bedeutung: Zuna¨chst bildet sich die Zwischenphase (Aggregate mit noch
nicht kristalliner Struktur), bis diese eine stabile Konzentration erreicht. Dann
bilden sich Kristalle in der Zwischenphase und wachsen dort langsam. Sobald das
Volumen der Zwischenphase pro Kristall durch Keimbildung und Wachstum der
Kristalle unter einen bestimmten Wert fa¨llt, kommen die Kristalle in Kontakt mit
der Lo¨sung. Im letzten Schritt wachsen sie so, bis die freien Proteinmoleku¨le aufge-
braucht sind. Ein Modell basierend auf diesen Annahmen kann die experimentell
beobachteten kinetischen Merkmale mit guter U¨bereinstimmung reproduzieren.
Unsere Ergebnisse weisen daher auf eine entscheidende Rolle der Aggregate bei
der Keimbildung sowie einen zweischrittigen Prozess hin. Außerdem demonstrie-
ren sie eine nicht-invasive Methode fu¨r Echtzeitbeobachtungen der Kinetik von
nicht-klassischen Wachstumsprozessen.
0.2.3 Publikation C: Zur Frage der zweischrittigen
Keimbildung in der Proteinkristallisation
Aufbauend auf Publikation B soll in Publikation C die metastabile Zwischenphase
im System BLG mit CdCl2 und ihr Einfluss auf die Keimbildung und das Wachs-
tum von Kristallen im oben beschriebenen zweischrittigen Prozess weiter unter-
sucht werden. Wa¨hrend die Kleinwinkelstreukurven an anderen Punkten des
Phasendiagramms im Bereich von Pseudo-c** sowie die zugeho¨rigen Analysen den
Befunden aus Publikation B stark a¨hneln, zeigt sich eine deutliche Abha¨ngigkeit
von der Salzkonzentration.
Serien von Proben nahe der oberen Grenze mit nur schwach variierter CdCl2
Konzentration (33 mg/mL BLG mit 17, 18, 19 und 20 mM) zeigen klar, dass
mit abnehmender Salzkonzentration gro¨ßere aggregierte Bereiche gefunden werden
und mehr Kristalle wachsen. Wa¨hrend die Keimbildungsrate anwa¨chst, nimmt die
Dauer der Wachstumsphase ab und die Kristalle werden, aufgrund der kleineren
Menge an Protein pro Kristall, nicht so groß wie bei ho¨heren Salzkonzentrationen.
Unterhalb von 17 mM befinden sich Probenbedingungen tief im zweiten Regime,
wo sich, aufgrund der starken Attraktion, massive Aggregate bilden und aus der
Lo¨sung ausfallen. Oberhalb von 20 mM CdCl2 sind die Lo¨sungen klarer und nur
kleine Aggregate werden beobachtet. Diese Proben kristallisieren nicht oder nur
sehr selten. Die Treibkraft fu¨r Kristallisation nimmt also beim U¨berqueren von
Pseudo-c** ab.
Wenn wir SAXS-Kurven aus unterschiedlichen Regimen vergleichen wird deut-
lich, dass die Streuung im ersten Regime vom Formfaktor von BLG (Dimer) do-
miniert wird. Im zweiten Regime kommt ein Anstieg bei kleinen q-Werten, also
großen Distanzen hinzu, der die Bildung von Aggregaten anzeigt. Im dritten
Regime und im Bereich von Pseudo-c** tritt der schon in Publikation B als Struk-
tursignatur des Kristallisationsvorla¨ufers beschriebene breite Peak auf. Die aus
Publikation B bekannte Analyse der SAXS-Daten wird in Publikation C erfolg-
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reich unter anderen Kristallisationsbedingungen durchgefu¨hrt. Wieder zeigen sich
der fu¨r einen Zweischrittprozess charakteristische Zusammenhang zwischen dem
Maximum in der Fla¨che unter dem breiten Peak und dem lokalen Maximum in
der Kristallisationsrate, sowie das Plateau in der Fla¨che unter den Bragg-Peaks
als Funktion der Zeit. Da, wie bereits mit Lichtmikroskopie beobachtet, bei hohen
Salzkonzentrationen nur wenige Kristalle wachsen, sind fu¨r die Zukunft Echtzeit-
SANS-Messungen (gro¨ßere Strahlbreite) geplant.
0.2.4 Publikation D: Zur Frage der Entwicklung
metastabiler Proteinaggregate
Thema dieser Publikation ist die strukturelle Entwicklung von BLG-Aggregaten in
Gegenwart von YCl3. Es wurden Proben ausgewa¨hlt, in denen zuvor die in Pub-
likation A beschriebenen nichtklassischen Kristallisationsprozesse beobachtet wur-
den. Um die Proben detaillierter beschreiben zu ko¨nnen, wurden diese bei Tem-
peraturen oberhalb der U¨bergangstemperatur Ttr pra¨pariert. Mittels einer Kom-
bination aus SAXS, SANS und VSANS (Neutronenstreuung bei noch kleineren
Winkeln, “very small angle neutron scattering”) konnte die Struktur auf unter-
schiedlichen La¨ngenskalen beschrieben werden, angefangen mit der Monomer–
Monomer-Korrelation innerhalb gro¨ßerer Partikel, u¨ber das BLG-Dimer und die
Korrelation zwischen Proteinclustern bis hin zur ra¨umlichen Anordnung der Clus-
ter.
Werden die Proben unter Ttr geku¨hlt, bleibt die hierarchische Struktur im
Wesentlichen erhalten. Es kommt jedoch zu einer Vera¨nderung der inneren Struk-
tur der Aggregate. So bildet sich die Monomer–Monomer-Korrelation vollsta¨ndig
zuru¨ck und die Cluster–Cluster-Korrelation wird sta¨rker. Zudem weisen die Streu-
daten klar Punkte auf, an denen sich die Intensita¨t der gestreuten Strahlung
mit der Zeit nicht a¨ndert. Diese isosbestischen Punkte weisen auf einen Prozess
mit zwei Zusta¨nden hin, die ein Gleichgewicht anstreben. Auf dieser Annahme
beruhende Fits reproduzieren die Streudaten sehr gut. Wir schließen daraus, dass
sich eine Zwischenphase ausbildet und dabei die zuvor vorhandenen, kleineren
Proteincluster aufbraucht.
Diese Erkenntnisse ko¨nnten sich in der Zukunft als hilfreich fu¨r das Versta¨ndnis
nichtklassischer Proteinkristallisation erweisen.
0.2.5 U¨bertragbarkeit der Kristallisationsmethode auf
andere Systeme
Die Kristallisation des Proteins Beta-Lactoglobulin in den vorgestellten Publika-
tionen beruht auf Nutzung des Pha¨nomens der “reentrant condensation”. In
den darin beschriebenen Experimenten sowie in vorangegangenen Studien [221,227]
wurde beobachtet und sich zu Nutze gemacht dass, durch die dort herrschende ide-
ale schwache Attraktion, nahe der Grenzen c* und c** (oder Pseudo-c** im Fall
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der zweiwertigen Salze CdCl2 und ZnCl2) und im Fall von HSA auch nach einer
flu¨ssig–flu¨ssig Phasenauftrennung [223] ideale Bedingungen fu¨r Proteinkristallisa-
tion zu finden sind.
Nun wurden eine Reihe anderer Protein–Salzsysteme auf den Einfluss von Ka-
tion und Anion auf RC, Ladungsumkehr und RC-induzierte Kristallisation getestet.
Eine untere Grenze c* wurde in allen untersuchten Systemen gefunden, eine obere
nur in einem Teil. Die Variation des Kations hat, trotz deutlicher Unterschiede in
der Ladungsdichte, nur geringe Auswirkungen. Bei Variation des Anions konnte
festgestellt werden, dass zwei der getesteten Proteine nur mit Chloridsalzen eine
obere Grenze aufweisen. Der Einfluss des Salzes ist jedoch noch nicht komplett
verstanden.
Eine der Hauptanwendungen von RC ist die Kristallisation von Proteinen durch
Anpassung der effektiven Wechselwirkungen zwischen den Proteinen. Tatsa¨chlich
konnten einige der getesteten Systeme erfolgreich kristallisiert werden, wenn auch
nicht alle. Aufbauend auf den Erfahrungen mit BLG wurden — erfolgreich vor
allem in Systemen mit HSA oder BLG — Proben fu¨r die Kristallisation gezielt
nahe der Konzentrationsgrenzen pra¨pariert.
Ein interessanter Ansatz fu¨r die weitere Entwicklung des Projektes ist die gezielte
gentechnische Modifikation von Proteinoberfla¨chen hin zu mehr negativ gelade-
nen Aminosa¨uren, um Kristalle ho¨herer Qualita¨t mit der Metallsalz-Methode zu
gewinnen.
0.3 Schlussfolgerungen und Ausblick
Im Folgenden werden die zentralen Ergebnisse dieser Arbeit zusammengefasst.
Sta¨rke und Vorzeichen der Wechselwirkungen zwischen negativ geladenen, globula¨-
ren Proteinen ko¨nnen durch RC angepasst werden. Die schwache Attraktion an
den Grenzen c* und (Pseudo-)c** bieten ideale Bedingungen fu¨r die Kristallisation
der Proteine, wie fru¨here Experimente zeigten und wie es auch in den in dieser
Arbeit betrachteten Systemen besta¨tigt werden konnte.
Die Ro¨ntgenstrukturanalyse an in Gegenwart von ZnCl2 und YCl3 gezu¨chteten
BLG-Kristallen haben eine hohe Auflo¨sung und wurden in der Proteinstrukturen-
Datenbank PDB hinterlegt. Die Metallionen sind ein integraler Bestandteil des
Kristallgitters und beide Kationen bilden durch Ionenbru¨cken neue Kontakte zwi-
schen Proteinen.
Wa¨hrend bei der Kristallisation nahe der ersten Grenze c* bislang keine Anzei-
chen fu¨r einen nichtklassischen Prozess beobachtet wurden, treten nahe der oberen
Grenze (Pseudo-)c** zusa¨tzliche Phasen vor der Kristallisation auf. Abha¨ngig von
der Temperatur wurden eine dichte flu¨ssige Phase oder Aggregate beobachtet.
Mo¨glich sind sowohl ein zweischrittiger Keimbildungsprozess, als auch die pa-
rallele Bildung von Kristallen und Aggregaten bzw. dichter flu¨ssiger Phase. Da
uns diese Unterscheidung nicht fu¨r alle Systeme mo¨glich war, bezeichnen wir
alle Kristallisationsprozesse, bei denen weitere Phasen außer der urspru¨nglichen
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Lo¨sung und dem Kristall als Endzustand auftreten, als “nonclassical” und tatsa¨ch-
liche Zwei- oder Mehrschrittprozesse in der Kristallkeimbildung als “two- / multi-
step nucleation”.
BLG in der Gegenwart von YCl3 wurde weiter unter Variation der Temperatur
untersucht. SAXS, SANS und VSANS Messungen an Proben ober- und unterhalb
der U¨bergangstemperatur zeigen Strukturen auf unterschiedlichen La¨ngenskalen
und ihre temperaturabha¨ngigen Vera¨nderungen. Eine Zweiphasen-Analyse repro-
duziert die Daten sehr gut.
Im System BLG+CdCl2 gelang es u¨ber Beobachtung der Kristallisationskinetik
mittels Echtzeit-SAXS, klare Hinweise auf einen Mehrschrittprozess zu finden.
Aufgrund der experimentellen Beobachtungen schlagen wir den folgenden Ablauf
vor: In den Aggregaten, die direkt nach der Probenpra¨paration entstehen, formt
sich eine noch nicht kristalline Vorla¨uferstruktur, aus der sich anschließend Kristalle
bilden. Diese wachsen zuna¨chst eher langsam. Erst, wenn genug Aggregatphase
durch Keimbildung und Wachstum der Kristalle aufgebraucht ist, kommen die
Kristalle in Kontakt mit der umgebenden, weniger dichten Lo¨sung. Wa¨hrend die
Keimbildung in dieser deutlich unwahrscheinlicher ist als in der dichten Aggregat-
phase, ist das Wachstum der Kristalle hier aufgrund der ungehinderten Diffusion
schneller. Ein auf diesen Annahmen aufbauendes Ratengleichungsmodell repro-
duziert die beobachtete Kinetik gut.
Weitere Experimente am System BLG+CdCl2 zeigen, dass mit steigender Salz-
konzentration im Bereich von Pseudo-c** sowohl die Menge an Aggregat, als auch
die Anzahl der beobachteten Kristalle abnimmt (die dann, aufgrund der gro¨ßeren
verfu¨gbaren Menge an Protein pro Kristall, gro¨ßer werden ko¨nnen).
Fu¨r die Zukunft sind SANS-Messungen in Echtzeit geplant, da hierbei kein
Strahlschaden auftritt und durch die ho¨here Strahlgro¨ße an mehr Kristallen ge-
messen werden kann. Ebenso ist geplant, vergleichbare Messungen und Analysen
fu¨r andere Protein-Salz-Systeme durchzufu¨hren, etwa an HSA in Gegenwart ver-
schiedener Salze.
Die Methode, Proteine mittels Metallsalzen zur Kristallisation zu bringen, ist
ein vielversprechender Ansatz fu¨r weitere Systeme. Durch gezielte Modifika-
tion der Oberfla¨chengruppen von Proteinen ko¨nnten besser streuende Kristalle
gezu¨chtet werden.
Abstract
Proteins and their interactions with each other are of interest for fundamental
research as well as numerous applications in biology, biochemistry or medical and
pharmaceutic industry. In recent years, research in our group has shown that
trivalent metal salts can cause a rich phase behavior in aqueous protein solutions,
including reentrant condensation, metastable liquid–liquid phase separation and
crystallization. The topic of this thesis is on the one hand the influence of control
parameters in these systems on protein aggregation and especially crystallization.
On the other hand, we focus on the discrimination between classical and non-
classical pathways of crystal nucleation and growth. We study mainly the model
protein β-lactoglobulin (BLG) in the presence of the divalent salts zinc chloride
and cadmium chloride and the trivalent yttrium chloride.
It has been observed that trivalent salts can cause a reentrant condensation in
protein solutions: below a certain salt concentration c* and above a second one,
c**, samples are clear, indicating stable solutions. At intermediate salt concentra-
tions, samples become turbid due to aggregation. The divalent salts CdCl2 and
ZnCl2 cause a first boundary in BLG solutions and a partial re-clearing at a salt
concentration we denote as pseudo-c**. Using SAXS, we show that the effective
interactions become less repulsive approaching c* and finally attractive. Although
the attractive interaction becomes weaker when pseudo-c** is crossed, repulsion is
not reached again. The weak attraction close to the boundaries provides optimal
conditions for crystallization. Depending on salt concentration and temperature,
different pathways are found. We discuss possible scenarios based on the phase
behavior of colloidal systems with short-range attractions. Structure determina-
tion by X-ray diffraction shows that the cations are an integral part of the lattice
and mediate new contacts by the formation of ion bridges.
While it was not possible to distinguish if the observed intermediate phases
are a direct precursor for crystals or merely act as an agent for heterogeneous,
classical nucleation in the system with ZnCl2, real-time SAXS measurements of
BLG in the presence of CdCl2 provide evidence for a multistep process around
pseudo-c**: in the SAXS data, a broad peak forms first, indicating an intermedi-
ate structure, followed by Bragg peaks. To quantify the relationship between the
crystals and their possible precursor, the area under the Bragg peaks and under
the additional broad peak were evaluated and plotted as a function of time. It
can be observed that the maximum amount of the intermediate coincides with the
steepest increase of the crystalline state. We propose a first step in which a non-
crystalline, ordered structure is formed within metastable aggregates, followed by
crystal nucleation in this precursor phase. Our observations further suggest that
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the number of crystals increases strongly in the beginning, but their growth speed
is low inside the aggregates that have a high viscosity which hinders the diffusion
of protein molecules. After enough aggregate material has been consumed by crys-
tal nucleation and growth, the crystals are in contact with the dilute solution and
grow faster. The number of crystals, however, stays almost constant in this stage.
Based on these assumptions, a rate equation model was applied which reproduces
the experimentally observed kinetics well. Increasing the salt concentration in the
vicinity of pseudo-c** leads to a reduction of aggregates and to fewer crystals that
grow larger due the larger amount of available proteins per crystal.
The nonclassical crystallization pathway described above suggests that the struc-
ture of the intermediate phase may be crucial for the subsequent crystal nucleation.
We thus performed a study on the structure of potential precursor phases in the
system of BLG in the presence of YCl3 on different length scales by a combination
of SAXS, SANS and VSANS. The monomer–monomer correlation within larger
compounds, the scattering of dimers as well as the correlation between clusters
and their spacial arrangement can be identified. When the system is cooled below
a certain transition temperature, changes in the internal structure of the inter-
mediate phase can be observed. Moreover, time-dependent SAXS measurements
show clear isosbestic points, allowing to describe the kinetics of the structural
evolution of the intermediate phase by a two-state model.
Experiments on other protein–salt systems suggest that our work can be, to
some extent, generalized. For some of the systems, structure determination by X-
ray diffraction has been performed successfully. In all cases, crystal contacts are
mediated by ion bridging. Tuning the protein–protein interactions by the addition
of multivalent metal salts provides a method for the growth of potentially high-
quality crystals.
Part I
Fundamentals

Chapter 1
Introduction
Interactions between proteins in aqueous solution are a fundamental process in
all living beings. They are influenced by a variety of control parameters such as
salt concentration, temperature and pH of the environment. The understanding
and control of protein interactions and the resulting phase behavior has a large
impact on applied science.
The topic of this thesis is tuning interactions in protein solutions by varying the
salt concentration, salt type and temperature towards the desired phase behavior
and especially crystallization. Crystallization itself is further investigated in order
to determine the pathways it follows.
This introduction starts with a motivation of this work and an insight into the
basic principles of phase transitions (Preliminary remarks, Section 1.1). Subse-
quently, the basics of crystallization (Section 1.2) and ion-induced interactions in
protein systems (Section 1.3) will be introduced. In the end, an outline of the
subsequent parts of this thesis is given.
1.1 Preliminary Remarks
1.1.1 Motivation
Aggregation or crystallization of proteins is of interest due to many reasons. The
undesired aggregation of proteins in the body plays an important role in many
diseases. Examples include sickle cell anemia that is caused by sickle hemoglobin
molecules forming polymer fibers within the red blood cells or age-related cataract
caused by the aggregation of the protein γ-crystallin in the vitreous fluid of
the eye [70]. Several neurodegenerative diseases such as Alzheimer’s Dementia,
Creutzfeldt-Jakob disease, Parkinson’s disease, amyotrophic lateral sclerosis and
Huntington’s disease are due to the irreversible formation of protein aggregates,
usually fibrils containing misfolded protein [3,121,155]. It has been shown that salts
can modulate the kinetics of fibril formation and that both ionic strength and
nature of the anion play a role [84].
Since the first half of the 20th century, protein crystallization was applied for
purification of proteins. Examples are various serum albumins, several enzymes
and many more [62]. In time, the importance of salts, solvents, pH and tempera-
ture were noted and the Hofmeister effects were applied to tune interactions and
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optimize conditions for protein crystallization. The importance of metal ions for
protein crystallization was discovered (in particular for the crystallization of in-
sulin where Zn2+ has proven to be crucial) [2,62]. Furthermore, over 90% of all
pharmaceutical products contain bioactive drugs in a crystalline state, mainly
for reasons of stability [47]. The continuing release of drugs, for example insulin,
provided by the slow dissolution of crystals in the body is beneficial, too [70,204].
The main application of protein crystals, however, is found in structural biology.
The three-dimensional structure of proteins is closely linked to their biochemical
function [127]. Therefore, the precise visualization of protein structures is essential
for the understanding of fundamental physiological processes but also for ratio-
nal drug design [124,127]. Especially in the era of the human genome project, the
sequencing of the human genome has offered enormous opportunities for the un-
derstanding of human diseases that are due to abnormal functioning of cells and
the development of drug therapies [40]. To solve the protein structures correspond-
ing to all coding DNA regions is therefore a desired yet challenging task [29].
Although information on protein structure can be gained by nuclear magnetic
resonance (NMR), mass spectroscopy and microcalorimetry, the universal and
most successful tool for structure determination still is X-ray diffraction. The
second most used method, NMR, is restricted to small macromolecules below
70 kDa [127]. Requirements for X-ray diffraction studies include relatively large
and highly perfect single crystals. However, growing such high quality crystals
from freshly expressed proteins is no easy task, remaining the major bottleneck in
protein structure determination [127]. Despite the important fields of application,
protein crystallization is often performed by trial and error approaches [127]. Nu-
merous interactions (partially anisotropic due to the inhomogeneous charge pat-
tern and irregular shape) of proteins with each other and with their environment
such as hydrogen bonds, electrostatic interactions, or van der Waals interactions
play a decisive role in protein crystallization [43,127], making it difficult to describe
this process by easy models. Attention should also be paid to the fact that for
most proteins, a low crystallization propensity increases the evolutionary fitness
of the organism. Although there are examples of protein crystallization featur-
ing survival benefits, this is rather exceptional and crystallization in vivo usually
compromises the viability of the cell [41,42]. Thus, in the process of evolution, most
proteins became hard to crystallize at least at physiological conditions [41].
Recent work has shown that we can tune protein interactions in solution induc-
ing a so-called reentrant-condensation and related phase behavior such as liquid–
liquid phase separation (LLPS) or crystallization by the addition of multivalent
salts [86,151,157,220,222,223,226,227]. This method is further pursued in order to optimize
the conditions for crystallization and especially to characterize and distinguish dif-
ferent mechanisms of nucleation and crystal growth. These are still not completely
understood and multiple pathways are currently discussed in the community. The
work in this thesis provides a deeper understanding of these processes in the in-
vestigated model systems.
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1.1.2 Remarks on Phase Transitions
In the following, a few thermodynamic principles of the topics of this thesis will
be discussed. The Helmholtz free energy F is useful for the calculation of thermo-
dynamic properties in systems with fixed temperature, number of particles, and
volume. If the pressure instead of the volume is held constant, the enthalpy H is
used (and minimized in an equilibrium state of a system with pressure reservoir).
The most commonly used free energy for the description of systems of globular
proteins, however, is the Gibbs free energy or free enthalpy G for processes at
constant temperature T and pressure P , where
G = U − TS + PV = H − TS (1.1)
with the volume V , the entropy S, and the internal energy U [70].
Thermodynamic stability is an important concept predicting how a system will
react to perturbation. A system is referred to as “stable” if the energy is at its
global minimum and the system will remain in its current state. A “metastable”
system translates to a local minimum. To reach the most stable state, an energy
barrier has to be overcome. If the system is in an unstable state, the slightest
fluctuation of a thermodynamic variable is sufficient to change into another, more
stable state [149].
A phase is characterized by certain properties of a material, for example its state
of matter, ferromagnetism or superconductivity [139]. If a phase becomes unstable
in the given thermodynamic conditions, a phase transition takes place [139]. In
order to be in equilibrium, temperature, pressure, and chemical potential of these
two phases have to be the same [70]. A distinction is drawn between first-order
and second-order phase transitions. In first-order transitions, thermodynamic
potentials such as G are continuous but their first derivatives, e.g.
S = −
(
∂G
∂T
)
P
V =
(
∂G
∂P
)
T
H =
(
∂(G/T )
∂(1/T )
)
(1.2)
show discontinuities and latent heat is associated to them. In second-order tran-
sitions, the potentials and their first-order derivatives are continuous while some
second-order derivatives approach infinity or are reduced to zero. This classifica-
tion can be extended to higher-order phase transitions [139]. Two- and higher order
phase transitions are not associated to latent heat and, in contrast to first-order
transitions, are accompanied by a change in symmetry (the liquid/gas critical
point is an exception).
The van der Waals equation of state provides a simple picture of the gas–liquid
transition [37]. It is shown in Equation 1.3 with the number of particles N , the
Boltzmann constant kB and the constants a and b. a takes into account the
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attractive interactions and b the excluded volume of the particles.(
P +
N2a
V 2
)
(V −Nb) = NkBT (1.3)
Introducing the molar volume V˜ and the molar quantities a˜, b˜
V˜ =
NAV
N
a˜ = N2Aa b˜ = NAb, (1.4)
the van der Waals equation can also be written as the following expression for
the pressure:
P =
NAkBT
V˜ − b˜ −
a˜
V˜ 2
. (1.5)
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Figure 1.1: Van der Waals isotherms at different temperatures (P as a function
of V˜ ) and Maxwell construction. Image adapted from Ref. [37] and modified.
Below a critical temperature (Tc), an isotherm P (V˜ ) of a van der Waals system
has a local minimum and a local maximum as shown in the curve marked as T1
in Figure 1.1. At molar volumes V˜ < V˜ L, the system is in its liquid state, at
V˜ > V˜ V , it is in the vapor state. Due to the rule of stability, (δP/δV˜ )T has to
be negative. Thus, the region marked as unstable in Figure 1.1 is not realized
in physical systems and the system rather splits into two phases. In reality, the
pressure remains constant between V˜ L and V˜ V , denoted as Pb, according to the
principle of equal areas (Maxwell construction) [33,37]: since the variation of the
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chemical potential µ along an isotherm is given by
dµ = V˜ dP (1.6)
and Pα = P β, µα = µβ for two phases α, β at the equilibrium,∫ V˜ β
V˜ α
V˜ dP = µβ − µα = 0 [37]. (1.7)
The construction shown in Figure 1.1 satisfies Eq. 1.7 as well as Pb(T1) = P
V (T1) =
PL(T1) with P
V the pressure of the vapor and PL the pressure of the liquid
phase [37].
The regions marked as metastable in Figure 1.1 represent a supersaturated vapor
and an overexpanded liquid. They can be reached under special conditions, not
violating the rule of stability, but convert to the two-state system if a sufficient
disturbance occurs [98]. The outer line (red in Figure 1.1) is called coexistence
line or binodal, the inner line (green, dashed) is called spinodal [139]. If the latter
is crossed, the system becomes unstable and immediately phase-separates. In
the metastable region between spinodal and binodal, an energy barrier has to be
overcome in order to achieve phase separation [85].
The critical isotherm T4 = Tc has a point of inflection at V˜c and no extrema. At
this critical point, the two phases become identical [10]. Above Tc, the isotherms
are monotonically decreasing functions such as T5 and T6. Only one fluid phase
exists at a given pressure for these temperatures [37].
These thermodynamic principles are also applicable to solutions, where the
multi-component analog of the gas–liquid transition can be observed: a dilute–
concentrated transition, also called LLPS or oiling out [10,102,142,171]. Particles in
solution can — at small concentrations where they do not interact much — be
understood in analogy to the gas. In both scenarios, a new phase in which the
molecules are present at much higher concentration forms. This concentration is
usually only slightly below that in a crystal [171]. In phase diagrams for protein
solutions, usually the volume fraction Φ is plotted as one of the variables.
In a regular binary solution with two components A and B at concentrations
cA and cB and G
0
A and G
0
B being the Gibbs free energies of the pure substances,
the Gibbs free energy of the solution is
G = cAG
0
A + cBG
0
B + ucAcB +RT [cAln(cA) + cBln(cB)] (1.8)
where R is the ideal gas constant [139]. The third term represents the energy of
interaction of particles A with particles B (with internal energy per unit mass or
volume u), the last term the entropy contribution of mixing. Assuming
x = cA cA + cB = 1 ⇒ cB = 1− x, (1.9)
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the metastability limit δ2G = 0 can be written as
−2ux(1− x) +RT = 0 (1.10)
which gives the spinodal curve shown in Figure 1.2 as dashed line [139]. Above the
critical point at x = 0.5 and Tc = u/RT , A and B are in a homogeneous solution
at all mixing ratios. Inside the spinodal, they separate. Using that the chemical
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Figure 1.2: Binodal and spinodal for a regular solution. The solution is
metastable between both curves and becomes unstable inside the spinodal.
Adapted from Ref. [139] and modified.
potential of a constituent is the same in the mixed and the separated system, the
coexistence curve (binodal) can be found [139]:
1− x
x
= exp
[
(1− 2x)u
RT
]
. (1.11)
Between binodal and spinodal, the system is metastable. Put into a metastable
two-phase state, e.g. due to a temperature change, a second phase nucleates within
a formerly single-phase system, being energetically favorable [147]. Solutions in this
region will phase separate via formation and growth of droplets after a sufficient
fluctuation [139].
Depending on the range of interaction, very different types of T (Φ) phase dia-
grams can be obtained. Colloidal systems are useful models here as presented by
Anderson and Lekkerkerker [7]. For a purely hard sphere system, a phase diagram
as shown in Figure 1.3a is found. A fluid (F) and a crystalline (C) phase are
found with a volume fraction range of coexistence (F+C). Introducing long-range
attractions (e.g. model for argon), the phase diagram dramatically changes as
shown in Figure 1.3b and a third phase, liquid (L) appears. If the attractions are
short-ranged such as in a typical protein solution, the (L+L) transition becomes
metastable, see Figure 1.3c. A similar phase diagram is found for short polymers [7].
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Figure 1.3: Phase diagrams for a) hard spheres. b) hard spheres with long-
range attractions. c) a “protein” system where the attraction is short-ranged.
The liquid–liquid transition becomes metastable. Reproduced from Ref. [7].
1.2 Nucleation and Crystal Growth
Before nonclassical crystallization processes can be discussed, this section intro-
duces “classical” crystallization itself. In the end, the peculiarities of protein
crystallization are discussed and open questions specified.
Crystallization starts from dissolved atoms, molecules or ions, its thermody-
namic driving force being the supersaturation of the solution [34]. The relative
supersaturation s is defined as
s =
c
ksp
(1.12)
with c the concentration of the species and ksp the equilibrium molecular solubility
product [34].
Since the magnitude of supersaturation, however, is not the only driving force
in the control of crystallization, it can only be a first thermodynamic approach to
the complex problem of crystallization [34]. Supersaturation can be translated into
attraction of molecules or ions leading to a non-statistical distribution of these
building blocks [34]. The relative supersaturation is connected to the change in
chemical potential ∆µ and therefore to the free enthalpy of the crystallization
process:
∆µ = −kBT · ln(s) (1.13)
Supersaturation can be achieved in different ways, for example by reactions gen-
erating the respective soluble, by a temperature or pressure jump or by changing
the pH [34].
Once the solution is supersaturated (i.e. s > 1), crystals can grow, but need a
so-called nucleus as starting point [34]: the minimum amount of the new phase that
can exist independently [47]. Nucleation is the local generation of a distinct, more
stable thermodynamic phase — in the case of crystal nucleation solid — from
a metastable one [202]. A distinction is drawn between homogeneous nucleation,
where the nucleus is formed from solution as soon as a critical supersaturation
is given and heterogeneous nucleation, where surfaces or contaminants like dust
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particles or crystal seeds act as starting point [34]. Heterogeneous nucleation is
favored if the interface energy of the crystal being in contact with the substrate
is lower than the interface energy of the crystal being in contact with the free
solution, which is the case especially for impurities very similar to the crystal
that can be used for crystal seeding [34]. Already a single foreign particle down
to molecular size could act as an agent for heterogeneous nucleation and even in
very pure solutions, heterogeneous nucleation occurs along surfaces such as the
container wall [34,43]. This circumstance makes it difficult to prove that nucleation
is ever completely homogeneous. Prior filtration often significantly reduces the
number of crystals [43]. A special case of heterogeneous nucleation can be observed
on surfaces with matching lattice where nucleation is especially fast. A mani-
fest example is the formation of a new layer on a growing crystal [171]. Although
heterogeneous nucleation is the normal case, most of the knowledge about mi-
croscopic dynamics of nucleation has been derived from simulation which usually
models homogeneous nucleation of very simple systems such as noble gases [171].
In colloidal systems, the particles can also be monitored directly.
Crystallization often is perceived as counter-intuitive in terms of entropy. As
stated before, T and P are usually held constant in protein crystallization exper-
iments and thus the thermodynamic potential that is minimized is the Gibbs free
energy. The equation for describing the Gibbs free energy change of a crystalliza-
tion process is
∆G = ∆H − T∆Sprotein − T∆SSolvent. (1.14)
∆Sprotein describes the (usually negative) change in entropy caused by the attach-
ment of protein molecules to the crystal. On the one hand, there is a loss of
entropy due to constrained rotational and translational degrees of freedom [70]. On
the other hand, there is a gain in vibrational entropy associated to new bonds at
molecular contacts [70]. ∆SSolvent describes the entropy change caused by the water
shells formed around proteins due to protein–water interactions. When the crystal
is formed, these water structures have to reorder. This term can be either posi-
tive or negative but ∆G has to be negative in order to enable crystallization [70].
Vekilov et al. showed that this trapping and release of water is a major factor
in protein crystallization, using three example systems [205]: human hemoglobin
C has a high positive enthalpy. Crystallization is only possible due to a large
entropy gain originating from the release of water. Apoferritin has a crystalliza-
tion enthalpy close to zero and the main driving force for crystallization is the
entropy gain due to the release of water, too. For lysozyme the entropic effect
is negative. Its crystallization is driven by the negative enthalpy. Even colloidal
systems of hard spheres can crystallize at high volume fractions, purely driven by
the increase in entropy due to the larger accessible volume for local movements in
the lattice [55].
In the following, classical and nonclassical pathways of crystal nucleation will
be discussed.
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1.2.1 Classical Nucleation Theory
The classical nucleation theory (CNT) is the most common formalism to ana-
lyze nucleation phenomena [34]. Its main concepts on the generation of nuclei of
a new phase were derived by Gibbs [60,61] (who considered the condensation of
vapor to liquid) and later refined by Volmer and Weber [210] (1926) and Becker
and Do¨ring [18] (1935) [56,197,202]. Ignoring lattices and therefore also defects, it is
essentially a theory for the nucleation of fluid phases [171].
In general, large aggregates of a new phase tend to grow further while small
ones tend to dissociate. This can be explained by their surface to volume ratio:
there are not enough intermolecular bonds in small aggregates to compensate for
the decrease in entropy associated with growth. For a spherical cluster with radius
r, this is included by a surface term proportional to r2, taking into account the
free energy cost of creating a vapor–liquid / solid–liquid interface [11]. In large
aggregates, however, a volume term proportional to r3 dominates. Thus, a free
energy barrier has to be overcome that is formed by the usually positive surface
term that hinders the formation of a new phase and the volume term driving the
reaction that includes the (negative) chemical potential difference between initial
and final state [34,43]. The barrier height is given by the change in Gibbs free energy
∆G (Equation 1.15, Figure 1.4), where ρ is the density of the bulk liquid and γ
the (vapor–liquid / solid–liquid) interfacial free energy density [11].
∆G =
4pir3ρ∆µ
3
+ 4pir2γ (1.15)
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Figure 1.4: The nucleation barrier in ∆G(r) is generated by a positive surface
term ∝ r2 and a negative volume term ∝ r3. At the critical cluster size r*, both
terms balance each other. For r > r*, further growth is favored. Image adapted
from Ref. [34] and modified.
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The maximum of ∆G(r) corresponds to the so-called critical cluster size. From
this radius r* on, the energy gain for the phase transition is larger than the loss
in surface energy for further growth of the so-called critical crystal nucleus [34,47].
Critical cluster sizes for water were found to consist of 20-35 molecules, depending
on the temperature, and of 24-36 for pentanol [34]. Critical nucleus sizes for proteins
were reported to range between five and 50 monomers [43]. However, these sizes of
the critical crystal nucleus also depend on the shape and structure of the nucleus
and in the CNT, a spherical solid cluster is always assumed [34].
The classical homogeneous nucleation rate J is given by [34]
J = K · exp
(−∆G
kBT
)
. (1.16)
K is a kinetic prefactor. It has been modified over the years — after it was found
to be inconsistent — but real nucleation rates still differ from the predicted ones by
orders of magnitude and especially show a systematic dependence on temperature,
indicating that the real crystallization scenario is more complicated. This can be
corrected by empirical functional factors but a physical explanation is missing [34].
CNT has six assumptions (and for each of them situations can be found where
they are not fulfilled). It assumes that nucleation is a one-step process (1). The
nucleus is assumed to grow one monomer at a time (2) and the nucleation rate does
not depend on the (for example thermal) history of the sample (3). Nucleation
occurs at a saddle point, i.e. a minimum in (Gibbs) free energy and a maximum
in other thermodynamic potentials (4) and the only source of slow kinetics is the
nucleation barrier (5). Finally, the crystal lattice is neglected (6) [171].
Although CNT is still a useful model for the crystal nucleation of simple liquids
or many ionic crystals, e.g. the crystallization of sodium chloride from the melt,
it often comes to its limits in more complex systems [171]. This will be discussed
in the following section.
1.2.2 Nonclassical Crystallization Processes in General
The term “nonclassical crystallization” covers numerous phenomena that deviate
from the classical nucleation view in one way or another: biominerals that show
single crystalline behavior in scattering experiments and have an unusual or com-
plex morphology are hard to explain in the classical picture of a single crystal
as a solid with a characteristic, rigid lattice with defined angles between certain
faces [34]. The same is true for mesocrystals (colloidal crystals built up from smaller
crystals) that usually scatter X-rays like a single crystal and can possess any outer
shape including curvatures [34]. Furthermore, CNT cannot predict the dependence
on temperature and the absolute values of critical supersaturations for various
substances such as water, alcohols or alkanes with high molecular weight. The
key source of these discrepancies is not entirely clear up to now [34].
Clusters often play an important role in crystallization and lead to nonclassical
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behavior in the sense that a nucleus does not grow particle by particle but by
coalescence of clusters of many particles [58]. A special case of nonclassical crys-
tallization involves a two-step (or multistep) mechanism of crystal nucleation, i.e.
an intermediate state, consisting of clusters, aggregates or a dense liquid phase,
forms first from the initial liquid phase. In a second step, this intermediate fur-
ther transforms into the final crystalline phase. Multiple intermediate states are
possible, too. The idea that the initial and final state are not the only ones goes
back to Ostwald’s step rule which was formulated in the end of the 19th cen-
tury [88,136]. It states that a system passes from one state to the one with the next
lowest free energy until it reaches the final state at the global minimum [106]. A
novel two-step mechanism of crystal nucleation was initially proposed for protein
systems and could be generalized for other molecules [62]. It has been proposed for
various systems such as Ca2+ salts and similarly weakly solvated species where
the formation of clusters and amorphous intermediates prior to crystallization can
be observed [34]. The lower the solubility of a species, the higher is the proba-
bility of finding amorphous precursor stages because a lower solubility increases
the apparent supersaturation, but also stabilizes amorphous nanoparticles against
redissolution [34]. Depending on the free energy landscape, a system can follow a
one-step route to the final crystal or a sequential process of structural and compo-
sitional changes. The intermediate phase closest to the initial phase in free energy
(usually the least dense one) is formed first and transforms step-wise to further
phases [34,171]. However, this is not always true since this transformation can be
altered by surface properties and impurities [171].
The precursor can also be a liquid phase. LLPS can be observed in protein
solutions and is also known to occur in systems of mineral salts such as CaCO3
[34].
Although the dense liquid phase accelerates crystallization in many systems, it
can also hinder it under certain circumstances: if the liquid is arrested (very slow
diffusion), then its formation can inhibit crystallization. If the “intermediate”
phase is too stable, then it persists and no crystals form [171]. On the other hand,
a not stable enough intermediate only forms transiently in microscopic amounts.
It has to persist long enough for crystals to nucleate in it.
A general problem for the understanding of experimental results from molecular
and ionic systems is that it is impossible to observe the nucleus directly [171]. Col-
loidal systems are, due to the large particle size and the slow dynamics, easier to
access. First indications for a two-step process in colloidal hard spheres were found
using time resolved laser light Bragg scattering [168]. Simulations by Kawasaki and
Tanaka [88] showed that a supercooled liquid may not be spatially homogeneous as
commonly expected, but has a medium-ranged structural order and this fluctu-
ating order can promote crystal nucleation. This might also be a reason for the
large discrepancy between estimations of the nucleation rate based on CNT and
experimental observations [88]. In 2014, Peng et al. and Tan et al. directly followed
the nucleation from the intermediate phase in a colloidal system by single-particle
resolution microscopy [141,190]. Figure 1.5 shows structures of crystal precursors
and nuclei in the early stage of crystallization. The precursors can be relatively
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ordered structures with different symmetries. The work provides details on the
structural aspects of two–step nucleation [67,190]. Although there are decisive dif-
Figure 1.5: Crystallization via a precursor stage. Blue dots represent liquid
particles, orange spheres relatively ordered precursor particles and brown spheres
nucleus particles. (a) Beginning of nucleation from precursors. (b) Subsequent
development of precursors around critical nuclei. (c) Subsequent development of
precursors around nuclei of post-critical sizes. Figure reproduced from Ref. [190].
ferences between protein and colloidal systems, these observations are important
and provide new insights for our understanding of crystallization processes.
Nonclassical crystallization processes have recently been discussed for protein
systems. This is the topic of the next section. In contrast to simple systems,
protein solutions cannot be sufficiently well described by easy theories. Protein–
protein interactions in a salt solution are the result of a subtle balance between
various forces such as Coulomb interactions, van der Waals forces, and affinity
of aqueous anions for hydrophobic patches on the protein surface [104,105]. The
existence of bonding patches implies that the proper spacial orientation of the
crystalline connection also has to be considered [127].
1.2.3 Experimental Studies of Nonclassical Protein
Crystallization
In recent years, several important experimental studies of nonclassical protein
crystallization have been performed. In 1994, George and Wilson found by exper-
imental observations that the second virial coefficient A2 plays an important role
for the crystallization of proteins [59]. Both repulsion and too strong attraction hin-
der the formation of crystals. The ideal conditions are given only within a narrow
window of A2 corresponding to weak attraction, the so-called crystallization slot.
Methods frequently used to determine these interactions are static and dynamic
light scattering (SLS, DLS), small angle X-ray scattering (SAXS) and small angle
neutron scattering (SANS) [21–24,59,128,206]. Protein interactions in solution can be
altered by the addition of ions. The strength of this influence depends on the
number and valency of the ions.
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The first prediction of a two-step pathway of protein crystallization by ten
Wolde [196] was followed by experimental observations. Galkin and Vekilov studied
the kinetics of the homogeneous nucleation of lysozyme and found that the nucle-
ation rate is beyond the predictions of the CNT. It has a maximum in the vicinity
of the LLPS boundary hidden below the solubility line in the phase diagram of
lysozyme solution [53,54]. In Gibbs’ original considerations, the initial and the final
phase only differ by one order parameter, namely density. In the nucleation of
crystals from solutions, however, they differ in at least two order parameters such
as density and structure [202]. In the modeled systems, these two parameters occur
simultaneously in off-critical compositions, similar to the classical setting. Close
to the critical point of LLPS, they fluctuate independently from each other [202].
A crystal nucleates if a structure fluctuation occurs in a (short lived and due to a
density fluctuation) region of locally higher density [202]. Other studies pointed out
that a maximum in crystal nucleation rate can be found close to the liquid–liquid
coexistence line, where the strongest density fluctuations occur [202].
This model suggests that the nucleation rate is higher in the protein-rich phase
after LLPS because of the higher protein concentration [196]. Moreover, the surface
energy at the interface between the dilute solution and the crystal is higher than
at the interface between dense liquid and crystal [222]. This could be confirmed
experimentally in some cases (e.g. for glucose isomerase [208] or hemoglobin [52]).
However, experimental observations also suggest that protein crystals in several
systems nucleate predominantly in the dilute phase or at the interface of both
phases, growing into the dilute phase [30,100,148]. The dense phase merely acts as a
protein reservoir in this case [100]. A possible explanation for this different mech-
anism could be that the stronger protein–protein interactions in the dense phase
could hinder the reorientation and adjustment of conformation of the proteins
towards a crystal [100].
As stated before, it is difficult to follow the nucleation process of proteins di-
rectly. Indirect experimental studies were performed applying quasi-elastic light
scattering, dynamic light scattering, X-ray and neutron scattering [70]. Extracting
the distribution of particle sizes from the scattering data can provide informa-
tion about the nucleation kinetics. However, it depends on various assumptions
concerning e.g. the particle shape [70]. It is also not clear if the observations only
involve homogeneous nucleation or heterogeneous nucleation as well [70].
1.2.4 Theoretical Understanding and Simulations of
Nonclassical Protein Crystallization
The topic of this section are theoretical studies and simulations of nonclassical pro-
tein crystallization processes. After George and Wilson described the crystalliza-
tion slot, Rosenbaum et al. established a link between their work and observations
that interactions between colloids can be tuned by adding polymers with varying
radii of gyration [71,153,154,197]. They showed that the temperature range in which
34 Chapter 1: Introduction
a large number of globular proteins crystallizes, maps on a narrow range around
the metastable critical point in the phase diagram calculated for colloids with
short-ranged attractions. At too high temperatures, no crystallization is observed
at all and at too low temperatures, the formation of aggregates dominates [71,197].
A similar crystallization window exists for colloids [197].
In 1997, numerical simulations performed by ten Wolde and Frenkel showed
that the presence of a fluid–fluid critical point changes the nucleation pathway in
homogeneous crystal nucleation dramatically [196]: the Gibbs free energy barrier,
which is the rate-limiting step in crystal nucleation, was calculated for a system
of spherical particles with a protein-like phase diagram with short-range attrac-
tions. Clusters consisting of multiple particles could be classified into belonging
to a liquid or a solid phase, depending on their local ordering. Furthermore, a
local density could be assigned to each cluster. It was found that well below the
critical temperature, an increase in crystallinity (number of solid-like particles be-
longing to a nucleus) proportional to the increase in density leads to the lowest
free-energy path to a critical crystal nucleus. This corresponds to the formation
of a highly crystalline cluster directly from the liquid phase. However, at the
critical temperature, the path of lowest free energy is found for the formation of
a liquid-like droplet with increasing density, followed by a structural change to-
wards higher crystallinity. The nucleation barrier at the critical temperature is
also significantly lower compared to other temperatures. The order parameters
structure and density therefore do not necessarily develop in a coupled fashion [196].
Thus, more than a century after Ostwald formulated his step rule on the basis of
macroscopic studies, findings in protein systems suggest an equivalent step-rule
on the microscopic level [197].
Theoretical considerations of Talanquer and Oxtoby [189] show that close to the
metastable critical point, the crystal nucleation of globular proteins changes dra-
matically and nucleation rates are increased by orders of magnitude.
Having analyzed a large series of simulation results, Vliegenthart and Lekkerk-
erker predicted optimum conditions for protein crystallization in phase diagrams
with a metastable gas–liquid region around the critical point and below [209]. The
first step in the pathways suggested by ten Wolde and Frenkel, the local increase
in density, can be due to critical concentration fluctuations or the formation of
liquid droplets after a metastable LLPS below the critical point [196,209]. Predict-
ing the critical temperature of isotropic potentials with short-range repulsion and
long-range attraction, Vliegenthart and Lekkerkerker considered both cases and
connected experimentally observed ideal conditions for protein crystallization (by
George and Wilson, see below) to phase diagram regions. Around the critical
point, they are found in different regions of the phase diagram than below the
critical point, as shown in Figure 1.6 [209].
It was also indicated by numerical simulations that at conditions typically used
for protein crystallization, small model protein clusters do not maintain a crys-
talline structure and protein crystal nucleation follows a two-step pathway [102].
Vekilov proposed the Gibbs free energy pathways shown in Figure 1.7b-c of two-
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Figure 1.6: Schematic phase diagrams indicating the optimum regions for crys-
tallization (a) around the critical point. (b) below the critical point. Image
adapted from Ref. [209] and modified.
step crystallization processes. While in the classical pathway only one Gibbs free
energy maximum is found (Figure 1.7a), a barrier that has to be overcome in order
for nucleation to occur, the free energy landscapes of two-step pathways show an
additional minimum corresponding to an intermediate phase. Close to the LLPS
boundary, the intermediate phase is unstable and consists of mesoscopic clusters.
In this case, the Gibbs free energy of the intermediate phase is higher than the
free energy of the initial solution (Figure 1.7b). For a macroscopic dense liquid
phase, the Gibbs free energy of the intermediate phase is lower than that of the
initial solution and therefore more stable (Figure 1.7c). Both pathways, however,
are metastable with respect to the crystalline phase [202,204]. Most probably, the
precursor for crystallization in protein solutions is not a general property [203].
1.2.5 Open Questions
There are still some open questions concerning protein crystals and the details of
their formation: obtaining good crystals that diffract in high resolution is still a
bottleneck and can lead to significant delays in research undertakings [162].
It is difficult to disentangle crystal nucleation and growth, which is why the term
“nonclassical crystallization” is often used instead of “nonclassical nucleation” [171].
Even “two-step nucleation” can be used for different scenarios of crystal nucleation
from a precursor. One possible realization are two separate nucleation events
from fluid to intermediate and from intermediate to the crystalline state. Another
pathway referred to as two-step nucleation is the nucleation promoted by density
fluctuations close to the LLPS spinodal or critical point, as originally proposed by
ten Wolde and Frenkel [196]. These alternative pathways are energetically favored
and therefore can enhance the probability of nucleation events.
How exactly a nucleation event starts is still controversial. The different possible
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(a)
(b)
(c)
Figure 1.7: (Gibbs) free energy pathways of crystallization processes. (a) Clas-
sical, one-step pathway with only one free energy barrier. (b) Two-step pathway
with an intermediate phase metastable to both the initial fluid and the final crys-
talline state. (c) Two-step pathway with an intermediate phase stable with respect
to the initial and metastable with respect to the final state. Image adapted from
Ref. [202,222], above shown modified version is also found in publication A.
mechanisms of nucleation and crystal growth are still not completely understood.
Progress has been made in observing the nucleation process in real space using
atomic force microscopy [94,111,119,181,201]. However, the characterization in ensemble
average of such an early stage of nucleation in bulk is still challenging.
1.3 Ion Induced Phase Behavior in Protein
Systems
Protein-protein interactions in a specific salt solution are the result of a sub-
tle balance between different forces. A combination of long-range repulsion and
short-range attraction leads to the formation of small equilibrium clusters [184]. At
high ionic strength, salt screens the electrostatic repulsion and the attractive con-
tributions dominate (increasingly with decreasing temperature). This can lead to
LLPS and related phenomena [184]. These are also crucial for the crystallization of
proteins and many aggregation-related diseases, as discussed in other sections of
this thesis.
Influencing phase behavior in protein systems ranges back to the Hofmeister
effect [78]. However, the focus of this section will be on phase behavior associated
with reentrant condensation (RC) of negatively charged globular proteins.
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1.3.1 Reentrant Condensation
RC is a concept known from systems such as DNA [133,134] or charged colloids [8].
The net charge of the respective particles changes sign with increasing concentra-
tion of a charged additive. At an intermediate additive concentration, the colloids,
DNA or other polyelectrolytes are neutral and condensate. This phenomenon has
recently also been found for negatively charged globular proteins in aqueous solu-
tion, triggered by the addition of trivalent salts such as YCl3
[220,226]. The diagram
shown in Figure 1.8 illustrates this reentrant condensation in protein systems: it is
divided into three regimes by two boundary salt and accordingly ion concentrations
c* and c**. Below c* (regime I), samples are clear, indicating stable solutions. At
intermediate salt concentrations between c* and c** (regime II), samples become
turbid due to aggregation and material falls out of solution. If c** is exceeded, the
condensed proteins redissolve and a one-phase state is reached again, the system
“re-enters” (regime III). This can be explained by an initial increase in attraction
between the negatively charged proteins due to cations binding to the initially
negatively charged protein surface [220,226]. Beyond c**, the strength of attraction
decreases again and eventually, the positive charge is strong enough to lead to
redissolution due to electrostatic repulsion. An effective charge inversion on the
surface side chains is supported by zeta potential measurements and Monte Carlo
simulations [220].
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Figure 1.8: Schematic reentrant condensation phase diagram. I, II, and III mark
the three regimes.
No condensation could be induced using the monovalent salt NaCl [220], nor by
the large complex SpeCl4, that is often successfully used for the condensation of
DNA [226]. The latter is possibly due to the rather small charge density of SpeCl4.
Likewise, no RC could be observed if multivalent salts (including SpeCl4) were
added to solutions of the positively charged globular protein lysozyme [226].
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The Derjaguin-Landau-Verwey-Overbeek (DLVO) theory is highly valuable in
the colloidal context and also has long been used for the description of the basic
phase behavior and particle–particle interaction in protein solutions. However,
RC cannot be described sufficiently by DLVO because of the complex geometry
and charge distribution [220]. On the other hand, the Debye-Hu¨ckel theory and
related concepts work well for the complex geometry but cannot be applied for
systems with strongly charged ions, where ion–ion correlations have to be consid-
ered and mean-field approaches therefore fail [220]. Likewise, theoretical approaches
employed for colloids and DNA usually fail in this case due to the different shape
and the more complex, irregular surface charge pattern [220].
Further, pH effects due to hydrolysis of metal ions should be taken into account.
RC phase diagrams for highly acidic salts such as AlCl3 or FeCl3 show a much
more narrow second regime compared with the rather neutral salts YCl3 and lan-
thanum chloride (LaCl3). This behavior can be explained by the interaction of pH
effects and the binding of multivalent cations [151]. The results of Roosen-Runge
et al. suggest that a combination of pH variation and multivalent counterions
provides control over attraction and repulsion between globular proteins [151]. The
addition of monovalent salt shifts c* and c** towards higher trivalent salt con-
centration [86]. This is reflected in the protein interactions as shown by SAXS and
reproduced by simulation. The Coulomb repulsion is varied by the concentration
of trivalent salt and screened by total ionic strength including the monovalent
salt, while an attractive interaction is established by the multivalent counterions
via bridging between proteins [86]. These results suggest that the interactions in a
protein system showing RC can be tailored by salt effects [86]. The fact that nearly
half of all protein families has a majority of acidic residues and thus are negatively
charged at neutral pH gave rise to the hope that the phenomenon of RC could be
observable in a large number of proteins [226].
1.3.2 Liquid–Liquid Phase Separation
Liquid–liquid phase separation (LLPS) is a phenomenon observed in a multitude
of systems including protein solutions, where it was first found in the eye lenses
of calf, rat and human [193,194], followed by a discovery in an aqueous lysozyme-
salt solution [81]. In Subsection 1.1.2, the general principle was introduced. In this
section, the focus is on LLPS in protein systems caused by multivalent metal ions.
In protein systems, LLPS is — caused by the relatively large size of proteins and
therefore short-ranged attractions — metastable with respect to the crystalline
phase, whereas a stable liquid phase exists for simple fluids [102]. The attractive
forces between molecules that lead to a transition into a protein-rich and a protein-
poor fluid also can enable crystallization [171]. Due to the missing energy barrier
and hydrodynamic effects accelerating phase separation but not crystallization,
LLPS through spinodal decomposition is significantly faster than crystallization
and can affect its kinetic pathway [191].
In recent years, it has been observed that a liquid–liquid phase separation re-
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gion often is found in a closed region of the second regime in a RC phase diagram.
The system of HSA with YCl3 was studied more in detail. In three dimensions
(temperature, salt concentration and protein concentration), the LLPS region has
the shape of an elliptic paraboloid. Under the microscope, denser droplets within
the more dilute surrounding could be observed after a LLPS. It was confirmed by
SAXS that the interactions are short-ranged attractive [224]. The isothermal bin-
odal was determined and the reduced second virial coefficient was used in order
to describe the interactions close to and far away from the binodal. It is nega-
tive (meaning attractive interactions) in both cases but increases approaching the
critical point, in accordance with theoretical predictions for colloid systems [216].
In protein systems as well as in atomic or colloidal systems, an upper criti-
cal solution temperature (UCST) is usually observed where LLPS occurs upon
cooling, in accordance to the explanation in Subsection 1.1.2. However, there are
also systems with a retrograde temperature dependence, where LLPS occurs at
high temperatures, e.g. several variants of hemoglobin [52,203]. This lower critical
solution temperature (LCST) behavior also was observed in other systems such
as polymers [12,130,163], polyethylene oxide – water systems [110] or aqueous solutions
of lutidine [103] or nicotine [36]. In reentrant condensation systems, LCST behavior
was found recently in BSA (and HSA) with YCl3
[25]. This cannot be explained
by attractive forces only. Instead, an entropic contribution has to be taken into
account. By increasing volume fraction of D2O instead of H2O as a solvent, the re-
gion of phase separation shrinks, until it has completely disappeared in pure D2O.
Isothermal titration calorimetry measurements show that the binding of Y3+ ions
to a protein is entropy-driven. The LCST behavior is explained by the entropy
gain due to released hydrated water molecules. At even higher temperatures, the
LLPS region is expected to close again [25].
1.3.3 Ion Induced Crystallization of Proteins
While crystallization is known since antiquity, the first crystallization of a protein,
hemoglobin, was reported in 1840 [62]. Under certain conditions, CNT has been
applied successfully for many systems, including protein solutions [180]. However,
in various studies of the crystallization of proteins, features beyond this simple
view have been discovered in the early stage of nucleation [171]. Compared to the
crystallization of small molecules, protein crystallization requires unusually high
supersaturation and occurs much more slowly [127]. A general difference arises from
the relatively large size of proteins: these systems often show an attractive inter-
action short-ranged compared to the particle size (which also applies to colloids).
Furthermore, the interactions between proteins are anisotropic due to their irreg-
ular shape and inhomogeneous charge pattern. Therefore, isotropic models fail
to describe complex properties of proteins such as their nucleation behavior [70].
Patchy models are to some degree more suitable to protein systems and have
therefore been used repeatedly in recent years [51,66,152,213,214].
Ideal crystallization conditions are found in a narrow range of weak attrac-
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tions, the crystallization-slot [59]. In a repulsive system, the proteins stay in so-
lution while too strong attractive interactions lead to stable amorphous aggre-
gates. Recent results indicate that sign and strength of protein–protein interac-
tions in a large number of systems can be modulated towards crystallization by
RC [86,151,220,226,227]. The physical mechanism of RC has been demonstrated to be
charge inversion [151,226]. The first regime at low salt concentrations is dominated
by electrostatic repulsion. In the second regime, at intermediate salt concentra-
tions, attractive forces become predominant which leads to the condensation of
protein molecules and the formation of big clusters. In the third regime at high
salt concentrations, proteins repel each other again. Specific binding of the cations
to surface-exposed side chains leads to the formation of ion bridges between pro-
tein molecules [227]. The cations enable the formation of the crystal lattice and in
addition can be used to solve the phase problem [227]. Thus, the effective protein-
protein interactions can be modulated by variation of the salt concentration. A
similar method was successfully applied for basic proteins and multivalent an-
ions: in a system of a tyrosinase isoform from Agaricus bisporus, Mauracher et al.
successfully added MgCl2 or Na6[TeW6O24]·22H2O (TEW) in order to induce crys-
tallization [116]. Hen egg-white lysozyme was likewise crystallized in the presence
of TEW. The negatively charged TEW molecules are part of the crystal lattice
and bind to positively charged protein sites [20].
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1.4 Outline
This thesis is divided into three parts. Part I introduces a motivation and fun-
damentals for the understanding of this work as well as the used materials and
methods. Part II comprises the results and is predominantly based on publica-
tions in scientific journals (labeled as publications A-D). Part III summarizes the
results and draws conclusions. It subsequently gives an outlook on probable de-
velopments and possible future work. The composition of Results & Discussion
(Part II) is listed in the following.
• [A] A. Sauter, M. Oelker, G. Zocher, F. Zhang, T. Stehle, and F. Schreiber.
Nonclassical pathways of protein crystallization in the presence of multiva-
lent metal ions.
Cryst. Growth Des. 14 (2014), 6357–6366.
• [B] A. Sauter, F. Roosen-Runge, F. Zhang, G. Lotze, R.M.J. Jacobs, and
F. Schreiber.
Real-time observation of nonclassical protein crystallization kinetics.
J. Am. Chem. Soc. 137 (2015), 1485–1491.
• [C] A. Sauter, F. Roosen-Runge, F. Zhang, G. Lotze, A. Feoktystov, R.M.J.
Jacobs, and F. Schreiber.
On the question of two-step nucleation in protein crystallization.
Faraday Discuss. 179 (2015), 41–58.
• [D] A. Sauter, F. Zhang, N. K. Szekely, V. Pipich, M. Sztucki and F.
Schreiber.
Structural evolution of metastable protein aggregates in the presence of triva-
lent salt studied by (V)SANS and SAXS.
In preparation.
• Complementary study: on the universality of inducing protein crystallization
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Chapter 2
Experimental
2.1 Materials and Sample Preparation
2.1.1 Proteins
The protein that was mainly used for the work presented in this thesis is β-
lactoglobulin (BLG) since it proved to be a good model system for the temperature-
dependence of the upper reentrant condensation boundary and crystallization in-
duced by multivalent metal salts [221,227]. An illustration is found in Figure 2.1. The
protein belongs to the group of lipocalins, small extracellular proteins, and is the
main protein of whey in the milk of many mammals [49]. Its physiological function
— if other than nutritional — remains unclear [162]. Transport and immunoregu-
latory functions have been discussed [49]. Around ten genetic variants have been
identified, but A and B are by far the most common ones [162]. For this work, BLG
from bovine milk, namely a mixture of the genetic variants A and B, that differ at
two of 162 amino acids in total (exchange of Asp64Gly and Val118Ala) [162,207], was
purchased from Sigma-Aldrich (Taufkirchen, Germany, product no. L3908, 90%
purity). A monomer has a molecular mass of about 18.3 kDa. At room tempera-
ture and a pH between 3.5 and 7.5, BLG in aqueous solution has a negative surface
charge (isoelectric point of 5.2) and is found predominantly in dimer state [44,207].
Additional proteins were used for the work presented in Chapter 7. The proteins
used in Section 7.1 were purchased from Sigma-Aldrich, too: serum albumins are
prevalent transport proteins in the blood plasma of mammals with a molar mass of
about 66 kDa [28,109]. Bovine serum albumin (BSA, 99%, A3059) and human serum
albumin (HSA, 97-99%, A9511), both with an isoelectric point (pI) of 4.7 [178],
were used in this study. The digestion protein pepsin from porcine gastric mucosa
(3200-4500 units/mg, P6887) has a molecular weight of 34.62 kDa and a pI between
2.2 and 2.8 [178]. Ovalbumin (OVA, 98%, A5503) from chicken egg white has a
molecular mass of 44 kDa and a pI of 4.54 [178]. The enzyme EpzP (Chapter 7.2)
was recently isolated and characterized biochemically. It is a globular, monomeric
protein with a very rigid barrel structure (diameter ≈ 45 A˚, height ≈ 32 A˚) and
with 302 amino acids, it has a molecular mass of 33.2 kDa. The theoretical pI
is 5.3 as a result of 40 Asp/Glu residues compared to 32 Lys/Arg residues. The
protein plays an important role in the biosynthesis of endophenazines [229].
In the case of most proteins, protein stock solutions were prepared by mixing
degassed MilliQ (18.2 MΩ, Merck Millipore, Darmstadt, Germany) water and pro-
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(a)
(b)
Figure 2.1: Asymmetric unit of BLG (dimer) from the pdb entry 3ph5 [227]. The
pictures were created with Visual Molecular Dynamics using the pdb data and
modified afterwards. (a) Representation of all atoms (except hydrogen) as spheres.
α-helices are shown in red, β-sheets in blue and other structures in purple. (b)
“Cartoon” of the secondary structures. The two monomers are shown in different
colors.
tein powder and keeping the mixture at 5◦C for one day for complete dissolving.
Exceptions were OVA and EpzP: OVA solutions were purified by size exclusion
chromatography. Typically, this protein was purified employing a flow rate of
1 mL/min and a buffer consisting in 50 mM HEPES (pH 7.5) and 150 mM NaCl.
Fractions corresponding to the Ovalbumin monomer were pooled and buffer was
exchanged with degassed MilliQ water using 10 kDa MWCO centrifugal concen-
trators and used as stock solutions. EpzP was produced in buffer (20 mM HEPES
at a pH of 7.5, 150 mM NaCl) which was — if pure water as a solvent was desired
— exchanged afterwards by degassed MilliQ water using centrifugal concentrators.
The real protein concentration of the stock solutions was measured subsequently
by ultraviolet-visible (UV-Vis) absorption spectroscopy (see below). If not in use,
protein stock solutions were stored at 5◦C.
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2.1.2 Salts
The multivalent salts mainly used in this work are zinc chloride (ZnCl2), cad-
mium chloride (CdCl2), and YCl3. They were purchased from Sigma Aldrich with
guaranteed purities of 97% for ZnCl2 (96468), 99.99% for CdCl2 (202908), and
99.99% for YCl3 (451363). For the work presented in Section 7.1, the following
additional salts, also purchased from Sigma Aldrich, were used: LaCl3 (449830),
cerium chloride (CeCl3) (450731), gadolinium chloride (GdCl3) (439770), yttrium
nitrate (Y(NO3)3) (237957, hexahydrate), yttrium sulfate (Y2(SO4)3) (326070, oc-
tahydrate), ytterbium chloride (YbCl3) (450073), ytterbium nitrate (Yb(NO3)3)
(217220, pentahydrate) and ytterbium sulfate (Yb2(SO4)3) (575089). All of the
cations in these salts belong to the rare earth elements, which consist of Sc, Y and
the lanthanoids (La and the fourteen following elements) [35]. Salt stock solutions
were prepared by giving the desired mass of salt on the basis of their molecular
weight into a volumetric flask which was subsequently filled with degassed MilliQ
water to dissolve the salt.
2.1.3 Sample Preparation and Survey of Solution
Properties
For sample preparation, deionized (18.2 MΩ) and degassed MilliQ water (H2O)
was used. An exception were samples for neutron scattering experiments and in-
frared spectroscopy, which were prepared in heavy water (D2O) with a purity of
99.9 atom % deuterium. To prevent the exchange with H2O from the air, paraffin
strips were wrapped around vials with D2O and D2O-based solutions. This also
prevents CO2 from dissolving in H2O and D2O solutions. All samples were pre-
pared by mixing protein stock solution, pure water and the respective salt stock
solution in the needed fractions. The used pipettes (purchased from Eppendorf,
Hamburg, Germany) have a a relative error between 0.2 and 1% and a systemati-
cal error between 0.6 and 3% [46]. The sample was homogenized by careful shaking
or by stirring with a pipette-tip. The room temperature was 21 ◦C, mediated by
air conditioning. If other or more exact temperature settings were needed, a water
bath was applied (±0.01 ◦C).
Ultraviolet-Visible Absorption Spectroscopy
Due to non-protein impurities and the own volume of the proteins, the real concen-
tration differs from the prepared one (measured mass of protein divided by added
volume of water). Therefore, the real protein concentration of every stock solution
and, in some cases, of samples was measured by UV-Vis absorption spectroscopy.
This was accomplished by means of a Cary 50 UV-Vis spectrophotometer from
Varian Inc. Santa Clara, USA with the software Cary WinUV.
Amino acids absorb ultraviolet light. Tyrosine, tryptophan, and, to a much
lesser extent, phenylalanine, are known to cause a characteristic strong absorbance
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of most proteins at a wavelength of around 280 nm which can be used to determine
the concentration of a protein if the ratio of the aforesaid amino acids (given by
the so-called extinction coefficient) is known [95]. The fraction of the incident light
that is absorbed is proportional to the sample thickness d, the concentration c
and the extinction coefficient , as described by the Lambert-Beer law:
log
I0
I
= cd (2.1)
where I0 is the intensity of incoming and I the intensity of transmitted light.
log I0
I
is also called “absorbance” [95].  is often given in units of l/(mol · cm)
(molar extinction coefficient, for concentrations in M = mol/l). In this work, the
specific extinction coefficient in units of l · g−1 · cm−1 and protein concentrations
in mg/mL = g/l are used.
The absorbance of the same cuvette filled with degassed MilliQ water has been
measured as a background and subtracted from the measurement of the protein
solution.
Size Exclusion Chromatography
Size exclusion chromatography (SEC), also called gel filtration, is a common tech-
nique for the purification of proteins or for analysis of the constituents of a pro-
tein solution. A column is filled with a porous material and a buffered, protein-
containing solution percolates through it. Larger proteins migrate faster because
they cannot enter the cavities of the porous beads of cross-linked polymer inside
the column. Taking advantage of this mechanism, the proteins are separated into
fractions based on their size [95]. Figure 2.2 yields an illustration. The amount of
protein in each fraction is determined by UV-Vis absorption at λ=280 nm. Other
types of column chromatography include separation according to the charge, bind-
ing affinity and other properties of the proteins [95].
Survey of pH Values
A Seven Easy pH instrument from Mettler Toledo, Columbus, USA was used to
monitor the change of the pH of protein solutions caused by salt addition. For
every pH value, the protein acquires a different surface charge [127]. If the pH fell
below the pI, this would invert the charge of the proteins used in this work which
are negatively charged at neutral pH. The pH changes caused by the addition of
salts in samples prepared for the work presented in this thesis were not strong
enough to reach or cross the pI. Thus, cation binding must be the main driving
force of the observed charge inversion [151,226]. Attention should be paid also to the
pH range in which the respective protein is stable and in its native conformation.
Regular pH measurements ensured that this range was not exceeded during our
experiments.
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Figure 2.2: Illustration of the size exclusion chromatography method. Larger
proteins migrate faster through the column matrix with pores of selected size.
Smaller proteins enter the pores and are slower because they take a longer path
through the column. Image adapted from Ref. [95].
2.2 Survey of Protein Stability
In order to ensure that no significant structural changes occur in the proteins
under the experimental conditions, Fourier transform infrared (FTIR) and circular
dichroism (CD) measurements were performed.
FTIR allows to monitor the stability of the protein secondary structure in
D2O. Infrared spectra result from the excitation of vibrational energy states in
molecules due to coupling of the electric field vector with the dipole moment of
the molecules. Each mode translates into a specific frequency [14,69]. From the
vibrational spectrum, information on the chemical structure, redox state, bond
lengths and strength, bond angles and conformation and more can be derived.
In the case of proteins, absorption of infrared light by amino acid side chains
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provides some information when protein reactions are investigated, but usually
the amide modes are investigated which are caused by vibrations of the peptide
groups [14]. In this thesis, the amide I and amide II bands are surveyed upon tem-
perature change and the addition of multivalent ions. Amide I is mainly due to the
C=O stretching vibration, while amide II is the out-of-phase combination of C-N
stretching vibration and N-H inplane bend [14]. Both are sensitive to secondary
structure (especially amide I at ∼1650 cm−1) [14]. Using a Michelson interferome-
ter, a collimated beam of radiation is split into two parts which are recombined
and interfere. By varying the path length difference with constant velocity, the
wavelength with maximum constructive interference is “selected” from the poly-
chromatic source [69]. As an instrument, the IFS 48 from Bruker (Billerica, USA)
was used. Protein solutions for FTIR measurements were prepared in D2O because
the absorption bands of H2O and proteins interfere. All spectra were corrected by
a background measurement of pure D2O.
CD is a technique that allows to investigate the secondary structure of pro-
teins taking advantage of the circular polarization [70]. Plane polarized light can
be understood as a combination of two circularly polarized components of equal
magnitude and different rotation direction. If these components are not absorbed
to equal extends by a sample, elliptically polarized light is detected as an output
signal. This is observed when the sample is optically active because it has a chiral
structure. This can be e.g. due to a carbon atom with four different substituents,
due to placement in an asymmetric environment (three-dimensional structure of
the molecule) or because it is covalently bound to the chiral molecule center [89].
In proteins, the CD signal is caused by the peptide bond, aromatic side chains
and disulphide bonds as well as by non-protein cofactors and ligands that acquire
chirality when bound in the asymmetric environment provided by the protein. In-
formation that can be obtained from protein samples by means of CD include the
secondary structure composition, a certain fingerprint of the tertiary structure,
and conformational changes such as protein folding [89]. For the CD measurements
performed for this thesis, a J-720 spectrophotometer from Jasco Inc. (Easton,
USA) was used.
2.3 Zeta Potential Determination
The charged surface of a protein in solution is surrounded by a distribution of ions.
The rather rigid inner shell formed by these ions is called Stern layer, the ions
further away from the protein form the diffuse layer [39]. The boundary between
the hydrodynamically mobile and immobile fluid is called slip plane or slipping
plane [39]. The ions within this boundary move with the particle. The potential
between the solution and the moving particle is called zeta potential [112]. An
illustration is found in Figure 2.3. The isoelectric point pI is the point at which
the zeta potential is equal to 0 [39].
The measurements were performed with a Zetasizer Nano ZS from Malvern
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Figure 2.3: Illustration of the zeta potential. Image reproduced from Ref. [112].
Instruments Ltd, Worcestershire, UK. An alternating electrical field was applied
to a U-shaped capillary cell. Using laser Doppler electrophoresis with a 633 nm
laser at a fixed angle of 173◦, the velocity of particles in the electrical field is
measured from which the zeta potential is calculated. All samples were filtered
using a 100 nm filter before the measurement. Zeta potential measurements were
performed to confirm the charge inversion in protein systems upon adding an
appropriate amount of salt.
2.4 Optical Microscopy and Crystallization
Methods
The crystallization of samples was followed by means of optical microscopy. The
microscope mainly used was an AxioScope A1 from Carl Zeiss Microscopy (Ober-
kochen, Germany) which allows automatized time-dependent picture series by the
software Zen 2012. Other employed microscopes are an Axioskop 40 from Carl
Zeiss Microscopy in a 277 K room and a DME from Leica Microsystem GmbH
(Wetzlar, Germany) in a 293 K room with attached cameras.
Prior to the crystallization experiments, protein stock solutions were filtered
using a 100 nm syringe filter in order to remove dust. The protein concentration
was determined afterwards by UV-Vis absorption spectroscopy. Sample conditions
were tested for crystallization using (micro-)batch setups in which drops of the
sample are prevented from evaporation [70]. This is also the underlying method
for most experiments followed by optical microscopy. For means of comparison,
experiments at several conditions were additionally performed using the vapor
diffusion hanging drop method [62]. In vapor diffusion methods, a drop of the
solution of protein, buffer and other ingredients such as salts is placed close to a
sealed reservoir with the same solution without protein. The two solutions are not
in contact with each other. The concentration difference drives the system towards
equilibrium concentration: water from the drop evaporates and is transferred to
the reservoir [70].
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For the quantitative analysis of microscopy pictures, samples were prepared in
a micro-batch setup between two hydrophobically coated glass slides sealed by
silicone. The small sample thickness of approximately 250-300µm minimizes the
effect of crystallization in different layers and keeps the number of crystals man-
ageable. The hydrophobic surfaces avoid wetting and heterogeneous nucleation.
Indeed, a significantly larger number of crystals was observed using glass plates
without hydrophobic coating. The number and visible area of crystals was eval-
uated by the open source program ImageJ [167]. Although a python program for
the automatized recognition of crystals (based on a script from F. Zanini) is being
developed, the crystals evaluated for the publications included in this thesis were
marked by hand since this method is still clearly more accurate. The average
length of the crystals in an image was estimated as L ≈√A/N with the number
of crystals N and the visible area of crystals A. L and N were plotted as a func-
tion of time (t). The nucleation rates can be estimated from the slope of a linear
fit of N(t), whereupon possible crystallites with a size below the observable length
scale that merge (Ostwald ripening) or do not grow large enough to be visible are
neglected.
2.5 Small Angle Scattering
Small angle scattering is widely used to determine protein–protein interactions in
aqueous solutions. For the studies presented in this thesis, both small angle X-
ray scattering (SAXS) and small angle neutron scattering (SANS) were applied.
Although there are naturally physical differences, the mathematical formalism
and most data analysis are similar for X-ray and neutron scattering [188]. In the
following, the basic concept is summarized. The basic setup of a scattering ex-
periment is shown in Figure 2.4. A beam of radiation or particles, respectively,
is deviated from its former trajectory by inhomogeneities in the sample it passes.
Since the distances of the setup (source–sample, sample–detector) are much larger
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Figure 2.4: Basic setup of a small angle scattering experiment. The 2D-image
is obtained from a SAXS measurement of 33 mg/mL BLG with 17 mM CdCl2.
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than typical sizes of inhomogeneities in the sample that are still larger than the
wavelength, the incoming wave vector ~kin and the outgoing, scattered wave vector
~kout can be considered as plane waves
[188]. We will only describe elastic scattering,
where energy and wavelength of incoming and scattered beam are the same [188]
and which is isotropic and thus only depends on the momentum transfer ~q with
|~q| = |~kout − ~kin| = 4pisin(θ)
λ
(2.2)
where 2θ is the scattering angle and λ the wavelength [70,188]. The strength of
interaction between beam and sample is given by the differential scattering cross
section (dσ/dΩ) defined as
dσ
dΩ
=
Iout
j∆Ω
(2.3)
with the flux j which is the number of photons (SAXS) or neutrons (SANS) in
the incident beam passing through a unit area per second and the solid angle
∆Ω [6,188].
The experimentally accessible intensity I (that is directly related to the struc-
ture of the sample) scattered by a unit volume can be defined as
I =
1
V
dσ
dΩ
=
∆j
j
1
T d∆Ω (2.4)
with ∆j being the fraction of flux that is elastically scattered in the direction
of the solid angle, the sample thickness d and its transmission T [98]. The mea-
sured total scattering intensity of different types of non-interacting particles can
be written as a linear combination of their individual scattering intensities [188].
The scattered radiation I(~q) depends, for a given beam and illuminated element
j, on the scattering length bj and the scattering length density ρj. The total scat-
tering length density ρ, that is, the density of scatterers of type j, can be written
as ρ(~r) =
∑
j ρj(~r)bj
[98]. It has different origins in X-ray and in neutron scatter-
ing: X-rays interact with the electron shell and neutrons interact with the nuclei
(and spins) [188]. For SAXS and SANS, the Born approximation can be applied,
assuming that the interactions of the beam with one scatterer do not influence the
scattering by others. Thus, the total scattering amplitude (A) for the illuminated
volume V is given by [98]
A(~q) =
∫
V
ρ(~r)e−i~q~rd~r (2.5)
and the measured intensity as
I(~q) =
A(~q)A∗(~q)
V
=
1
V
∫
V
∫
V
ρ(~r)ρ(~r′)e−i~q(~r−
~r′)d~rd~r′. (2.6)
In particulate systems, a form factor P (~q) and a structure factor S(~q) can be
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defined. The intensity for a single particle is given by
Ipart(~q) = Apart(~q)A∗part(~q) = V 2partP (~q) (2.7)
with the form factor
P (~q) =
1
V 2part
∫ ∫
ρ(~r)ρ(~r′)e−i~q(~r−
~r′)d~rd~r′ (2.8)
of the particle [98]. For several diffusing particles that interact with each other,
the scattering intensity varies and the time average is measured instead of Eq. 2.6,
which is equivalent to the statistical average for ergodic samples. If the particles
are spherical (or parallel in a nematic / smectic phase) with identical interactions,
the expression further simplifies and the total scattering intensity can be written
as
I(~q) = ΦVpartP (~q)S(~q) (2.9)
with the volume fraction Φ and the structure factor
S(~q) = 1 +
N − 1
V
∫
V
g(~r)e−i~q~rd~r. (2.10)
g(~r) is the pair correlation function of the centers of mass of the particles [98].
In order to describe the effective interactions, structure factors are calculated
from interaction potentials. The potentials used for the structure factor fits in
this work (after radial averaging of the intensity) were, depending on the phase
diagram region, a screened Coulomb potential, a hard sphere or a sticky hard
sphere potential. The hard sphere potential (with the hard sphere diameter σ) is
defined as
UHS(r) =
{
∞ r ≤ σ
0 r > σ.
(2.11)
The sticky hard sphere potential is defined as [15]
USHS(r) =

∞ r < σ
−u σ < r < σ + ∆
0 r > σ + ∆.
(2.12)
with the stickiness parameter
τ =
1
12∆
exp(−u/kT ) (2.13)
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and the perturbation parameter ∆
∆ = ∆/(σ + ∆) (2.14)
∆ is the width of the square well, and u is its depth [90]. Finally, the screened
Coulomb potential is defined as [73,77]
USC(r) =
{
Z2e2
ε(1+κDσ/2)2
exp(−κD(r−σ))
r
r > σ
∞ r ≤ σ (2.15)
with Z the protein surface charge, e the electronic charge, and ε the dielectric
constant of the solvent. κD is the inverse of the Debye screening length, determined
by the ionic strength of the solution and σ is the effective sphere diameter of the
ellipsoid the axes a, b, b.
2.5.1 Peculiarities in SANS and SAXS
Whether SANS or SAXS are more suitable depends on the sample of interest.
Some samples have more contrast for neutrons and others for X-rays, which is
connected to differences in the scattering process [98]: In the case of neutrons, the
scattering length bj (with dσ/dΩ(~q) = b
2
j for a point scatterer) depends on the
isotope of the sample and its spin and does not depend on the atomic number in
a monotonic way [179]. For X-rays, bj decreases monotonically with decreasing λ
and increasing θ and is proportional to the atomic number, since the scattering
depends on the number of orbital electrons and can therefore be described by the
local electron density [98,179]. Near atomic binding energies, the atomic scattering
factors are described by additional terms (“anomalous” scattering) [145].
By choosing solvents with appropriate electron density, the scattering of certain
components of the sample can be masked out in SAXS experiments. However, for
contrast variation studies, usually SANS is applied because of the enormous differ-
ence in the interaction of neutrons with hydrogen (1H) and deuterium (2H) [145]. In
SAXS experiments, radiation damage can occur — especially to biological samples
— due to the high flow of energy [219].
2.5.2 Sample Preparation and Data Analysis
For the work presented in this thesis, SAXS measurements were performed at the
beamline ID2 at the ESRF (European Synchrotron Radiation Facility, Grenoble,
France) using a flow-through capillary cell or, in the case of time-resolved mea-
surements, a vertical quartz capillary. Exposure times were between 0.05 and
0.1 s. For time-dependent SAXS, the measurement started about 2-3 min after
mixing. To ensure the consistency of the measurements, the sample was shifted
vertically and data were collected from different positions. This cycle was re-
peated every 2-5 min. SANS measurements were performed in rectangular quartz
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cells with a path-length of 1-2 mm. All SANS data presented in this thesis were
collected at FRM2 (Garching, Germany) at the instruments KWS1, KWS2, and,
for very small angle neutron scattering (VSANS), at KWS3. The two-dimensional
intensity pattern was averaged azimuthally.
At low protein concentrations and with NaCl for screening, the form factor of
BLG was determined experimentally. Naturally, it can be fitted very well by the
crystal structure of the BLG dimer (PDB code of 1BEB [27]) using CRYSOL [186].
Spheres or ellipsoids, however, have also been shown to be good models for the
form factor of BLG dimers or clusters. To describe the effective interactions, struc-
ture factors (using the average structure factor approximation from a monodis-
perse spherical system [31] with effective sphere diameters) derived from model
potentials were used for data analysis. Data fitting for the determination of the
interaction potential was performed using IGOR Pro with macros developed at
NIST [90].
While a so-called Guinier plot gives the radius of gyration Rg of the particles
and a Porod plot gives information about scattering inhomogeneities such as sur-
face roughness through the Porod exponent [72], the Beaucage model is well suited
for the analysis of small-angle scattering data from complex systems with multi-
ple levels of related structural features (e.g. fractal and particulate systems). It
yields multiple sets of radii of gyration and power law exponents from different
structural levels by modeling the Guinier region and the Porod region [16,17,72]. It
is characterized by three fitting parameters per structural level: the radius of gy-
ration Rg, the Porod exponent d and the Guinier scaling factor G (from which
the Porod scaling factor B can be derived) [72]. The scattering intensity can then
be expressed as
I(q) = G · exp
(−q2R2g
3
)
+B ·
[
erf
(
qRg√
6
)3
· 1
q
]d
(2.16)
for one Guinier and one Porod region, or, in the case of multiple levels, as [16]
I(q) ≈
n∑
i=1
{
Gi · exp
(−q2R2g(i)
3
)
+Bi · exp
(−q2R2g(i+1)
3
)
·
[
erf
(
qRg(i)√
6
)3
· 1
q
]di .
(2.17)
For the analysis performed in the publications B and C, the degree of crys-
tallinity was monitored. All curves were divided by the first one. Two Bragg
peaks and a broad peak that we interpret as typical length within larger aggre-
gates (and therefore as a measure for the amount of precursor phase) were fitted
by scaled Gaussians. The areas under these Gaussian functions were plotted in
dependence of time and further discussed.
2.6 Structure Determination by X-ray Diffraction 55
2.6 Structure Determination by X-ray
Diffraction
In 1934, X-ray crystallography entered biology by the first picture of a protein
(pepsin) crystal [19,62]. Since then, protein crystallography has developed to the
stage where the protein data bank (PDB) contains over one hundred thousand
biological macromolecular structures [1].
Like SAXS, X-ray crystallography involves a sample placed into a collimated
beam of X-rays and measuring the intensities of the scattered photons [145]. In
solution scattering, the signal is averaged over all molecule orientations relative
to each other as well as to the experimental setup and is therefore radially sym-
metric and continuous. Diffraction from a crystal, in contrast, results in a much
larger signal of discrete diffraction maxima caused by the convolution of the lat-
tice onto the continuous transform. In contrast to SAXS, crystallography allows
the determination of structures at atomic resolution [145]. Single crystals exhibit
a long-ranged translational order that leads to interference of diffracted X-rays
and a characteristic spot pattern [34]. An example is shown in Figure 2.5. These
spot positions allow the calculation of lattice plane distances and the orientation
of the crystal lattice [34]. Polycrystalline aggregates, in contrast, lead to a ring-like
pattern, known as powder diffraction, due to the random orientation of crystalline
building units [34].
Figure 2.5: Diffraction pattern of a BLG crystal at 1.82 A˚. The experimental
conditions for crystallization were 33 mg/mL BLG with 6.8 mM YCl3 at 4
◦C.
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If the amplitudes and phases of all scattered waves are known, the electron
density map, which represents the atomic positions within the unit cell, can be
obtained by Fourier transform [162]. Mathematically,
S(h, k, l) =
∑
j
fjexp[2pii(hxj + kyj + lzj)] (2.18)
where S(h, k, l) is the structure factor, h; k; l are the Miller indices, and xj, yj, zj
are the positions of the jth atom in the unit cell and fj is the resolution-dependent
atomic scattering factor. The fundamental problem (the “phase problem”) for the
analysis of crystal structures is that the phase gets lost since only the intensities
are measured which are obtained by taking the square of S(h, k, l) [145]. When
the position of several atoms is known, this often allows successive identification
and phase calculation [162]. One possibility is to introduce heavy atoms or atoms
with anomalous scattering into the crystals and then identify their positions [145].
The shape and size of a unit cell of a three-dimensional crystal are defined by the
length of three axes and the three angles between them (a, b, c and α, β, γ). If
internal symmetries within a unit cell containing multiple molecules apply to the
entire lattice, they constrain the parameters of the unit cell. The smallest set of
structural information that is needed to reconstruct the complete crystal lattice
by symmetries and lattice translations is called asymmetric unit [145].
Part II
Results & Discussion

Chapter 3
Publication A. Nonclassical
Pathways of Protein Crystallization in
the Presence of Multivalent Metal Ions
Cryst. Growth Des. 14 (2014), 6357–6366.
Andrea Sauter, Melanie Oelker, Georg Zocher, Fajun Zhang, Thilo Stehle and
Frank Schreiber
Contributions
Research design AS, FS, FZ
Experiments AS, GZ, MO, FZ
Data analysis and interpretation AS, FZ, GZ, MO
Paper writing (structural biology part) GZ, MO, TS
Paper writing AS, FS, FZ
Using bovine β-lactoglobulin as a model system, we have studied the crystal-
lization pathways in the presence of the di- and trivalent salts ZnCl2 and YCl3.
Previous work has shown that protein solutions undergo a reentrant condensation
(RC) phase behavior in the presence of YCl3, i.e. a condensed phase occurs in
between two boundary salt concentrations, c*< c**. In the presence of ZnCl2,
c* also exists, but protein solutions with high salt concentrations do not become
completely clear at higher protein concentrations (> 20 mg/mL). We thus denote
this diffuse transition as pseudo-c**. Small angle X-ray scattering measurements
show that the effective interactions change from repulsion to attraction near c*;
and attractive interactions dominate around pseudo− c**. Solutions near c* and
pseudo− c** provide the optimized conditions for growth of high quality protein
single crystals, but with different pathways. While crystal growth near c* follows
the classical one-step nucleation pathway, crystallization around pseudo−c** (for
zinc) or c** (for yttrium) follows a nonclassical process with an intermediate phase
appearing before crystallization. Furthermore, the intermediate phases strongly
depend on the crystallization temperature. Samples with high salt concentrations
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exhibit a typical transition temperature (Ttr), below which the solutions become
turbid. When crystallizing near Ttr, the intermediate phase consists of protein
clusters; below Ttr, the intermediate phase corresponds to macroscopic protein
aggregates which can further relax into a dense liquid phase before crystalliza-
tion. However, the experimental data cannot distinguish whether nucleation oc-
curs within or outside of the intermediate phase. Possible scenarios are discussed
based on the equilibrium phase behavior of colloidal systems with a short-range
attraction. The crystallographic analysis of the resulting crystals shows that metal
ions are an integral part of the crystal lattice. Both types of metal ions can create
new protein contacts in the crystal lattice via bridging; however, yttrium creates
more bridging contacts compared to zinc.
3.1 Introduction
Crystallography is the dominating method for structure determination of bio-
logical macromolecules. Its major bottleneck is the crystallization from protein
solutions and growing single crystals with adequate quality. The molecular inter-
actions in protein solutions, in particular their connection to the crystallization
process, are not completely understood, and crystal growth is typically performed
by trial and error experiments [43].
Recent progress in protein and colloid crystallization as well as biomineraliza-
tion has shown nonclassical features in the early stage of nucleation [56,171,196,202,211].
While classical nucleation theory (CNT) predicts that molecules form nuclei in a
supersaturated solution with the exact density and structure of the crystals in
the final stage [7,56,172], nonclassical pathways suggest an intermediate phase (clus-
ters or dense liquid phase) existing in between the initial solution and the final
crystalline state [56,171,196,202]. The free energy landscapes of nonclassical path-
ways show an additional free energy minimum corresponding to the intermediate
phase. Computer simulations of homogeneous crystal nucleation performed by
ten Wolde and Frenkel using a colloidal model with short-range attractive in-
teractions suggested that the presence of large density fluctuations close to the
critical point of liquid–liquid phase separation (LLPS) affects the pathway for the
formation of a crystal nucleus [196]. The free-energy barrier that has to be over-
come is considerably lowered if the change in density occurs before the structural
change [196]. While the theoretically predicted two-step nucleation near the critical
point is difficult to verify experimentally, accumulated experimental observations
in various systems have shown the nonclassical features of crystallization under
certain conditions [30,53,54,58,202]. Even in simple hard-sphere systems, simulations
and experiments suggest a two-step nucleation process with amorphous clusters
as precursors [75,113,114,164,168].
A different type of cluster phase has been proposed for concentrated protein
solutions that is not caused by density fluctuations: Large clusters consisting
of 105 to 106 proteins have been observed in lysozyme and hemoglobin systems
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outside the LLPS region [65,137,138]. An approach to find an electrostatic model for
clusters with up to 103 molecules was pursued by Hutchens and Wang [79]. This
model is, however, limited by the Debye screening length and cannot explain the
experimentally observed large clusters. Nevertheless, these large protein clusters
have been demonstrated to play an important role in the protein crystallization
process which cannot be explained by CNT [65,97,137,138,181].
In practice, an occasionally used and successful strategy to induce protein crys-
tallization is the addition of multivalent ions [120,132,199,218]. Divalent ions have been
proven crucial for the generation of high quality crystals of insulin and other pro-
tein complexes [165,200]. We have shown previously that trivalent salts such as YCl3
can induce a reentrant condensation (RC) phase behavior in many acidic proteins
such as β-lactoglobulin (BLG) [151,183,220,222,226]. For a given protein concentra-
tion, when the salt concentration is below c* and/or above c**, protein solutions
are clear. At salt concentrations between c* and c** (with c*< c**), protein con-
densation occurs including aggregation, LLPS and crystallization [224,227]. Interest-
ingly, depending on the position in the phase diagram, classical crystallization or a
temperature-dependent nonclassical crystallization process has been observed [227].
Further studies suggested that proteins form clusters in the presence of trivalent
metal ions that can form either a dense liquid phase or crystals depending on the
kinetics [183,223]. However, establishing a complete picture of the nucleation mech-
anism in the presence of the metastable intermediate phase and its role is still a
challenge.
In this work, we aim to provide new insights into the nonclassical pathways for
protein crystallization in the presence of multivalent metal ions. We first deter-
mine and compare the macroscopic phase behavior and crystal growth pathways
for BLG with a trivalent salt, YCl3, and a divalent salt, ZnCl2. We further charac-
terize the effective protein–protein interactions in the molecular level using small
angle X-ray scattering. Finally, we explore the role of multivalent metal ions based
on the high resolution crystal structure on the atomic level. We hypothesize that
the difference in valency will lead to a different binding affinity of the metal ions
to the protein surface [108], which may affect the resulting crystal lattice and the
kinetics of crystal growth. By providing more detailed experimental observations
of crystal growth under various conditions and the structural analysis of the pro-
tein crystals, we aim to address the following questions: Which crystallization
pathways are followed and what is the structure and morphology of the crystals?
What is the role of multivalent ions in stabilizing the crystal lattice as well as
inducing the different pathways of crystallization? Are there differences between
ZnCl2 and YCl3, concerning the pathway of crystallization and the ion-bridging?
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3.2 Experimental Section
3.2.1 Materials and Sample Preparation
Protein and salts were purchased from Sigma-Aldrich. The guaranteed purities
were 90% for BLG from bovine milk (L3908), 97% for ZnCl2 (96468) and 99.99%
for YCl3 (451363). A BLG monomer consists of 162 amino acids and has a molec-
ular mass of about 18.3 kDa. Under physiological conditions, it is found predomi-
nantly as a dimer [207]. With an isoelectric point (pI) of 5.2, it is acidic and carries
a net charge of -10 e at neutral pH [44].
All samples were prepared by mixing the required amount of salt stock solution,
deionized (18.2 MΩ) degassed Millipore water and protein stock solution. Stock
solutions were prepared by dissolving the protein powder or salt in deionized
degassed Millipore water. The concentration of BLG solutions was determined by
UV absorption measurements using an extinction coefficient of 0.96 l · g−1· cm−1
at a wavelength of 278 nm [182]. A Seven Easy pH instrument from Mettler Toledo
was used to monitor the pH of protein solutions caused by salt addition. All
samples had a pH above the pI (between 6.2 and 6.9). Since most buffers can
affect the phase behavior and the solubility of salts, no additional buffer was used
to avoid the effect of co-salts.
The transition temperature, Ttr, for samples with high salt concentration was
determined by turbidity measurements. Samples were prepared in a water bath
at 313 K and then slowly cooled down to 278 K with a cooling rate of about
0.1 K/min. Pictures were taken every 2 K, and the temperature of the transition
from clear to turbid was assigned as Ttr.
3.2.2 Methods
Small Angle X-ray Scattering (SAXS) and Data Analysis
SAXS measurements were performed at the ESRF, Grenoble, France at beamline
ID02. The samples were measured using a flow-through capillary cell with a thick-
ness of about 10µm at sample-to-detector distances of 1, 2, and 5 m. The sample in
the scattering volume was exchanged for every exposure. For each sample, 10 ex-
posures of 0.1 s or 20 exposures of 0.05 s each were measured. The two-dimensional
(2D) intensity pattern was corrected to an absolute scale and azimuthally averaged
to obtain the intensity profiles. Afterward, the solvent background was subtracted.
More detailed information on data reduction and q-resolution calibration can be
found in the literature [80,129].
Small-angle X-ray scattering data can be used to obtain information on the pair
interaction potential [63,74,187]. The scattering intensity, I(q), for a nonspherical
system, can be expressed by
I(q) = N(∆ρ)2V 2P (q)S¯(q). (3.1)
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where q = 4pi
λ
sin(θ/2) is the scattering vector, θ is the scattering angle, N is the
number of protein molecules per unit volume in the solution, ∆ρ = ρp − ρs is
the electron density difference between the solvent and the solute, and V is the
volume of a single protein. P (q) is the form factor of a given protein, i.e. the scat-
tering from a single protein molecule after orientation averaging. A form factor
of an oblate ellipsoid with semiaxes a and b is used to model the protein BLG.
At low protein and salt concentration, the SAXS data were fitted by the crystal
structure of the BLG dimer (PDB code of 1BEB [27]) using CRYSOL [186]. The
structure factor S¯(q) is calculated using the average structure factor approxima-
tion from a monodisperse spherical system [31], with an effective sphere diameter
which is calculated from a virtual sphere with the same second virial coefficient
as the ellipsoid [82,223]. In the following parts and for simplicity, we use S(q) to
denote S¯(q). To describe the effective interactions in protein solution, structure
factors derived from model potentials were used for data analysis. Data fitting
for the determination of the interaction potential was preformed on IGOR Pro
with macros developed at NIST [90]. More details of data analysis can be found in
previous work [80,225].
Protein Crystallization and Crystal Structure Analysis
Crystallization was performed at 277, 293, and 312 K by the vapor diffusion hang-
ing drop method or by batch crystallization in small glass bottles or cuvettes.
The concentrations ranged from 3 to 65 mg/mL BLG and 0-50 mM ZnCl2 or 0-
20 mM YCl3, respectively. The crystallization process was followed with trans-
mission optical microscopes: a DME from Leica Microsystems Inc. in a 293 K
room, an Axioskop 40 from Zeiss with an installed Nikon E995 digital camera in
a 277 K room and an AxioScope.A1 from Zeiss with an included AxioCam ICc5,
temperature-controlled by a water bath with a precision of 0.05 K.
X-ray analysis was performed with two typical crystals from different regions
of the phase diagram (BLG-Zn-2: 10.0 mg/mL BLG and 2 mM ZnCl2; BLG-Zn-
20: 3.4 mg/mL BLG and 20 mM ZnCl2) both grown at 277 K. Single crystals were
prepared and transferred into the corresponding salt concentration including glyc-
erol (30-34% (w/v)). The crystals were flash frozen in liquid nitrogen and stored
until data collection. Data collection was performed at beamlines X06DA at the
Swiss Light Source in Villigen, Switzerland, and P13 at PETRA III in Hamburg,
Germany. Data processing was performed with the XDS package [87]. Structures
were solved by molecular replacement as implemented in PHASER [117] using co-
ordinates for BLG (Protein Data Bank (PDB) code 3PH5) as search template,
followed by a simulated annealing refinement as implemented in PHENIX [4] to
avoid model bias. Zinc ions were placed on the basis of an anomalous difference
map calculated with FFT [195]. The models were refined by several cycles of model
corrections with COOT [45] and reciprocal space refinement with REFMAC5 [125].
Final refinement steps included TLS parametrization. Water molecules were incor-
porated manually with COOT. Figures were generated with PyMOL [169]. Models
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were validated with MolProbity [32] and deposited to the Protein Data Bank (PDB)
with accession numbers 4LZU and 4LZV. The structures of BLG crystallized in the
presence of YCl3 (PDB codes 3PH5 and 3PH6) were determined in our previous
work [227].
3.3 Results
3.3.1 Phase Behavior of BLG in the Presence of ZnCl2
and YCl3
Previous work [227] showed a strongly temperature-dependent behavior for solutions
of BLG with YCl3 near c**. At higher temperatures, the samples were clear
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Figure 3.1: (a) Experimental phase diagram of BLG with ZnCl2 and YCl3. In
both cases, a reentrant condensation (RC) phase behavior was observed. Purple
arrows mark the conditions for SAXS measurements. Inset: Photos of a series
of samples with a BLG concentration of 3.4 mg/mL and increasing ZnCl2 con-
centrations (from left to right: 0.1 mM, 0.3 mM, 1 mM, 20 mM, and 50 mM). (b)
Transition temperature of BLG in the presence of ZnCl2 or YCl3. [A-E] mark
samples for the study of crystal growth in the following.
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and thus in regime III. Upon cooling, they became turbid below a transition
temperature Ttr. Similar behavior was also observed in the presence of ZnCl2 for
samples within the pseudo-c** zone. Ttr decreases linearly with increasing salt
concentration for both salts (Figure 3.1).
3.3.2 Temperature-Dependent Crystallization of BLG in
the Presence of ZnCl2 and YCl3
Crystals were observed in the second regime of Figure 3.1a with both ZnCl2 and
YCl3. Using optical microscopy, we followed the crystallization procedure of BLG
with different salt concentrations (ZnCl2) at different temperatures. Close to (ei-
ther slightly above or below) c*, our observations suggest that the crystallization
follows the classical one-step pathway; i.e., crystals nucleate directly from a su-
persaturated solution and grow larger without any visible cluster or LLPS phase,
similar to experiments with YCl3
[227]. Under our experimental conditions, this
crystallization pathway did not depend on the crystallization temperature.
Close to (pseudo)-c** (i.e., the second boundary for both ZnCl2 and YCl3),
different growth processes depending on temperature were observed. A typical
example is shown in Figure 3.2 for a sample close to its transition temperature
(6.5 mg/mL BLG and 10 mM ZnCl2 at 312 K ∼ Ttr, [a] in Figure 3.1b). No macro-
scopic LLPS was visible, but massive amorphous clusters appeared before crys-
tallization. The amorphous clusters are metastable with respect to the crystals:
they dissolved and disappeared at the end of crystallization.
(a) (b)
(c) (d)
Figure 3.2: Typical crystallization pathway in the pseudo-c** zone near Ttr.
Crystals grown at 312 K: 6.5 mg/mL BLG with 10 mM ZnCl2. (a) Directly after
preparation at 313 K. (b-d) After 7, 10 and 24 h, respectively.
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For the same sample at 293 K, well below Ttr (Figure 3.3, label [b] in Fig-
ure 3.1b), a different growth process was observed. With time, a network of clus-
ters forms and further relaxes into a liquid-like structure, similar to the viscoelastic
behavior described in literature for polymers and for lysozyme [93,191,192]. Based on
the fact that these areas are growing and merging, we conclude that they are
liquid, not gel. By focusing on different depths of the sample solution, one could
see that this structure forms predominantly at the lower glass interface. However,
this is mainly due to the higher density of the liquid-like network structure in-
stead of preferential wetting on the glass slide as demonstrated by the hanging
drop experiments (see Supporting Information, Figure A.1). Furthermore, crystal
growth mainly starts from the interface between the dense and the dilute liquid
phases. During crystal growth, the dense liquid phase is consumed.
(a) (b)
(c) (d)
Figure 3.3: Typical crystallization pathway in the pseudo-c** zone below Ttr.
Crystals grown at 293 K at the liquid-glass interface: 6.5 mg/mL BLG with 10 mM
ZnCl2. (a) Turbid sample directly after preparation. (b) Network-like dense liquid
structure after 2 h. (c) After 7 h, the dense regions grew and crystals were visible.
(d) After 24 h, crystal growth had consumed all dense liquid material.
Previously, we were able to show the strong dependence of protein crystallization
on salt concentration (YCl3) and temperature
[227]. Here, we give an example of
the same sample near c** that follows different pathways by varying temperatures
below Ttr, similar to the experiments with ZnCl2 described above. In Figure 3.4,
the crystal growth process of a sample with 33 mg/mL BLG and 6.0 mM YCl3
at 293 K (labeled [c] in Figure 3.1b) is shown. This temperature is close to Ttr
and the sample was slightly turbid at first, but no macroscopic LLPS was visible
(Figure 3.4a). Crystallization occurred after about 3 days (Figure 3.4b). With
crystal growth, the turbid solution became clear and only crystals were visible in
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(a) (b)
(c) (d)
Figure 3.4: Pictures originate from samples prepared by the hanging drop
method without prior centrifuging. Crystal growth at 293 K with a protein con-
centration of 33 mg/mL and 6.0 mM YCl3, close to the transition temperature.
No liquid phase was visible but turbidity caused by large clusters. (a) After 3.5 h.
(b) After 75 h. (c) After 101 h. (d) After 165 h.
(a) (b)
(c) (d)
Figure 3.5: Formation of droplets at the sample-glass interface in a cuvette and
crystal growth at 277 K. The sample has a concentration of 33 mg/mL BLG and
6.0 mM YCl3. (a) Directly after preparation: turbid sample. (b) After 2 h: fine
liquid network. (c) After 23 h: large dense liquid regions. (d) After 54 h: crystals.
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the end. No crystal growth was observed at temperatures above Ttr. Well below
Ttr, another process was observed (Figure 3.5). When quenched to 277 K (sample
[d]), the solution becomes turbid quickly and massive amorphous clusters are
clearly visible (Figure 3.5a). With time, these clusters formed a liquid network
(Figure 3.5b and c). Crystal growth was observed mainly at the interfaces and
the dense liquid-like network is consumed in the end. A similar crystallization
pathway was also observed for samples with higher protein concentrations. An
example is shown in Figure 3.1b. The sample contained 65 mg/mL BLG and
13 mM YCl3, the transition temperature is about Ttr = 310 K. When crystallized
at 293 K (sample [e]), a liquid-like network as an intermediate step was observed
(shown in the Supporting Information, Figure A.2). This behavior is very similar
to that observed in Figure 3.3.
The crystallization procedures at different temperatures are inconsistent with
the classical nucleation theory. The appearance of an intermediate phase (macro-
scopic LLPS or microscopic clusters) before crystallization indicates that an addi-
tional free energy minimum exists in between the supersaturated solution and the
final crystalline state. Since the resolution of the optical microscope used in this
work cannot distinguish whether the nucleation starts directly from the dense liq-
uid phase or the cluster phase (or rather takes place as heterogeneous nucleation
at the droplet surface), we simply denote the observed crystallization processes as
different nonclassical pathways. The interesting observation here is that for the
same sample below the transition temperature, depending on the depth of quench,
the intermediate phase of the crystallization can be microscopic clusters or macro-
scopic LLPS. The physical mechanism of this observation will be discussed after
the structural analysis of the resulting crystals.
3.3.3 Effective Protein–Protein Interactions Revealed by
SAXS
SAXS was used to characterize the effective interactions in protein solutions under
conditions similar to the crystallization conditions. We first determined the form
factors of proteins in different regimes using samples with low protein concentra-
tion, i.e., 3.3 mg/mL (Figure 3.6a). At very low salt concentrations, the SAXS
data can be well fitted using the crystal structure of the BLG dimer (PDB code
of 1BEB) using Crysol [186], which can be simplified by an ellipsoid form factor
with axis a=38 A˚ and b=19 A˚. The respective fitting parameters are shown in the
Supporting Information, Table A.1. It was found that the values of a and b were
nearly constant and a > b in the first regime (i.e. for 0.1 and 0.3 mM ZnCl2).
With 20 and 50 mM ZnCl2, the values of b became larger and a < b, indicating
the formation of oblate-like clusters in the third regime. The minimum in scat-
tering intensity at a q of ≈ 0.18− 0.25 A˚−1 in Figure 3.6a and b, is dominated by
the form factor. This is in contrast to the data from BLG solutions in the pres-
ence of YCl3
[223], where a peak was observed at 0.22 A˚−1 that was assigned to the
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Figure 3.6: SAXS measurements at 3.3 mg/mL and 65 mg/mL BLG with various
ZnCl2 concentrations. For better visibility, the curves were shifted in intensity
and only every third data point is shown. (a) Fitted form factors for 3.3 mg/mL
BLG (continuous lines: ellipsoid form factor, dashed line: form factor from crystal
structure). (b) SAXS measurements at 65 mg/mL BLG with ZnCl2 concentrations
in the first and third regime. (c) Calculated structure factor of 65 mg/mL BLG
with part of the ZnCl2 concentrations from b.
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monomer-monomer correlation within the clusters. The reason for this difference
may be the stronger bridging effect of yttrium in comparison to zinc as explained
in the following section.
Samples in the condensed regime were also measured, but due to the precipita-
tion of proteins, these results were not used for further analysis.
SAXS data for samples with higher protein concentrations were analyzed for
the effective interactions. Figure 3.6b and c present the SAXS data and calcu-
lated structure factor for samples with 65 mg/mL BLG and various salt concen-
trations. The corresponding c* and pseudo − c** are around 7 mM and 30 mM,
respectively. At low salt concentration, i.e. well below c*, the SAXS data can
be well described by a combination of an ellipsoid form factor and a screened
Coulomb structure factor [73,77], indicating repulsive interactions between protein
molecules. The strength of repulsion decreases with increasing salt concentration
and the fitted surface charge continuously decreases upon approaching c* (Sup-
porting Information, Table A.2). In the third regime, an ellipsoid form factor with
a sticky hard sphere structure factor was used [15], which represents a short-ranged
attractive interaction potential. The obtained volume fractions are close to the
calculated value and the interaction strength decreases if the salt concentration is
further increased from pseudo− c**.
In summary, our SAXS measurements suggest that the effective interactions
are repulsive and dominated by the surface charges of proteins at low salt con-
centrations (ZnCl2). With increasing salt concentration, the repulsive potential
is reduced and the potential becomes attractive approaching c*. In the third
regime, the effective interactions are still attractive, but decrease in strength with
increasing salt concentration in good agreement with the visual observation that
the solutions become less turbid. Because the attractions in the condensed regime
are too strong for the growth of high quality crystals, the SAXS measurements
indicate that the optimized conditions of crystallization would be near the two
boundaries. These results are consistent with previous studies of BLG solutions
in the presence of YCl3
[223].
3.3.4 Crystal Structures and the Role of Multivalent
Metal Ions
We determined the structures of two crystals (BLG-Zn-20, BLG-Zn-2) to reso-
lutions of 2.44 A˚ and 2.40 A˚ respectively, including the zinc positions that could
be determined unequivocally. Both crystals belong to space group P32 2 1 and
contain one monomer in the asymmetric unit. The 2-fold axis of the biological
dimer is aligned with the crystallographic axis. Although the same space group
has been reported for BLG crystals earlier [146], this crystal form is new and differs
in the unit cell dimensions. The crystal packing of BLG with zinc ions is shown in
Figure 3.7a. Data collection and refinement statistics of both structures are given
in the SI in Tables A.3 and A.4.
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The positions of zinc ions were determined by an anomalous density map us-
ing the Bijvoet differences as Fourier coefficients and relative occupancies were
determined during the refinement process. In both cases, one crystal contact is
mediated by a zinc ion. Furthermore, a different number of additional zinc ion
binding sites is not contributing to the crystal lattice formation.
The analysis of the cation binding sites in BLG-Zn-2 shows that the crystal
contact is mediated by a zinc ion (zinc 1 in Figure 3.7), which is coordinated by
residues D53 and E74 from one protomer and E158 and H161 from a symmetry
related protomer (Figure 3.7b). An additional zinc binding site is found at H146,
without mediating a crystal contact. In contrast to the fully occupied zinc 1
binding site, this site is only partially occupied (30%) at a concentration of 2 mM
ZnCl2. An image is found in the SI in Figure A.4.
The zinc ions in BLG-Zn-20 mediating a crystal contact are coordinated by the
same residues found in BLG-Zn-2 with the exception of E158 (Figure 3.7c). This
residue is located at a different position. The zinc binding site at H146 (shown
in Figure 3.7d) is found in BLG-Zn-20 as well, but the occupancy is higher (75%)
compared to BLG-Zn-2 which is in good agreement with the ZnCl2 concentration.
Furthermore, 3.3 A˚ away from the carboxy group of E158, a peak in the anomalous
map indicates the presence of an additional zinc site. Modelling of a zinc ion with
low occupancy resulted in long binding distances to E158 (shown in Figure 3.7e)
which indicates a very loose metal binding site and was therefore not included in
the final structure coordinates. A second additional binding site can be found at
E51 with an occupancy of ca. 70% (shown in Figure 3.7c).
A packing analysis of both structures was performed by PISA [91]. In addition to
the dimeric interface, which buries solvent accessible areas of 514 A˚2 and 590 A˚2 for
BLG-Zn-2 and BLG-Zn-20, respectively, additional proteinaceous contacts build
up the crystal lattice ranging from 35 A˚2 to 278 A˚2. In case of 2 mM ZnCl2, the
crystal contact mediated by zinc 1 has an interface of 73 A˚2 and in case of 20 mM
ZnCl2, the area has a size of 77 A˚
2. For the additional zinc binding sites, the
interface areas are 42 A˚2 for zinc 2 in the structure with 2 mM ZnCl2 and 40 A˚
2
and in case of 20 mM ZnCl2 39 A˚
2 for zinc 2 and 3, respectively.
In previous study, we determined structures of BLG crystallized in the pres-
ence of different concentrations of YCl3 on the basis of its phase diagram (PDB
codes 3PH5 and 3PH6, Ref. [227]). We reported four yttrium ions in the BLG-Y
structures, all of them were coordinated by acidic side chains and contribute to
the lattice formation. One yttrium site (yttrium 4) showed substantially lower
occupancy when lower concentrations of YCl3 were applied in the crystallization
process. BLG-Zn crystals share some similarities with BLG-Y, but also strong dif-
ferences. As in BLG-Y, the bridging metal ions in BLG-Zn are coordinated mainly
by acidic side chains, which is obvious, as acidic side chains compensate for the
positive charge of the metal ions. In BLG-Zn, zinc ions are moreover coordinated
by histidine residues, e.g. H161 at zinc 1. Coordination of zinc by histidine side
chains is frequently observed in nature, e.g. in the family of zinc finger proteins
(Ref. [170]). In contrast to BLG-Y, where four sites built up a three-dimensional
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(a)
(b)
(c)
(d) (e)
Figure 3.7: (a) Crystal packing of BLG crystallized with 2 mM and 20 mM ZnCl2.
Two representative dimers are colored blue and green. Asymmetric units are rep-
resented by different color shades. Other monomers in the unit cell are represented
in gray. Zinc ions are presented as gray spheres. Representative zinc ions are col-
ored red (zinc ion mediating the crystal contact of the two representative dimers)
and blue. Additional zinc sites identified in BLG-Zn-20 exclusively are colored
magenta and orange. (b-e) Cation binding sites in BLG-Zn-2 (b) and BLG-Zn-20
(c-e). Density maps were calculated with FFT [195]. Sigma levels of the maps are
σ = 1.0 for 2Fobs-Fcalc maps (gray) and σ = 4.0 for anomalous maps (orange).
Zinc 4 is not included into the coordinates due to its long binding distances.
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Table 3.1: Comparison of BLG-Y and BLG-Zn Structure
space group binding sites bridging sites
BLG-Y P21 21 21 4 4
BLG-Zn P32 2 1 4 1
crystal lattice, we identified a single zinc ion contributing to the lattice formation
(Figure 3.7b, Table 3.1). Another zinc site was identified, coordinated solely by
H146 (Figure 3.7d), and it did not contribute to protomer-to-protomer interac-
tions. Interestingly, this site revealed a concentration-dependent effect similar to
yttrium 4 in BLG-Y. Moreover, at higher zinc concentrations an additional metal
ion was identified. A highly speculative explanation for the reduced amounts of
bridging metal ions might be found in the decreased Lewis acid character of zinc
ions compared to yttrium ions, which might hamper the intermolecular bridging
effect. This is in good agreement with the observation that main crystal contacts
in BLG-Zn derive from proteinaceous interactions. In summary, crystallographic
analysis indicates that the bridging effect of high valency metal ions promotes new
protein contacts and stabilizes crystal lattice with both metal salts.
3.4 Discussion
We have determined the phase behavior of the globular protein BLG in the pres-
ence of the divalent salt ZnCl2. The phase behavior is similar to that observed
for BLG solutions in the presence of trivalent salts, such as YCl3. However, the
RC behavior in the presence of ZnCl2 is not generally found for other acidic pro-
teins examined, such as BSA and HSA. Despite this specificity, the solutions near
the second phase boundary show similar temperature-dependent phase transitions.
Moreover, while crystallization follows the classical one-step pathway near c* with
both salts, the crystal growth near (pseudo)-c** follows nonclassical pathways de-
pending on the crystallization temperature. These findings and their possible
interpretation are summarized in Figure 3.8. In the following, we discuss our ex-
perimental observations based on the established phase behavior in model colloidal
systems.
Colloidal systems with short-range attraction exhibit a phase diagram (T , c)
with a metastable LLPS [7]. Although such a phase diagram is to be determined
for the investigated systems, the observed temperature-dependent intermediate
phases can still be explained using Figure 3.8a. At salt concentrations close to c*
(top), the crystallization follows a classical one-step process and does not depend
strongly on temperature. The hidden LLPS, if it exists, is far below the gas-crystal
(G-C) phase boundary (outside the observed temperature range) under these con-
ditions. Lowering the temperature for crystallization within the G-C region does
not change the nucleation behavior. This pathway is labeled as ”1”. At high salt
concentrations, close to (pseudo)-c** (bottom), the existence of an intermediate
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Figure 3.8: (a) Possible location of investigated samples in a typical phase di-
agram (T , c plane) for colloidal systems with a short range attraction. Samples
near c* may have a metastable LLPS region far below the G-C boundary, whereas
samples near (pseudo)-c** have a LLPS region very close to the G-C bound-
ary (in both BLG-Y and BLG-Zn). Adapted and modified from Ref. [7]. (b)
Free energy landscape of the different crystallization pathways. The additional
minimum corresponds to the formation of intermediate phases during the non-
classical crystallization. Adapted and modified from Ref. [202]. (c) Summary of
the observed crystallization pathways. ”Path-1” represents the classical one-step
pathway which is followed by samples near c*. ”Path-2” and ”Path-3” represent
nonclassical pathways with an intermediate phase of protein clusters and macro-
scopic LLPS, respectively, that are followed close to (pseudo)-c**. Note that these
nonclassical pathways are not necessarily the same as the ”two-step” mechanism
proposed in theory [196]. Details are discussed in the text.
phase suggests that the liquid-liquid (L+L) coexistence region is very close to the
G-C phase boundary. When quenching the solution only slightly below the tran-
sition temperature, the sample is in the state labeled as ”2” in the sketched phase
diagram. This position is slightly below the G-C boundary, but importantly, it is
also very close to the binodal of LLPS. Under these conditions, density fluctua-
tions lead to the formation of a microscopic protein cluster phase before crystal
nucleation occurs. This scenario (”Path-2”) is shown in Figures 3.2 and 3.4. At
higher temperature, the gas phase region is reached and no crystallization can be
found anymore. If the sample is quenched deeper, i.e. to location ”3” which is
well below the LLPS boundary, then macroscopic metastable LLPS occurs as the
intermediate phase before nucleation. This scenario (”Path-3”) has been shown
in Figure 3.3 and 3.5.
The corresponding free energy landscapes of these three pathways are described
in Figure 3.8b. In the classical pathway associated with ”Path-1”, there is one free
energy maximum, an energy barrier that has to be overcome in order to nucleate.
The free energy landscapes of the nonclassical pathways show an additional min-
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imum corresponding to the intermediate phase. If the free energy of the interme-
diate phase is higher than the free energy of the initial solution, the intermediate
phase is unstable and consists of mesoscopic clusters. This could be the case for
samples close to the LLPS boundary like ”Path-2”. If the free energy of the in-
termediate phase is lower than that of the initial solution, the metastable phase
is a macroscopic dense liquid phase, e.g. ”Path-3”. This has been summarized in
Ref. [202].
In Figure 3.8c, the observed crystallization pathways are illustrated. For samples
prepared close to c*, nucleation occurs directly in the supersaturated solution
with no intermediate structure or phase transition. This classical pathway is
referred to as ”Path-1”. Near (pseudo)-c**, two different nonclassical pathways
are observed depending on the crystallization temperature. ”Path-2” describes
the crystallization of samples located near the LLPS binodal in Figure 3.8a where
density fluctuations lead to the microscopic clusters before nucleation. ”Path-
3” describes that protein solutions first undergo a macroscopic LLPS as it locates
deep inside of the LLPS region before crystallization starts. However, the existence
of an intermediate phase does not mean that the nucleation occurs within protein
clusters or the dense liquid phase. Our observations as well as other experimental
studies [30] suggest that crystallization takes place rather at the interface of dense
and dilute regions than within the dense phase. These nonclassical pathways
observed experimentally are not the same as the two-step process first predicted
by ten Wolde and Frenkel [196]. The theoretically predicated ”two-step” mechanism
describes one nucleation event in which the two order parameters (density and
structure) develop in two different time scales, i.e. the supersaturated solutes first
undergo a density development and form clusters or macroscopic coexistent liquid
phases. In the second, subsequent step, the clusters or the dense liquid phase with
already higher density undergoes a structure change and complete the nucleation
event. In practice, however, another nonequilibrium phase behavior in the dense
phase, i.e. gelation, may prevent the second step of structure formation as any
conformation change in a gel state will be extremely slow.
On the other hand, when looking at the phase diagram in Figure 3.8a (bottom),
because the G-C and L-L phase boundaries are very close, samples located in this
region face two potential phase transitions, i.e. both crystallization and LLPS. Ki-
netically, LLPS occurs faster than crystal nucleation as the corresponding energy
barrier is lower. Energetically, LLPS is metastable with respect to the crystalline
state. From this point of view, one cannot completely rule out the possibility of
two parallel classical phase transitions. Further studies should focus on real-time
characterization of the role of the intermediate phase on the nucleation process,
the early nucleation, and growth kinetics of such a nonclassical crystallization
process.
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3.5 Conclusion
We have studied the influence of the di- and trivalent electrolytes ZnCl2 and YCl3
on protein (BLG) crystallization on levels from macroscopic phase behavior to
the effective intermolecular interactions and further down to the atomic crystal
structures.
A reentrant condensation phase behavior has been observed in protein solutions
with both salts, i.e., a condensed regime exists between c* and (pseudo)-c**.
The reentrant effect is weaker with ZnCl2, which might be mainly due to its
lower valency compared to YCl3 and other trivalent salts. SAXS measurements
indicate that both salts can tune the effective protein–protein interaction from
repulsive to attractive by crossing c*. Above (pseudo)-c**, the interactions are still
attractive but decrease with further increasing salt concentration. The effective
attractions near c* and (pseudo)-c** provide the optimum conditions for protein
crystallization.
Crystal growth in these areas followed by optical microscopy show different
scenarios: while crystal growth near c* follows a classical one-step pathway, two
different nonclassical pathways are observed close to (pseudo)-c** depending on
the crystallization temperature. If the crystallization temperature is close to the
transition temperature, the intermediate phase is a microscopic cluster phase. If
the sample is quenched well below the transition temperature, the intermediate
phase corresponds to a macroscopic LLPS. These temperature-dependent nonclas-
sical pathways are discussed based on the phase behavior of colloidal systems with
a short ranged attraction where a metastable LLPS region exists below the G-C
coexistence line. Furthermore, crystallographic analysis of the resulting high qual-
ity protein single crystals demonstrates that the multivalent metal ions provide
new contacts within the lattice via bridging.
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We present a real-time study of protein crystallization of bovine β-lactoglobulin
in the presence of CdCl2 using small angle X-ray scattering and optical microscopy.
From observing the crystallization kinetics, we propose the following multistep
crystallization mechanism that is consistent with our data. In the first step, an
intermediate phase is formed, followed by the nucleation of crystals within the
intermediate phase. During this period, the number of crystals increases with time,
but the crystal growth is slowed down by the surrounding dense intermediate phase
due to the low mobility. In the next step, the intermediate phase is consumed by
nucleation and slow growth, and the crystals are exposed to the dilute phase. In
this stage, the number of crystals becomes nearly constant, whereas the crystals
grow rapidly due to access to the free protein molecules in the dilute phase. This
real-time study not only provides evidence for a two-step nucleation process for
protein crystallization but also elucidates the role and the structural signature of
the metastable intermediate phase in this process.
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4.1 Introduction
Protein crystallization is the bottleneck of many projects in structural biology,
since, in general, suitable crystallization conditions cannot be reliably predicted [127].
In classical nucleation theory, the solute molecules reversibly aggregate in the su-
persaturated solution and form nuclei with the density and structure of the crystals
in the final stage. While classical nucleation theory has been successfully used in
many systems, including protein crystallization under certain conditions [180], var-
ious studies in the crystallization of proteins, colloids and clathrate hydrates as
well as biomineralization have shown features beyond the classical view in the
early stage of nucleation [34,57,58,83,171,211].
In contrast to atomic systems, proteins and colloids often have an attractive
interaction short-ranged compared to the size of the particles, as demonstrated
by experiments [30,64,65,100,137,138], theory [79,198], and simulations [164,196]. Such short-
ranged attraction leads to a liquid–liquid phase separation (LLPS) which is meta-
stable with respect to the crystalline phase [7,70,142,196,202]. For these systems, a
two-step (or multistep) mechanism of crystal nucleation has been discussed, i.e.
an intermediate state, either cluster, aggregates or a dense liquid phase, exists
between the initial solution and the final crystalline state and may serve as the
nucleation precursor. We note that throughout this paper, we use the term ’aggre-
gates’ instead of ’clusters’ to avoid misinterpretation. An important theoretical
prediction is that nucleation is favored in the dense liquid intermediate phase com-
pared to the dilute phase, since the surface energy of the dense phase is closer to the
final crystalline state, and the free energy barrier for nucleation is lower [171,196,202].
However, experimental observations in several protein systems suggest that crys-
tals nucleate mainly from the dilute phase or at the interface of the dense liquid
droplets and grow outside of it into the dilute phase [30,100,148]. Despite the existing
various theoretical concepts, clear experimental evidence and suitable methods to
distinguish the early stage of nucleation are rather rare [161,168,181,228]. Early stud-
ies of protein crystal growth in real space using atomic force microscopy have
revealed many important features of the metastable protein clusters and their role
in the nucleation process [94,111,119,181,201]. However, the quantitative real-time in
situ characterization of the transition kinetics and microscopic structure from the
metastable intermediate phase to the stable crystalline phase is still a challenge.
Our previous studies have shown that trivalent salts such as YCl3 lead to a
reentrant condensation and metastable liquid–liquid phase separation phase be-
havior in many solutions of negatively charged proteins [220,224,226,227]. Importantly,
crystal growth depends on the exact location in the phase diagram: Depending on
external control parameters such as salt concentration and temperature, classical
crystallization or a temperature-dependent nonclassical process were observed, but
could not be analyzed in further detail regarding kinetics and nucleation mecha-
nism. The optimum crystallization conditions were found close to the reentrant
condensation phase boundaries [227].
In this work, we investigate the crystallization kinetics of the globular pro-
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Figure 4.1: Schematic of all processes in two possible pathways of crystallization.
(a) Nucleation directly from the liquid, parallel formation of ”intermediates” that
are redissolved or consumed by the growing crystals. (b) Intermediates are formed
first and act as precursor for crystal nucleation.
tein β-lactoglobulin (BLG) in the presence of the divalent salt CdCl2 by real-time
SAXS and optical microscopy. BLG has turned out to be a good model system for
crystallization by tuning the protein interactions utilizing reentrant condensation
with trivalent salts. Here, we focus on the effect of the formation of aggregates
on the crystallization process and which crystallization pathways are followed. In
a distinct phase diagram region, protein aggregates form before crystallization.
Given the dimensions of proteins, a direct optical visualization of the nucleation
process in protein solutions is not possible. Here, we employ the method of real-
time SAXS, monitoring the nucleation process by means of structural information
on the solutes such as protein monomers, crystals, and intermediates. These ex-
periments raise interesting questions regarding protein nucleation. A model is
proposed to explain the main features of the experiments. Different scenarios of
crystal formation can be compared to the kinetic data. While the classical one-step
nucleation describes the direct nucleation and growth from a homogeneous solu-
tion, in particular two nonconventional pathways are discussed (see Figure 4.1):
first, a parallel process of one-step crystal nucleation accompanied by an ”in-
termediate” that forms and dissolves in the solution depending on concentration
(Figure 4.1a). In this pathway, crystal growth takes place via the liquid or possibly
by incorporation of aggregates, which, however, are not essential for crystal nu-
cleation. Second, a two-step process of crystal nucleation within an intermediate
that forms first from solution and is later transformed to crystals (Figure 4.1b).
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4.2 Experimental
Lyophilized protein powder of β-lactoglobulin (BLG) from bovine milk and the
divalent salt cadmium chloride (CdCl2) were purchased from Sigma-Aldrich (prod-
uct no. L3908 and 202908) and used as received.
Stock solutions were prepared by dissolving the protein powder or salt in deion-
ized (18.2 MΩ) and degassed Millipore water. All samples were prepared by mix-
ing the needed amount of protein, salt stock solution, and Millipore water. The
protein concentration was determined by UV absorption using an extinction coef-
ficient of 0.96 mL·mg−1cm−1 at a wavelength of 278 nm [182]. To avoid the effect of
buffer on the phase behavior, no additional buffer was used for sample prepara-
tion. The pH of the solutions was monitored using a Seven Easy pH instrument
from Mettler Toledo and was in between 6.0 and 7.0. Compared with the pI = 5.2
of BLG [44], the pH effect of added salt could not lead to the charge inversion of
proteins [151,226]. All experiments were performed at 293 K.
Circular dichroism (J-720 spectrophotometer from Jasco Inc.) and Fourier
transform infrared spectroscopy (FTIR) (IFS 48 from Bruker) were applied to
monitor the stability of the protein secondary structure under the experimental
conditions.
Crystal growth was followed by optical microscopy (DME from Leica Microsys-
tem GmbH or AxioScope A1 from Zeiss). Before crystallization, protein stock
solutions were filtered (100µm). The crystallization process was performed using
either a vapor diffusion hanging drop method or a batch method between two
narrow glass slides (thickness approximately 300µm), sealed by silicone. Both
methods gave similar results.
SAXS measurements were carried out at the ESRF, Grenoble, France at beam-
line ID02. With a sample-to-detector distance of 2 m and an energy of 16047 eV,
the accessed q-range was 0.06-4.3 nm−1. Details of the beamline, data collection,
and calibration can be found in Ref. [129]. For time-resolved SAXS measurements,
freshly prepared sample solutions in a quartz capillary were quickly transferred
to the sample station and the measurement started about 2-3 min after mixing.
SAXS data were collected every 2-5 min depending on the samples. The exposure
time was 0.05 s. To check the consistency of the measurements, the sample was
shifted vertically to different positions. This cycle was repeated every 2-5 min.
Only the data from one position as a function of time was used for the data
analysis shown below, but data from all positions are consistent with our analysis.
4.3 Results
4.3.1 Experimental Phase Diagram and Protein Stability
To provide a basis for the kinetic studies, we first present the experimental phase
diagram of BLG in the presence of CdCl2 (Figure 4.2). Upon adding CdCl2,
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Figure 4.2: Experimental phase diagram of BLG and CdCl2 at room temper-
ature. Yellow stars mark the conditions used for the SAXS experiments. Inset:
Samples with a fixed BLG concentration (10 mg/mL) and increasing CdCl2 con-
centrations (from left to right: 0.6, 0.8, 30, and 90 mM).
BLG solutions show a sharp transition c* from a clear solution at low CdCl2
concentrations (regime I) to a turbid one with massive precipitates at higher
CdCl2 concentrations (regime II). At further increased salt concentrations, the
precipitates are gradually dissolved and the solution becomes less turbid, but
not completely clear even for a very high salt concentration. This is in contrast
to systems with trivalent salts where we observed a second border c** above
which samples become completely clear again (reentrant effect) [220,226]. We define
this partial transition zone to clear solutions as pseudo-c**. The region above
pseudo-c** is denoted as regime III. Zeta potential measurements show that a
CdCl2 concentration-dependent charge inversion of the protein takes place (S.I.,
Figure B.1b). In Figure 4.2, stars mark the conditions used for the real-time SAXS
measurements. Under the current experimental conditions, no liquid–liquid phase
separation was observed in BLG solutions in the presence of CdCl2, in contrast
to some of the other protein-salt systems showing reentrant condensation [224]. In
these cases, the liquid–liquid phase separation region is found as a closed area
within the second regime.
We emphasize that the observed protein condensation is not caused by a change
of the protein structure induced by CdCl2. We have performed Fourier transform
infrared (FTIR) and circular dichroism spectroscopy for a broad protein and salt
concentration range as presented in Figure 4.3. Both techniques indicate no sig-
nificant change on the secondary structure of the protein. Time-dependent FTIR
spectra of the amide I and II bands also confirm that no significant structural
change occurs during the entire crystallization process (S.I., Figure B.1a).
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(a) (b)
Figure 4.3: (a) FTIR results (amide I and II) for a BLG concentration of
20 mg/mL and CdCl2 concentrations between 0 and 30 mM (covering all three
regimes). (b) Circular dichroism spectra for samples with a BLG concentration of
0.2 mg/mL and CdCl2 concentrations between 0 and 5 mM.
4.3.2 Crystallization Followed by Optical Microscopy
Crystallization of BLG in the presence of CdCl2 was observed within a wide range
of the above shown phase diagram. Slightly below and above c*, no indications
for a multistep process were observed: Crystals nucleate directly from a solution
and grow larger without any visible clustering or liquid–liquid phase separation
(Figure 4.4a-c). The typical shape of the crystals is needle-like under these con-
ditions. In contrast, in the transition zone of pseudo-c** (Figure 4.4d-f), protein
aggregates form quickly after sample preparation and the solution observed by
optical microscopy becomes more turbid. During crystallization, the turbid so-
lution becomes gradually clearer, indicating that the aggregates are consumed.
Removing the aggregates by centrifuging can significantly reduce the number of
crystals, as also shown in other protein systems [181].
We further analyze the time dependence of the number and size of crystals.
The visible area A of crystals in the microscopy pictures was determined by the
open source program ImageJ [167]. The average crystal length can be estimated as
L ≈√A/N , whereN is the number of crystals in the respective image. Figure 4.4g
shows the evolution of L andN with time. In the beginning, the number of crystals
increases linearly and then saturates. After the visible crystals stop increasing in
number, they still significantly increase in size. The increase in L is slow until
80 min, then faster growth starts and eventually saturates due to depletion of
protein. The effect of centrifuging on the number of crystals and the acceleration
of the growth rate after 80 min suggest that nucleation is closely related to the
amount of protein portioned in aggregates formed in the early stage of sample
preparation.
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Figure 4.4: Real-time observation of crystal growth by optical microscopy. (a-c):
Crystallization of a clear sample slightly below c* (6.5 mg/mL BLG with 0.7 mM
CdCl2), directly after preparation (a), after 30 min (b) and after several days
(c). (d-f): Nonclassical crystallization in the pseudo-c** zone (3.3 mg/mL BLG
with 7 mM CdCl2) 20 min (d), 30 min (e), and 120 min after preparation (f).
(g): Quantitative analysis of a nonclassical crystallization process for a sample
within pseudo-c** (20 mg/mL BLG with 15 mM CdCl2, see also video in S.I.).
The number of crystals N (filled red circles, left axis) and the average length
L =
√
A/N (open diamonds, right axis) are plotted as a function of time. Right:
Evaluation of the area A of crystals.
4.3.3 Crystal Growth Followed by Real-Time SAXS
Because of the fast crystallization process and limited resolution of optical mi-
croscopy, it is impossible to deduce the role of protein aggregates on the nucleation
process by this method. For this purpose, we employ real-time SAXS to follow
the early stage of crystallization. Figure 5.5 shows time-resolved SAXS data for
crystallization slightly below c* (Figure 5.5a) and within the transition zone of
pseudo-c** (Figure 5.5c). By dividing each curve by the first one, we monitor the
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evolution of the samples. This is shown in the bottom projections of the 3D-plots.
In Figure 5.5b,d, I(q, t) and I(q, t)/I(q, t = 0) are plotted at selective times for
further discussion. For comparison, the form factor of BLG is also shown (blue
dotted line).
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Figure 4.5: Real-time SAXS curves for 33 mg/mL BLG with 4 mM (a-b), i.e.
slightly below c*, and 20 mg/mL BLG with 15 mM CdCl2 (c-d), i.e. within pseudo-
c**. (a,c) 3D surface illustration of I(q, t). The bottom projections are created
from all curves divided by the first one. The arrow in (c) points to an additional
structure forming before crystallization. (b,d) Single I(q, t) and I(q, t)/I(q, t = 0)
curves at selective times multiplied by constant factors for better visibility. The
blue dotted line shows the form factor of BLG at low concentrations.
Below c*, the scattering curves change gradually with time. After an induction
time (20 min in the example shown in Figure 5.5a-b), Bragg peaks appear and grow
with time. Less pronounced Bragg peaks at later times are caused by crystals
sedimenting out of the beam position. This is occasionally observed close to
c*, where the samples are less viscous than within the pseudo-c** zone. Apart
from that, the underlying shape of the curves barely changes with time. No
indication of states other than solution and crystal was found. Similar behavior
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was found for other samples slightly below and above c*. Hence, close to c*, the
crystallization process is consistent with the observation by optical microscopy
and can be explained by classical nucleation theory.
Importantly, within the region of pseudo-c**, I(q, t) follows a power law of
q−2 at low q directly after preparation (the change of the exponent is shown in
Figure B.2 in S.I.), deviating strongly from the form factor of BLG under physio-
logical conditions (blue dotted line in Figure 5.5b,d). This is consistent with the
formation of aggregates after sample preparation [63,99]. The data were analyzed
by normalizing the time-dependent I(q, t) by I(q, t = 0), which minimizes the ef-
fect of the form factor and the aggregate formation in the system and emphasizes
the time-dependent relative changes. With increasing time, a broad maximum at
0.7− 1.4 nm−1 appears (Figure 5.5c-d). Since scattering probes molecular and so-
lution structures directly and thus is sensitive to changes of particle correlations,
the time-dependent change of this broad peak can be interpreted as the evolu-
tion of a new structural feature within the larger aggregates at length scales of
about 10 nm. Over time, this broad peak increases in intensity until Bragg peaks
start to be observed. The two most pronounced Bragg peaks located at 1.01 and
1.27 nm−1 overlap with the broad maximum. The intensity of the Bragg peaks
increases with time, whereas the broad peak shrinks and eventually disappears.
Similar crystallization behavior was also observed for other samples within the
region of pseudo-c** (cf. Figure 4.2).
To quantify the relationship between the aggregates (broad peak) and crystals
(Bragg peaks) as a function of time, we use the concept of the degree of crys-
tallinity known from semicrystalline polymers [185] for further data analysis: The
intensity at the minimum (at around 0.5 nm−1) was subtracted to set Imin to zero.
Then, the broad peak in I(q, t)/I(q, t = 0) was fitted by a broad scaled Gaus-
sian, and the remaining Bragg peaks were fitted by two further (sharp) Gaussian
functions (Figure 4.6a). For different times, the enveloped area of the broad re-
gion, Ainterm, and the area of the Bragg peaks, ABragg, were followed over time,
monitoring the crystallization kinetics.
Figure 4.6b shows Ainterm (red spheres) and ABragg (green stars) as a function
of time. The formation of the intermediate phase starts from the very first mea-
surements on, increasing with time up to a maximum after approximately 42 min.
Afterwards, Ainterm decays gradually to zero. ABragg, on the other hand, is zero in
the beginning and becomes visible after 30 min. Interestingly, the increase with
time is nontrivial: After reaching a plateau around 50-80 min, ABragg increases
dramatically. For further understanding, we show the first time derivative of
ABragg which represents the crystallization rate (blue dashed line in Figure 4.6b,
right axis), calculated at each point in time from the average of the incoming and
outgoing slope. Interestingly, dABragg/dt has a local maximum corresponding to
the maximum of Ainterm, suggesting that the crystallization rate is proportional
to the amount of protein in these aggregates. Recalling the observation in Fig-
ure 4.4g, the early stage of crystallization can be interpreted as dominated by the
nucleation events. This suggests that nucleation occurs within the intermediate
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Figure 4.6: Analysis of the time-dependent data. (a) For data analysis, the areas
of the intermediate and crystalline part of I(q, t)/I(q, t = 0) were evaluated. (b)
Red spheres (left axis) show Ainterm(t), the integral of the broad Gaussian function,
connected to the intermediate state from 0.4 to 1.3 nm−1. Green stars (left axis)
show ABragg(t), the integral of the two Bragg peaks in this area. The blue dashed
line (right axis) shows the time derivative of ABragg(t), the crystallization rate.
The growth rate has a local maximum at the total maximum of Ainterm(t). (c) A
rate equation model based on physically meaningful processes reproduces the ex-
perimental kinetic features. The light-cyan area marks the nucleation-dominated
regime and is followed by the growth-dominated regime (no sharp transition).
phase. The strong increase in ABragg after 80 min can be related to the growth-
dominated stage as observed in Figure 4.4g. The same behavior could be observed
for other conditions within the region of pseudo-c** followed by real-time SAXS.
An analysis for a sample with 33 mg/mL BLG with 17 mM CdCl2 can be found
in the S.I., Figures B.3-B.5. In contrast, all tested conditions close to c* show no
signs of the existence of an intermediate phase between the initial solution and
the final crystalline state.
4.3.4 Discussion: Parallel One-Step Processes versus
Two-Step Process
Based on the above presented real-time results from both optical microscopy and
SAXS, we suggest the following crystallization mechanism: In the first step, pro-
tein aggregates form as an intermediate and crystals nucleate from the aggregate
precursor after a short induction time. The nucleation rate is thus proportional to
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the amount of the intermediate phase; as expected for such a two-step nucleation,
a local maximum in the crystallization rate (and hence a point of inflection in
ABragg) occurs when Ainterm is at its maximum. Crystal growth is slow, possibly
due to the slow dynamics of molecules within the aggregates, which makes it diffi-
cult for proteins to diffuse to the growth front. However, such slow dynamics may
be sufficient for nucleation as less molecules are involved in this process. We note
that if the intermediate is in a kinetically arrested state (even slower dynamics),
nucleation can be strongly impeded [202].
In the second step, the intermediate phase is consumed by nucleation and crys-
tal growth, and the crystals grow rapidly by consuming free protein from the
dilute phase. Proteins in the dilute phase (also in small aggregates as indicated
from SAXS profiles and earlier studies [221]) can be easily incorporated into the
crystal lattice. Importantly, the nucleation rate in the second step is significantly
reduced, which further demonstrates the likely role of the protein aggregates as
the precursor of a two-step nucleation process. All observations are explained very
naturally using the two-step nucleation pathway based on clearly defined physical
concepts (Figure 4.1b).
The proposed two-step nucleation mechanism can be further supported by using
a rate equation model. Before looking into different quantitative models of the
nucleation process, we note three qualitative model-free aspects directly from the
data: (a) The intermediate forms very fast, while the initial crystal nucleation
and growth are much slower. (b) Given the fast formation of intermediate, the
disappearance of the intermediate has implications for its nature. At the time
of disappearance, a considerable concentration in the liquid phase is still present,
since the crystal growth is taking place even later. Thus, the intermediate is not in
equilibrium with the liquid phase, but rather supplied by an excess concentration
in the supersaturated liquid. (c) The plateau in the crystal formation indicates
that the initial crystal growth is much slower than the final crystal growth.
One possible scenario involving an intermediate and crystals is a picture of two
parallel one-step processes as sketched in Figure 4.1a. The intermediate would
form from the supersaturated solution, and subsequently dissolve again, once the
liquid phase is depleted by crystal nucleation and growth. While this scenario is
consistent with observation (a) and (b) above, it cannot explain the plateau (c).
Given the fast kinetics of the formation of the intermediate (a), the concentration
in the liquid stays rather constant at the saturation concentration (b). Thus, once
crystals are present, crystal growth should occur with a similar steeply increasing
signature as in the late growth state, instead of being stagnant for some period.
Thus, the parallel picture fails to explain an essential aspect observed in the
experiment.
We note that it may be possible to introduce ad hoc technical modifications of
the one-step parallel scenario to force-fit the data. Note that these modifications
necessarily would violate a picture of a one-step process along classical nucleation
theory, and rather suggest an effective multistep process. We also note that the
existence of heterogeneous nucleation or the combination of heterogeneous and
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homogeneous nucleation processes might lead to an overall growth kinetics similar
to two or multiple parallel nucleation process, which again will not explain the
plateau. Furthermore, these modifications would rely on a certain combination
of parallel one-step processes, which makes the consequential two-step mechanism
more feasible to explain the experimental results.
The second scenario is the picture of a two-step process of crystal nucleation
from a previously formed intermediate as represented by Figure 4.1b. As shown
in Figure 4.6c, a related model of rate equations based on processes with a clear
physical meaning reproduces all features with very good agreement with the data.
In the following, the system is described in terms of the mass fractions of protein
in the liquid solution (L), in the intermediate phase (I) and within crystals in
the solution (CL) and intermediate phase (CI); (x)+ equals x for positive x and 0
otherwise.
First, the intermediate forms from the solution until the liquid solution reaches
a stable mass fraction L0: ∆I = kI(L−L0)+. Second, crystals nucleate slowly from
the intermediate: ∆n = knI. Third, the crystal growth within the intermediate
depends on the amount of crystals and intermediate: ∆gI = kgIICI . Forth, once
the intermediate phase is consumed and falls below a certain volume per crystal,
the crystals become exposed to the liquid phase: ∆t = ktCI(αICI − I)+. αI is the
ratio of the critical intermediate volume per crystal volume. Finally, once crystals
emerged into the liquid phase, the crystal growth in the liquid phase consumes
the free protein molecules: ∆gL = kgLLCL.
Consequently, the rate equations read
∂tL = −∆I −∆gL (4.1)
∂tI = ∆I −∆n −∆gI (4.2)
∂tCI = ∆n −∆t + ∆gI (4.3)
∂tCL = ∆e + ∆gL (4.4)
with the initial conditions L(0) = 1, I(0) = 0, CI(0) = 0, and CL(0) = 0. The
temporal evolution has been calculated with the Euler method using the following
choices of model parameter: kI = 0.05 min
−1, kn = 0.02 min−1, kgI = 0.1 min−1,
kgL = 0.2 min
−1, ke = 1.0 min−1, L0 = 0.7, and αI = 0.2. Note that the absolute
values of the rates are consistent with the physical picture from this work and
all parameters take physically reasonable values. We emphasize that the general
qualitative result is robust against slight changes of the absolute values.
4.4 Conclusion
In summary, our real-time SAXS and optical microscopy study of protein BLG
crystallization in the presence of CdCl2 provides evidence for a two-step nucleation
mechanism, i.e. protein aggregates form first as an intermediate and crystals nu-
cleate within these aggregate precursors after an induction time. The nucleation
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rate is thus proportional to the amount of the intermediate phase, consistent with
the appearance of a local maximum in the crystallization rate at the maximum
quantity of the intermediate. However, the crystal growth rate is low, which might
be due to the low mobility of proteins within the aggregates. This step lasts until
the intermediate phase is consumed by crystallization, then crystal growth be-
comes faster as proteins in the dilute phase can diffuse to and incorporate into
the growth front directly. In contrast, the nucleation rate is significantly reduced,
which further demonstrates the role of the protein aggregates as the precursor of
a two-step nucleation process. The experimental observations on the nonclassical
growth kinetics have been interpreted using a rate equation model. In addition,
these measurements demonstrate a noninvasive method to study in situ and in
real-time the kinetics of nonclassical growth processes on nanometer length scales.
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We report a real-time study on protein crystallization in the presence of multiva-
lent salts using small angle X-ray scattering (SAXS) and optical microscopy, par-
ticularly focusing on the nucleation mechanism as well as the role of the metastable
intermediate phase (MIP). Using bovine beta-lactoglobulin as a model system in
the presence of the divalent salt CdCl2, we have monitored the early stage of crys-
tallization kinetics which demonstrates a two-step nucleation mechanism: protein
aggregates form a MIP, followed by the nucleation of crystals within the MIP.
Here we focus on characterizing and tuning the structure of the MIP using salt
and related effects on the two-step nucleation kinetics. The results suggest that
increasing the salt concentration near the transition zone pseudo − c** enhances
the driving force for both MIPs and crystal nucleation leading to slow crystalliza-
tion. The structural evolution of the MIP and its effect on subsequent nucleation
is discussed based on the growth kinetics. The observed kinetics can be well de-
scribed using a rate-equation model based on a clear physical two-step picture.
This real-time study not only provides evidence for a two-step nucleation process
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for protein crystallization, but also elucidates the role and the structural signature
of the MIPs in the nonclassical process of protein crystallization.
5.1 Introduction
Studies of the early stage of nucleation in various systems have revealed new features
which cannot be explained using the classical nucleation theory [34,57,58,83,171,211]. A
large body of experimental results supported by theory and simulations suggest
that a metastable intermediate phase (MIP) exists before the final crystal structure
is formed [20,30,64,65,79,100,137,138,161,164,168,181,196,198,228], i.e. the solutes in the supersat-
urated solution form in a first step either small clusters or a macroscopic dense
liquid phase. In the second step, the nucleation occurs within the MIPs. This
two-step nucleation mechanism has originally been proposed by ten Wolde and
Frenkel for crystallization of a colloidal system with short-range attraction and
near the critical point of the metastable liquid–liquid coexistence line [196]. The
two-step nucleation mechanism can be considered as an example of Ostwald’s step
rule in the microscopic world [197]. Later, this concept has been widely used under
various conditions [34,57,58,83,161,168,171,181,202,211,228].
While the two-step mechanism seems plausible for certain experiments, direct
observation of such a process is not easy. Recently, direct visualization of the
crystallization kinetics and pathways of nucleation in colloidal crystallization be-
came possible and provided detailed information on the MIP and the transition in
colloidal suspensions. Colloidal systems exhibit similar phase behavior as atomic
and molecular systems, and their large particle sizes enable visualization on a
single-particle level. Using this technique, Tan et al. studied the liquid-solid phase
transition and observed the formation of a metastable precursor under their exper-
imental conditions, regardless of the final state and the interaction potential [190].
Peng et al. studied the kinetics of a solid-solid phase transition using single-particle
resolution video microscopy. They observed that the transition between two dif-
ferent solid states occurs via a two-step diffusive nucleation pathway involving
liquid nuclei [141]. This pathway is favored in comparison with the one-step nucle-
ation because the energy of the solid/liquid interface is lower than that between
the solid phases.
While these experimental observations on colloidal systems demonstrate that
the two-step nucleation follows Ostwald’s step rule for simple liquids [88,107,161,198],
the application of this concept to other systems, in particular the protein crystal-
lization, is still challenging. The dimensions of proteins on the nanometer scale
limit the applicability of optical methods for the study of the MIP formation.
Because of the larger size and slow dynamics of colloids, the microstructural ar-
rangement of colloidal particles relaxes typically in a time scale of seconds, which
leads to various non-equilibrium phenomena in these systems. Moreover, the
interaction potentials in these colloidal systems are isotropic, whereas the effec-
tive protein-protein interactions are often non-isotropic involving hydrophobic and
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Figure 5.1: Illustrations of different pathways of crystal nucleation and growth.
(a) Classical one-step pathway. (b) Parallel process of aggregate formation and
crystal nucleation. (c) Multi-step process with precursor (MIP) for nucleation.
electrostatic patches as well as ion-bridges. The quantitative description remains
poorly understood [143,173,225].
For these systems, in which the direct visualization is not possible, an other
method has to be developed to characterize the MIP and the nucleation and
growth kinetics. Here, we argue that the two-step nucleation can be distinguished
from the classical one-step process by following the overall crystallization kinetics.
When a MIP exists, particular care should be paid for distinguishing the sequential
and the parallel pathway. The sequential pathway corresponds to the real two-
step nucleation, in which the crystals nucleate from the MIP. The parallel pathway
consists of the parallel formation of MIP and crystals in two one-step nucleation
events from the liquid. The different pathways are illustrated in Figure 5.1.
For a one-step nucleation and growth mechanism with or without MIPs, the nu-
cleation and growth are mainly determined by the supersaturated initial solution.
The overall growth kinetics is expected to show an increase first and to saturate
later. By contrast, for a two-step mechanism, nucleation may occur in both the
MIPs and the initial supersaturated solution, and the nucleation rates are differ-
ent due to the different interfacial energies. Furthermore, the subsequent crystal
growth rates are different too. Therefore, a characteristic two-step growth kinetics
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is expected, dominated by MIP and the initial solution, respectively. More details
will be discussed based on the rate equation model in this paper. Indeed, in our
recent study using time-resolved SAXS and optical microscopy, we have identi-
fied the kinetic signature of two-step nucleation in crystallization of the protein
β-lactoglobulin (BLG) in the presence of CdCl2
[160]. The first step of kinetics is
dominated by the two-step nucleation and growth within the MIP, i.e. protein
aggregates as a MIP are formed, followed by the nucleation of crystals within
the MIP. During this period, the number of crystals increases with time, but the
growth rate is slow due to the low mobility of surrounding aggregates. The second
step of kinetics is dominated by the growth in the dilute phase: the consumption
of the MIP leads to the exposure of the crystals to the free molecules in the dilute
phase, which accelerates the crystal growth. In this work, we focus on the effect
of the structural property of MIP on the nucleation and growth of the two-step
nucleation mechanism.
5.2 Experimental
5.2.1 Materials and Sample Preparation
The globular protein β-lactoglobulin (BLG) from bovine milk (product no. L3908),
CdCl2 (202908) was purchased from Sigma-Aldrich. For sample preparation,
appropriate amounts of salt stock solution, millipore water and protein stock so-
lution were mixed. Stock solutions were prepared by dissolving the salt or protein
powder in deionized (18.2 MΩ) and degassed millipore water. The protein concen-
tration of stock solutions was determined by UV absorption measurements using
an extinction coefficient of 0.96 l · g−1· cm−1 at a wavelength of 278 nm [182]. All
samples in this work were prepared without additional buffer since buffers can
affect the phase behavior of proteins and the solubility of salts. The pH of the
solutions was monitored using a Seven Easy pH instrument from Mettler Toledo.
The pH values for all experimental conditions were above the pI = 5.2 of BLG [44].
Therefore, cation binding is the main driving force of charge inversion instead of
pH [44,151,226]. All experiments were performed at room temperature of 293± 1 K.
5.2.2 Optical Microscopy
Time-dependent protein crystallization was followed by the transmission optical
microscope AxioScope.A1 from Zeiss. The protein stock solution was filtered
(pore size 100µm) in advance. Samples were prepared using a micro-batch setup
with two hydrophobically coated glass slides sealed by silicone (sample thickness
≈ 250-300µm). Images were taken by an included camera AxioCam ICc5.
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5.2.3 Small-Angle X-Ray and Neutron Scattering (SAXS
and SANS)
Small angle X-ray scattering (SAXS) measurements were performed at the ESRF,
Grenoble, France at the beamline ID02. Different energies of 16047 eV and 12460 eV
were used for two different beamtimes, and the sample-to-detector distance was
2 m with an accessed q-range of 0.06 to 4.3 nm−1 or 0.04 to 3.9 nm−1, respectively.
Ex-situ measurements were performed using a flow capillary cell. For real-time
measurements, samples were measured using quartz capillaries in a vertical cap-
illary holder that were quickly loaded and transferred to the sample station after
sample preparation. Measurements started about 2-3 min after mixing and took
place every couple of minutes during the whole crystallization process. The beam
position in the sample was shifted after each exposure (duration 0.05 s) to avoid
radiation damage. For further details on the beamline, calibration and data col-
lection see Ref. [129].
SANS measurements were carried out at KWS1 at FRMII, Munich, Germany.
The applied sample-to-detector distances were 1.5 and 8 m which covers a q-range
from 0.04 nm−1 to 3.1 nm−1 at a wavelength of 7 A˚ (∆λ/λ = 10 %). Protein-salt
solutions in D2O were filled in rectangular quartz cells with a path-length of 2 mm.
The beam size on the sample was 6 mm x 12 mm. Plexiglas was used as secondary
standard to calibrate the absolute scattering intensity. The data correction and
absolute intensity calibration were obtained using the software QtiKWS [144].
5.3 Results
5.3.1 Experimental Phase Diagram of BLG with CdCl2 or
ZnCl2
We first describe the experimental phase diagram of our system which provides
the basis for the following kinetic studies on protein crystallization. Our stud-
ies of globular proteins in solutions containing multivalent metal ions have re-
vealed complex phase behavior including reentrant condensation (RC), metastable
liquid–liquid phase separation (LLPS) and crystallization [86,151,183,220,222,224,226,227].
A similar experimental phase diagram, like the one shown in Figure 5.2, has been
observed for several proteins in solution in the presence of trivalent metal ions.
The physical mechanism of this RC behavior is due to the effective charge inver-
sion of proteins and a cation-mediated attraction, presumably by intermolecular
bridges of multivalent cations [152,227]. With an isoelectric point below 7, the pro-
teins used in our work are acidic at neutral pH. At low salt concentrations, proteins
carry negative net charges, and the electrostatic repulsion stabilizes the solution.
Adding trivalent metal ions into the solution, the binding of metal ions to the
carboxyl groups on the protein surface reduces the effective net charge. Above
a certain salt concentration c*, electrostatic repulsion is not strong enough to
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balance the attractive potential, and samples phase separate and become turbid
(”regime II”). The interesting observation of this system is that with further in-
creasing salt concentration, the continuous binding of metal ions to the protein
surface leads to a charge inversion, which again establishes the long range elec-
trostatic repulsion. Therefore above a second boundary (experimentally rather
broad), c**, the solutions become completely clear again. The charge inversion
and the effective attraction mediated via multivalent metal ions have been further
investigated by experiments, simulations and theoretical studies [5,86,92,151,152].
Figure 5.2: Experimental phase diagram of BLG with ZnCl2 and CdCl2
[158,160].
Both salts share the similar c*, below and above which the protein solutions
are clear and turbid, respectively. Further increasing salt concentration, samples
become gradually less turbid, but not completely clear again, and this transition
zone is denoted as pseudo − c**. The black ellipse marks the conditions mainly
used in this work (33 mg/mL BLG with 15-20 mM CdCl2).
Previous studies on β-lactoglobulin (BLG) systems with divalent salts ZnCl2
and CdCl2 showed a similar experimental phase behavior (Figure 5.2)
[158,160]. For
these divalent salts, the samples above a certain salt concentration become gradu-
ally less turbid, but not completely clear again, and this transition zone is denoted
as pseudo − c**. Both boundaries induced by CdCl2 and ZnCl2 are remarkably
similar as shown in Figure 5.2. In comparison to the trivalent salt YCl3, both tran-
sitions are shifted towards higher salt concentrations [158]. Although the reentrant
effect is not complete, a charge inversion with increasing divalent salt concen-
tration has been observed in both cases (S.I., Figure C.1). Note that the phase
behavior shown in Figure 5.2 was observed for BLG only, but not for bovine or hu-
man serum albumin (data not shown), which suggests a more specific interaction
between these divalent ions and BLG [158].
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We emphasize that the observed protein condensation is not caused by changing
of the protein structure induced by CdCl2, ZnCl2 or other multivalent salts, as
demonstrated in previous work using Fourier transform infrared (FTIR) and circu-
lar dichroism spectroscopy for a broad protein and salt concentration range [80,160].
Both techniques indicate no significant change on the secondary structure of the
protein. Moreover, the successful growth of high-quality crystals and fine struc-
tural analysis confirm that the proteins are still in their native state [158,227].
5.3.2 Crystallization Followed by Optical Microscopy
?
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Figure 5.3: Image series of protein crystallization for samples with a BLG con-
centration of 33 mg/mL and CdCl2 at different time: (a) 17 mM, (b) 18 mM, (c)
19 mM and (d) 20 mM (increasingly less turbid). (a1) 0, (a2) 50 min (a3) 75 min
(a4) 100 min after preparation. (b1) 0 (b2) 75 min (b3) 100 min (b4) 3 h. (c1) 0,
(c2) 100 min, (c3) 3 h, (c4) 6 h. (d1) 0, (d2) 3 h, (d3) 6 h and (d4) 10 h. Videos of
the crystallization process in (a) and (d) can be found in the online S.I.
Crystallization of BLG in the presence of CdCl2 and ZnCl2 was observed within
a wide range of the above shown phase diagram (Figure 5.2) [158,160]. Slightly be-
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low c*, no indications for a multi-step process were observed: Crystals nucleate
directly from a solution and grow larger without any visible aggregation or LLPS.
In contrast, in the transition zone of pseudo-c**, protein aggregates form quickly
after sample preparation and the solution observed by optical microscopy becomes
more turbid. In the case of ZnCl2, the aggregates further relax into a liquid-like
network before crystallization starts [158]. During crystallization, the turbid solu-
tion becomes gradually clearer, indicating that the aggregates are consumed. If
the aggregates are removed by centrifugation, the number of crystals or the nucle-
ation rate can be significantly reduced, as also shown in other protein systems [181].
The two different growth pathways have been observed for the same protein, BLG
with a trivalent salt, YCl3
[158,227].
Within the pseudo − c** region, the crystallization of BLG in the presence of
CdCl2 follows a two-step pathway via aggregates
[160]. Here, we study a series of
samples with fixed protein concentration but varying salt concentration. Variation
of the salt concentration changes the strength of the attractive potential, therefore
the driving force of formation of both MIP and nucleation. Crossing pseudo− c**
from low to high salt concentrations, the driving force is reduced. Figure 5.3 shows
time series of images of crystallization for samples with 33 mg/mL BLG and CdCl2
concentrations of 17, 18, 19 and 20 mM. Below 17 mM, the sample solution is deep
in regime II, where massive amorphous aggregates form and precipitate quickly
from the solution due to the strong attraction. Although crystallization can still
be observed, only a small fraction of the amorphous aggregates can turn into the
crystalline phase. Above 20 mM, solutions become nearly clear, and only small
aggregates are visible under microscope. Crystallization in these solutions becomes
extremely slow or do not crystallize at all.
From the images shown in Figure 5.3, one can see that with 17 mM salt, large
aggregates are still formed, but the nucleation rates are also high. We emphasize
that nearly all crystals are associated with the network. Nearly no crystals form in
the dilute phase. In contrast to the high nucleation rate, the crystal growth period
is short. After about 2 h, no visible change can be observed anymore, and the
resulting system contains a large number of small crystals and most of the network
or the amorphous aggregates has turned into the crystalline phase. Increasing the
salt concentration by only 1 mM, to 18 mM, the overall phenomenological picture
changes dramatically. Large aggregates are still visible, but not well connected to
each other. The number of crystals is reduced but the final crystals are bigger.
Further increasing the salt concentration, protein aggregates become smaller and
the number of crystals is further reduced, but the crystal size is larger. In the
end, the MIP is consumed by crystal growth and the solutions become clear. The
averaged number of crystals normalized by the area of 1 mm2 as a function of time
is plotted in Figure 5.4 for three conditions. The number of crystals increases first
with time, then saturates. The nucleation rates in the early stage are obtained
from the slope of a linear fit, they are 1.44±0.08, 0.32±0.03 and 0.08±0.01 min−1
for 18 mM, 19 mM and 20 mM CdCl2, respectively. This decrease of nucleation
rate is expected as the driving force is reduced with increasing salt concentration.
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Figure 5.4: Number of crystals as a function of time in a normalized area from
Figure 5.3 for samples with 18 mM, 19 mM and 20 mM CdCl2. For the 19 and
20 mM plots, three series of picture sets were analyzed and averaged for better
statistics.
5.3.3 Structure of MIP Revealed by SAXS and SANS
Due to the limited resolution of optical microscopy, SAXS and SANS were used
for studying the structure and the role of the MIP on the crystallization process.
We first show typical SAXS results in Figure 5.5a for samples with a low protein
concentration of 6.5 mg/mL and CdCl2 concentrations covering all three regimes.
In regime I, the scattering curve (with 0.5 mM salt) is dominated by the form
factor of the BLG dimer, which is consistent with the literature that BLG occurs
predominantly as a dimer at room temperature and pH between 3.5 and 7.5 [207].
In regime II, with 1 mM salt, the high q part is still dominated by the form factor,
but in the low q region, the increase of intensity indicates the formation of protein
aggregates. In the third regime (12 - 90 mM, not all data are shown), a new
feature forms shortly after preparation at q ≈0.7 nm−1 and a sharp peak occurs
at 2.2 nm−1, as indicated by the arrows in this figure. A previous study of BLG
in solution in the presence of YCl3 has shown that this maximum corresponds
to the monomer-monomer correlation due to the bridging effect [221]. Here, in the
presence of CdCl2, the peak is sharper. A possible explanation is the formation of a
highly ordered fiber-like structure which gives such diffraction peak corresponding
to the axial translation of the subunit (BLG monomer). Similar diffraction peaks
have been observed in the solution scattering of F-actin [156].
Figure 5.5b presents SAXS data for samples under similar conditions as for the
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Figure 5.5: (a) SAXS measurements at a protein concentration of 6.5 mg/mL
with CdCl2 concentrations covering all three regimes of RC (marked by I, II, III).
(b) Selected SAXS profiles at the time when the broad peak is well developed for
samples in regime III with 33 mg/mL BLG and 15, 17, 18.5 and 20 mM CdCl2,
respectively. Data are shifted upward for clarity.
real-time optical microscopy study in Figure 5.3. The SAXS profiles were collected
during the crystallization process at a time at which the broad peak at q ≈0.7 nm−1
has already developed, but Bragg peaks have not appeared yet. With 15 mM salt,
the sample is located deep in regime II. While large aggregates are visible from
optical microscopy (Figure 5.3a), SAXS profile shows a rather weak shoulder at
q ≈0.7 nm−1, indicating less order within the large aggregates. Increasing salt
concentration increases the ordering inside of the aggregates as the broad peak
becomes more pronounced. The data set with 17 mM salt was collected at a
different beamtime with higher resolution and also shows the monomer–monomer
correlation peak at q around 2.2 nm−1.
We further measured a similar set of samples using SANS. In this case, the sam-
ples were prepared in D2O instead of H2O for better contrast. Neutron scattering
causes no radiation damage to the proteins in solution, and most importantly,
SANS measurements apply a large beam size (6 mm x 12 mm) which covers a
much larger volume containing a reasonable number of crystals. This is in con-
trast to SAXS measurements with a beam size of 0.3 x 0.15 mm which contains
a limited number of crystals in the case of crystallization in Figure 5.3c and d.
The measurements were carried out for freshly prepared samples, 2 h and 6 h after
preparation, respectively. The results shown in Figure 5.6 suggest that the samples
behave very similar as in H2O. First of all, in all cases, the fresh samples show
the broad peak at q ≈0.7 nm−1 which has been identified as the characteristic
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Figure 5.6: BLG 33 mg/mL with 15, 17 and 20 mM CdCl2 in D2O measured by
SANS. Data are shifted upward for clarity. The mismatch of the SANS curves
(especially visible for 20 mM after 2.5 h) was caused by measurements at different
detector positions together with the fast kinetics occurring in the sample.
structural feature of the MIP. However, due to the low time resolution, the details
of the development of this peak cannot be followed. Nevertheless, for the sample
with 20 mM salt, it is visible that this broad peak develops and becomes more
pronounced after 2 h. In addition to this broad peak, the monomer–monomer
correlation peak at q around 2 nm−1 is pronounced in all cases which is in good
agreement with the SAXS measurements. The slight shift of monomer–monomer
peak to the low q value in SANS is due to the hydration effect [223]. Secondly, after
certain time, smeared Bragg peaks appear for all samples. At the same time,
the broad peak (MIP) reduces its intensity or completely disappears. Although
the low resolution of SANS at the high-q region smears the Bragg peaks, their
positions are consistent with the SAXS measurements.
Both SAXS and SANS measurements reveal the similar structural feature of
MIP, i.e. the local ordering within the large protein aggregates characterized by
a broad peak at q ≈0.7 nm−1 and the monomer–monomer correlation peak at q
around 2 nm−1. As discussed in the following section, the broad peak is closely
related to nucleation and crystal growth. It thus becomes the structure signature
of MIP.
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5.3.4 Crystallization Kinetics Followed by Real-Time
SAXS
To extract information on the underlying crystallization process, we employed
real-time SAXS measurements on the crystallization kinetics with high time and
structural resolution. Figure 5.7 shows examples of time-resolved SAXS measure-
ments for 33 mg/mL BLG with 17 (a) and 20 mM CdCl2 (b) in 3D surface il-
lustration and 2D projection, additional data for samples with 15 and 18.5 mM
CdCl2 were shown in S.I., Figure C.2. The bottom 2D projections are created by
dividing all curves by the first one and therefore visualize the ongoing changes in
the system with time. Selected I(q, t)/I(q, t = 0) curves are further presented in
Figure 5.7c&d. The SAXS curves of both samples feature a strong increase at low
q which hardly changes with time, indicating the presence of large aggregates con-
sistent with the observation by optical microscopy. With increasing time, a broad
peak located at q ≈0.7 nm−1 develops that has been assigned to the nucleation
precursors (MIP) [160]. Once Bragg peaks appear, the most pronounced ones at
1.01 and 1.27 nm−1 overlap with the broad peak. The intensity of the Bragg peaks
increases with time, while the broad peak shrinks. In the I(q, t)/I(q, t = 0) plots
(Figure 5.7c&d), it is clear that the broad peak appears before the Bragg peaks
and becomes stronger with time. At the end of the crystallization, the broad peak
shrinks and eventually disappears (Figure 5.7a&c).
From the optical microscopy experiments (Figure 5.3) one observes that the
MIP forms before crystallization starts and is consumed during crystal growth.
From real-time SAXS measurements one can see that the typical broad peak
for MIP follows the same development: it appears first and develops and once
crystallization starts it reduces its intensity and eventually disappears. Based on
these observations, we propose to use the relative change of the area of this peak
(representative of MIP) and the two Bragg peaks which overlap with it to quantify
the relationship between the MIP and the crystalline phase as a function of time.
At this point, we use the concept of crystallinity from semi-crystalline polymer
systems for further data analysis [185]. After subtraction of the intensity at the
minimum, the broad peak in the I(q, t)/I(q, t = 0) curves was fitted by a scaled
Gaussian function and the Bragg peaks by two further (sharp) Gaussians [160].
The crystallization kinetics can be followed by the enveloped area of the broad
region, Ainterm, and the area of the Bragg peaks, ABragg, as a function of time.
This method is further illustrated in an animation that can be found in the online
S.I. Figure 5.8a displays an example of such analysis for a sample with 33 mg/mL
BLG and 17 mM CdCl2. The development of MIP (Ainterm) shows a maximum
around 40 min, and the overall crystallinity (ABragg) has a plateau between 40
and 60 min, and then grows faster. Interestingly, the overall growth rate, i.e. the
first derivative of ABragg on time, gives a maximum located also around 40 min,
indicating that the overall crystal growth rate in the early stage strongly depends
on the development of the MIP.
We have performed real-time SAXS measurements on all four salt conditions
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Figure 5.7: Protein crystallization followed by real-time SAXS measure-
ments. Samples contain 33 mg/mL BLG with 17 mM CdCl2 (a&c) and 20 mM
CdCl2(b&d), located in the transition zone of pseudo-c** (i.e. at the upper end of
regime II). (a&b) Three-dimensional plot of I(q, t). The bottom projections are
created from I(q, t)/I(q, t = 0) and thus monitor the evolution of the curves with
time. (c&d) Selected I(q, t)/I(q, t = 0) curves for the evolution of Bragg peaks
and the amorphous peak. Data are shifted upward by a constant factor for better
visibility.
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Figure 5.8: Time-dependence of the area of the broad peak (Ainterm) and the
Bragg peaks (ABragg). Green spheres (left axis) show Ainterm(t), the integral of the
broad Gaussian function connected to the intermediate. Blue stars (left axis) show
ABragg(t), the integral of the two Bragg peaks in this area. (a) BLG 33 mg/mL
with 17 mM CdCl2. For clarity and better statistics, always three data points of
Ainterm(t) and ABragg(t) were merged into one. The dashed red line in corresponds
to the first derivative of the area of Bragg peaks as a function of time (right axis).
(b) BLG 33 mg/mL with 20 mM CdCl2.
followed by optical microscope. However, as seen from Figure 5.3, the number of
crystals decreases and the size of crystals increases with increasing salt concen-
tration. This makes the real-time SAXS measurements challenging as the number
of the crystals within the illuminated volume drops significantly. We have tried
to compensate this by measuring more positions from the sample. This is partly
successful, but the time resolution is reduced as only one or two out of ten spots
show the development of the Bragg peaks. As shown in Figure 5.8b, less data for
Bragg peaks than the MIP are shown. Nevertheless, one can still recognize the
interesting kinetics: first the MIP develops relatively fast and becomes saturated
after 120 min. Within the current experimental time scale, only a minor fraction
of crystalline phase was detected. The experimental observations on the kinetics
including particularly the non-monotonous crystallization rate (red dashed line
in Figure 5.8a) agree well with a simple model, which will be discussed in the
following section.
5.4 Modeling with Rate Equations
In order to compare the observed kinetic features also more quantitatively to
possible crystallization scenarios, we employed rate equation models. As essential
variables of the modeling, L, I, CI and CL denote the mass fractions of free
monomers in the liquid, intermediate, crystals in the intermediate and crystals in
the liquid. The three paradigmatic cases for the crystallization process shown in
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Figure 5.1 are presented as follows:
Classical Nucleation L → CL: The classical nucleation theory contains a
one-step nucleation process of the critical nucleus from the homogeneous solution.
After nucleation, crystallites grow larger from the solution. In terms of modeling,
∆nL = knL and ∆gL = kgLLCL represent the nucleation and the growth term with
rates kn and kgL. Using these, the process can be easily modeled by the following
set of rate equations:
∂tL = −∆nL −∆gL (5.1)
∂tCL = ∆nL + ∆gL
Parallel Process I ↔ L → CL: In this nonclassical process, we assume that
in addition to the one-step crystallization process, a reversible intermediate is
formed in the solution, competing with crystallization for the free monomers. In
addition to the nucleation and growth term from the classical one-step nucleation,
we include the formation of the intermediate with the term ∆I = kI(L− I). The
corresponding set of rate equations reads
∂tL = −∆I −∆nL −∆gL (5.2)
∂tI = ∆I
∂tCL = ∆nL + ∆gL
Two-step Nucleation Process L → I → CI → CL: For the true two-
step nucleation, the formation of an intermediate is followed by the nucleation of
crystallites within the intermediate. After the subsequent growth of the crystallites
has consumed the intermediate, crystals emerge into the remaining liquid and grow
further. Table 5.1 describes the steps in more detail and lists the rate terms. Using
these, the rate equations read
∂tL = −∆I −∆gL (5.3)
∂tI = ∆I −∆nI −∆gI
∂tCI = ∆nI −∆e + ∆gI
∂tCL = ∆e + ∆gL
The results of the three models are shown in Figure 5.9 with the model param-
eters from another study [160] (see also figure caption). For the classical nucle-
ation (Figure 5.9a), nucleation and growth of crystals speed up, until the liquid
is halfway consumed, and saturate until complete consumption of the liquid. In
the parallel process (Figure 5.9b), the intermediate competes with crystallization
and slows down the crystal nucleation and growth considerably. It is important
to notice, however, that the crystallization rate is homogeneously increasing until
saturation. By contrast, the two-step process (Figure 5.9c) shows the formation of
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Processes Rates Parameters
1. Formation of intermedi-
ate until the remaining
solution is stable
∆I = kI(L− L0)+ L0
kI
mass fraction of
stable solution
formation rate
2. Crystal nucleation
within the intermediate
∆nI = knI kn nucleation rate
3. Crystal growth within
the intermediate
∆gI = kgIICI kgI growth rate in
intermediate
4. Crystals emerge into
the liquid once interme-
diate is consumed
∆e = keCI(αICI − I)+ αI
ke
critical ratio of
intermediate and
crystals
emergence rate
5. Crystal growth in the
liquid
∆gL = kgLLCL kgLgrowth rate in
liquid
Table 5.1: Summary of the proposed two-step process. From the intermediate
formed firstly from the liquid, crystals nucleate and grow until they consume the
intermediate. Subsequently, the crystals emerge into the liquid and grow from
the free monomers. (x)+ stands for x for positive x and zero otherwise. L, I, CI
and CL denote the mass fractions of free monomers in the liquid, intermediate,
crystals in the intermediate and crystals in the liquid, respectively.
a plateau in the crystal mass fraction. After increasing at small times, the crys-
tallization rate drops again considerably, whereas it increases monotonically for
both one-step cases until saturation (Figure 5.9d). This particular feature of the
two-step process is caused by the nucleation and slow growth in the intermediate,
while the crystals grow faster once emerged into solution. Thus, the occurrence
of the plateau indicates the presence of a multi-step nucleation process.
The large number of model parameters does not allow for a reliable extraction
of nucleation rates via model fits to the kinetic analysis of the SAXS data. We
emphasize that this is not a problem of the model or the data quality, but the
complex pathway that involves many coupled processes. As an example, the
amount of crystal nucleation within the MIP depends not only on the rate kn, but
also on the amount of MIP. The latter is mainly determined by the supersaturation
represented by L0, at least for fast formation of the MIP compared to crystal
nucleation. Only based on fitting the kinetic data from SAXS, an decrease in
L0 will sequentially cause a decrease in kn. While thus additional information
e.g. on the supersaturation are required for a real quantitative fit, the qualitative
signatures of the two-step process such as the plateau in the crystal fraction can
still be used to provide evidence for the scenario of a two-step nucleation process.
Nevertheless, this simple model can reproduce the experimental crystallization
kinetics at different conditions. This can be achieved either by varying the rate
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Figure 5.9: Comparison between different crystallization scenarios: (a) Classical
nucleation from a homogeneous liquid and subsequent growth of the crystallites.
(b) Parallel processes, representing the formation of an intermediate and the in-
dependent nucleation from the liquid with subsequent growth of the crystallites.
(c) Two-step nucleation process involving the formation of an intermediate from
which the crystals nucleate (see Table 5.1 for further details). The following pa-
rameter values were used to show the good qualitative agreement of the model with
the data set in Figure 5.8a: ke = 0.15 min
−1, L0 = 0.2, αI = 0.2, kgL = 0.6 min−1,
kI = 0.03 min
−1, kn = 0.02 min−1, kgI = 0.2 min−1. An additional model plot
reproducing the data set in Figure 5.8b can be found in the S.I., Figure C.3). (d)
Comparison of the crystallization rates dC/dt. While one-step and parallel nucle-
ation processes show a monotonous speed-up until saturation, the two-step process
can have a non-monotonous signature with two maxima. The model parameters
were chosen for all three models to be the same: kI = 0.05 min
−1, kn = 0.02 min−1,
kgI = 0.1 min
−1, kgL = 0.2 min−1, ke = 1.0 min−1, L0 = 0.7, αI = 0.2.
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parameters or by choosing the amount of MIP which approximately approaches
L − L0 = 0.2. This value can be determined experimentally by following the
protein concentration in the supernatant with time using UV-visible spectroscopy.
A tentative experiment for sample with 20 mM CdCl2 leads to the value of 0.2.
Further experiments are needed to refine this parameter.
5.5 Conclusions and Outlook
We have investigated the two-step nucleation process of protein crystallization in
solutions by following the overall crystallization kinetics using real-time optical
microscopy and SAXS. The experimental results together with a rate equation
model provide evidence of two-step nucleation in the early stage of crystallization.
The BLG-salt (CdCl2) solutions were chosen at the transition zone of pseudo−c**,
where small aggregates form after sample preparation. These protein aggregates
serve as the metastable intermediate phase (MIP) during crystallization.
SAXS and SANS reveal that the MIP shows a certain local ordering instead of
random aggregates as monitored by a broad shoulder at intermediate q ≈0.7 nm−1,
and a monomer-monomer correlation peak at q around 2 nm−1. Real-time SAXS
results show that the crystallization kinetics is proportional to the development
of the MIP in the early stage of crystallization, i.e. the appearance of a local
maximum in the crystallization rate at the maximum quantity of the intermediate.
In the late stage of crystallization, a plateau is developed due to the transition from
nucleation controlled in the early stage to growth controlled after the consumption
of MIP. This transition in the overall crystallization kinetics is a typical feature for
the two-step nucleation in the early stage. These experimentally observed kinetics
can be reproduced using a rate equation model.
For further real-time measurements, we note that the smaller beam size and
scattering volume of SAXS can be compensated by using SANS. The combination
of real-time SAXS and SANS can provide more systematic information of the
crystallization kinetics.
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We present a study of the structural evolution of protein aggregates in solu-
tions of a globular protein, β-lactoglobulin (BLG), in the presence of YCl3. These
aggregates are often observed before crystallization starts and metastable with
respect to the crystalline phase. Here we focus on the characterization of the
structures of this intermediate phase at different length scales using a combina-
tion of VSANS, SANS and SAXS. Our results reveal a hierarchical structure from
monomer, dimer, compact cluster to fractal protein aggregates. Upon cooling, the
overall hierarchical structure is preserved, however, the evolution of the internal
structure within the aggregates with temperature is clearly visible: the monomer–
monomer correlation peak disappears completely, the cluster–cluster correlation is
enhanced. At a larger length scale, the fractal dimension of protein aggregates in-
creases. Moreover, the time-dependent SAXS measurements during a temperature
ramp show clear isosbestic points and the kinetics of the structural evolution of
the metastable intermediate phase can be well described using a two-state model.
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6.1 Introduction
Protein crystallization, as an important research field, provides not only the most
successful way for determining high resolution 3D structures of bio-macromolecules,
but also rich conditions for understanding the early stage of crystallization. For
example, it is very common to observe oil-like droplets in the crystallization assay
before crystals appear. This liquid–liquid phase separation (LLPS) in protein solu-
tions has been demonstrated to be metastable with respect to the crystalline phase,
thus the co-existence line is located below the solubility line in a typical phase
diagram of protein solutions [26,38,54,126,212]. In addition, mesoscopic protein clus-
ters have been observed in concentrated solutions for several proteins [64,96,137,181].
Counter-balanced interactions have been reported to lead to equilibrium clusters
as well as dynamic clusters in concentrated protein solutions [101,177,184]. Impor-
tantly, the existence of protein clusters or a metastable LLPS may change the
kinetic pathway of crystal nucleation dramatically.
The pioneering work by ten Wolde and Frenkel showed that far from the meta-
stable LLPS region nucleation follows the classical mechanism, i.e. nuclei form
directly in a supersaturated solution with the structure and density of the final
crystalline phase [7,56,172]. However, when approaching the critical point, dense
liquid-like droplets form first which further follow a structural change towards
crystallization [196]. In the last decade, increasing evidence has shown that clus-
ters, amorphous nanoparticles and other precursors may serve as an important
intermediate for crystallization [13,50,64,65,122,131]. Theoretical studies and simula-
tions suggest that the existence of a metastable intermediate phase can promote
crystal nucleation [79,196,198]. Huge efforts have been focused on characterizing the
structure of these intermediate phases for a better understanding of the early
stage of crystallization and the role of the intermediate phase on crystal nucle-
ation [30,64,65,100,137,138,161,174,181,228].
In our previous work, we found that multivalent metal ions provide an effi-
cient way in tuning the effective protein–protein interactions in solution, leading
to complex phase behavior including reentrant condensation (RC), metastable
LLPS, cluster formation and crystallization [151,183,220,222,224,226,227]. The rich phase
behavior induced by these metal ions provides not only the optimized conditions
for protein crystallization, but also model systems for studying the pathways of
protein crystallization [158–160]. Figure 6.1 shows the experimental phase diagram of
β-lactoglobulin (BLG) in the presence of YCl3. We observe the so-called reentrant
condensation behavior, i.e. a phase separated state (Regime II) exists in between
two boundary salt concentrations c*< c**, outside of regime II, the samples are
clear. The physical mechanism of this RC behavior is due to the effective charge
inversion of proteins and a cation-mediated attraction [152,227]. Similar phase be-
havior has been observed for several proteins in solution in the presence of trivalent
metal ions [151,220,224,226].
Studies on the protein crystallization in different regions of Figure 6.1 have
shown that close to c*, crystallization takes place without visible precursor. Close
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Figure 6.1: Experimental phase diagram of BLG in the presence of YCl3 de-
termined at 21◦C. Regimes I, II, III corresponds to clear, turbid and clear state,
respectively. Conditions in regime I are plotted as black squares, conditions in
regime II as red circles and conditions in regime III as green triangles. Small
white circles mark samples that crystallized after one week at 4◦C. The blue
rectangular marks sample conditions we focus on in this work. Different crystal-
lization pathways are observed. Close to c*, crystallization takes place without
visible precursor, which is labeled as classical; Close to c**, aggregates or a dense
liquid phase are observed before crystallization, which is labeled as nonclassical.
to c**, samples have a transition temperature, Ttr. When samples are prepared
at temperatures above Ttr, the solution is clear. Below Ttr, the solution becomes
turbid immediately by forming large protein aggregates or a dense liquid phase,
depending on the sample conditions [158,221,227]. After an induction time, nucleation
starts and crystal growth consumes the intermediate phase. In the end, only
crystals are left [158,227].
One of the interesting observations on the intermediate states is the morphology
change of protein aggregates with time. Optical microscopy observations clearly
show that the turbid solutions with amorphous protein aggregates develop into a
network of aggregates which further relaxes into a liquid-like structure [158]. Based
on the fact that these areas are growing and merging, they are most likely in a
liquid state instead of a gel [158,227], although this is still an open question. In fact,
little is known about the internal structures of the intermediate and their develop-
ment with time. This information may be crucial for the subsequent nucleation.
For a deeper understanding of the role of the metastable intermediate phases in
protein nucleation and crystallization, we performed a systematic study of the
structures and their evolution with time and temperature by small angle X-ray
and neutron scattering. In particular, we aim to characterize the structural fea-
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tures of these protein aggregates or liquid-like networks at different length scales
and the kinetics of the structural evolution.
6.2 Experimental Section
6.2.1 Materials
The globular protein β-lactoglobulin (BLG) from bovine milk (product no. L3908)
was purchased from Sigma-Aldrich. This product is a mixture of the genetic
variants A and B, that differ at two positions in the primary sequence of 162
amino acids in total [207]. At room temperature and neutral pH, BLG is acidic
(isoelectric point of 5.2) and predominantly in dimer state [44,207]. YCl3 was also
purchased from Sigma-Aldrich as a anhydrous powder with a purity of 99.99%
(product no. 451363).
For sample preparation, appropriate amounts of salt stock solution, degassed
MilliQ (18.2 MΩ, Merck Millipore) water and protein stock solution were mixed.
Stock solutions were prepared by dissolving the salt or protein powder in deionized
(18.2 MΩ) and degassed MilliQ water. The protein concentration of stock solutions
was determined by UV absorption measurements using an extinction coefficient
of 0.96 l · g−1· cm−1 at a wavelength of 278 nm [182]. All samples in this work were
prepared without additional buffer since buffers can affect the phase behavior
of proteins and the solubility of salts. The pH of the solutions was monitored
using a Seven Easy pH instrument from Mettler Toledo. The pH values for all
experimental conditions were above the pI = 5.2 of BLG [44].
6.2.2 Methods
Fourier transform infrared spectroscopy (FTIR) (IFS 48 from Bruker) was applied
to monitor the stability of the protein secondary structure under the experimental
conditions as a function of temperature, salt concentration and further treatment.
Samples in the same composition but in heavy water (D2O) were prepared for the
better signal-to-noise ratio.
Small angle X-ray scattering (SAXS) experiments were performed on beamline
ID2 at the ESRF (Grenoble, France) using a sample-to-detector distance of 2 m.
The beam energy was set to 16 keV, the accessed q values ranged from 0.006 to
0.34 A˚−1. The data sets were reduced by subtracting the scattering of pure salt
solution as a background and normalized to absolute intensities. The samples were
measured using a quartz cell with a diameter of 2 mm. For the time-resolved mea-
surements, the exposure time was 0.1 s, the waiting time between measurements
was 300 s, and the data saving and transfer took about 6 s. More detailed infor-
mation on q-resolution calibration and data reduction can be found in Ref. [80,129].
Small angle neutron scattering (SANS) was performed at FRM2 (Garching,
Germany) at the instrument KWS-2. The utilized neutron wavelength was 4.5 A˚
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with ∆λ/λ=20%. The sample-to-detector distances were 2, 8 and 20 m. The
resulting total q-range was 2.2·10−3 to 0.34 A˚−1.
Very small angle neutron scattering (VSANS) was performed at FRM2 (Garch-
ing, Germany) at the instrument KWS-3 with a sample-to-detector distance of
10 m and allowed us to cover a large q range. The applied neutron wavelength
was 12.8 A˚ with ∆λ/λ=20%, resulting in a q-range from 2.3·10−4 to 2.1·10−3 A˚−1.
Samples for neutron scattering were prepared in D2O for better contrast. In-
tensity profiles were obtained by correcting the 2D intensity pattern to absolute
scale and azimuthal averaging. The solvent background was subtracted after-
wards. Data reduction and absolute intensity calibration was performed using the
program QtiKWS provided by JCNS [144]. Data fitting was preformed using Orig-
inPro (two-state analysis) and IGOR Pro with macros provided by NIST [90].
6.2.3 Data Analysis
The scattering intensity of SANS experiments of protein solutions can be described
as
I(q) = Np(∆ρ)
2V 2p P (q)S(q) +Binc (6.1)
where Np is the number density of proteins per unit volume; Vp is the volume of
a single protein; ∆ρ is the difference in scattering length density between protein
and the solvent; Binc is the incoherent background; P (q) and S(q) are the form
factor and the structure factor, respectively. The momentum transfer is defined
as q = 4pi/λ ·sin(θ) with the scattering angle 2θ. The size and shape of structures
at different length scales, such as the native dimer and aggregates, are described
using a spherical or ellipsoidal form factor. The effective interactions are described
using structure factors calculated from different potentials that are listed in the
following.
The hard sphere potential is defined by
UHS(r) =
{
∞ r ≤ σ
0 r > σ
(6.2)
with the hard sphere diameter of σ. The corresponding structure factor is obtained
by solving the Ornstein–Zernike (OZ) equation numerically with the Percus–
Yevick (PY) closure [9].
The sticky hard sphere potential is used to describe the short range attraction
between protein clusters, which is defined by [15]
USHS(r) =

∞ r < σ
−u σ < r < σ + ∆
0 r > σ + ∆
(6.3)
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where τ is the stickiness parameter
τ =
1
12∆
exp(−u/kT ) (6.4)
with the perturbation parameter ∆,
∆ = ∆/(σ + ∆). (6.5)
∆ is the width of the square well, and u is the depth [90].
The screened Coulomb potential is used to describe the long range electrostatic
repulsion of protein clusters due to the accumulated charges, which is defined
by [73,77]
USC(r) =
{
Z2e2
(1+κDσ/2)2
exp(−κD(r−σ))
r
r > σ
∞ r ≤ σ (6.6)
with Z the protein surface charge, e the electronic charge, and  the dielectric
constant of the solvent. κD is the inverse of the Debye screening length, determined
by the ionic strength of the solution and σ the effective diameter of the ellipsoid
with the axes a, b, b.
The Beaucage model was applied which is well suited for the analysis of small-
angle scattering data from complex systems that contain multiple levels of related
structural features like fractal and particulate systems. It yields multiple sets of
a radius of gyration and a power law from different structural levels by modeling
the Guinier and Porod regions [16,17,72]. The multiple levels of scattering intensity
can be expressed as
I(q) ≈
n∑
i=1
{
Gi · exp
(−q2R2g(i)
3
)
+Bi · exp
(−q2R2g(i+1)
3
)
·
[
erf
(
qRg(i)√
6
)3
· 1
q
]di .
(6.7)
It is characterized by three principal fitting parameters per level: a radius of
gyration Rg, a Porod exponent d and a Guinier scaling factor G (from which a
Porod scaling factor B can be derived) [72].
6.3 Results
6.3.1 Hierarchical Structure Characterized by (V)SANS
and SAXS
We first present an overview of interactions and structures in protein solutions
as a function of salt concentration and temperature. In order to study the struc-
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Figure 6.2: Structure and interactions of protein-salt mixtures characterized by
SANS in dependence of temperature and salt concentration. The protein concen-
tration was fixed to 67 mg/mL, the salt concentrations were 12, 13, 14 and 15 mM
YCl3. Data collected at two temperatures, 35
◦C and 5 ◦C, are presented. The
times given in the legend are the starting times. The measurements themselves
lasted 2.5 hours each. The black arrows label an additional structural change that
is more pronounced with high salt concentration. Model descriptions for different
q ranges are shown in lines and discussed in detail in the main text.
tural evolution as a function of temperature (observable range 0-40 ◦C), we chose
samples with transition temperatures Ttr close to or below 35
◦C, samples with a
BLG concentration of 67 mg/mL and YCl3 concentrations between 12 and 15 mM.
According to the experimental phase diagram in Figure 6.1 which was obtained
at room temperature, these samples are in the upper area of regime II. Increasing
temperature shifts the samples into Regime III. When prepared at 35 ◦C, the sam-
ples with 13-15 mM salt were clear, only the sample with 12 mM salt was turbid
indicating a higher Ttr. When cooled down to 5-10
◦C, all samples became turbid.
Figure 6.2 shows SANS results for these samples at 35 ◦C and 5 ◦C. Measure-
ments between the first and the last run are shown in the supporting material
(Figure D.1). At 35 ◦C, the SANS curves for all samples are similar in the high
q region, but the intensity at the low q region decreases with increasing salt con-
centration. For the sample with 12 mM salt, the low q upturn is consistent with
the observation that this sample is already turbid at 35 ◦C, which becomes more
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Figure 6.3: Hierarchical structure of protein aggregates characterized by
(V)SANS and SAXS for samples with 67 mg/mL BLG and 15 mM YCl3 at 35 and
5 ◦C. The merged SANS data are from KWS-3 (VSANS) and KWS-2 (SANS).
SAXS data of the same sample at 35 ◦C show an additional monomer-monomer
correlation in the high q region. The structural interpretation at different length
scales is also shown.
significant at 5 ◦C due to the formation of more compact large aggregates. The
other samples, however, do not have such strong intensity increase at the low q
region of this q range even after 21h at 5 ◦C.
The SANS measurement curves at 35 ◦C show two main steps in intensity at 0.03
and 0.18 A˚−1, which can be explained by the contribution of small protein clusters
and the native dimer of BLG, respectively, consistent with previous measurements
on this system [221]. The dimer contribution has developed a visible dimer–dimer
correlation peak. It was further analyzed using a simple spherical form factor and
a hard-sphere potential. The radius of the spherical dimer form factor is about
15 A˚ and was fixed for further data fitting. The volume fraction is between 0.22
and 0.23 and slightly decreases with increasing salt concentrations. The detailed
fitting results are shown in the supporting material (Table D.1).
For the cluster contribution, the scattering intensity in the low q region (below
0.03 A˚−1) decreases with increasing salt concentration. A correlation peak appears
which becomes even stronger at lower temperature. With 14 and 15 mM YCl3, the
shoulder at 0.03 A˚−1 develops to a cluster–cluster correlation peak. At q values
between 0.04 and 0.07 A˚−1, all curves show an asymptotic linear trend with slopes
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between -3.5 (start) and -4 (end). This behavior satisfies Porod’s law and implies
that the scatterers at this length scale (clusters) have a compact, non-fractal
structure with a sharp interface. A model fit of the curves for 14 and 15 mM YCl3
using a screened Coulomb potential together with an ellipsoid form factor shows
that the overall net charge increases with increasing salt concentration. While the
charges are nearly constant with decreasing temperature, the effective size of the
ellipsoid form factor and the volume fraction increase (Table D.1). With 13 and
12 mM YCl3, the data is better described using the hard-sphere and sticky hard-
sphere potential, respectively, indicating that the effective interactions between
the clusters undergo a transition from repulsion to attraction with lowering salt
concentration.
The development of the cluster-cluster correlation can be understood as the
accumulation of net charge. Studies on the reentrant condensation have demon-
strated the effective charge inversion of proteins upon increasing salt concentration
crossing the second regime [220,226]. When these samples are prepared at high tem-
perature (35 ◦C), they are in the third regime, i.e. the effective surface charge is
already positive, but the strong bridging effect of the metal ions leads to still
attractive overall interactions. However, with increasing the size of clusters, the
net charge of the clusters accumulates, and when the charge is high enough, a fur-
ther increase of the cluster size will be prohibited by the re-established Coulombic
repulsion.
While there is no visible change for the dimer contribution during cooling, the
slopes for the clusters decrease, leading to a new shoulder visible at 0.08 A˚−1
at the low temperature for all samples. Additional structure change at 0.12 A˚−1
(labeled using a black arrow) occurs at lower temperature and is more pronounced
with high salt concentration. These new features may correspond to structures of
D = 2pi/q ≈ 78 and 52 A˚, respectively. The formation of this hierarchic structures
also suggests that proteins within the clusters have a certain flexibility for re-
arrangement upon cooling.
The hierarchical structure of the protein aggregates for samples with 67 mg/mL
BLG with 15 mM YCl3 were further characterized using VSANS and SAXS to
cover a broader q-range. As presented in Figure 6.3, the combined (V)SANS and
SAXS data at 35 and 5 ◦C provide the structure information from monomer–
monomer correlation, compact clusters up to fractal aggregates in length scales
from nanometer to µm. These structures at different length scales can be described
with the assembled structures of protein (schematics) in the figure.
The extended VSANS data in the low q region clearly show the increase in
intensity at both temperatures. The asymptotically linear increase in intensity at
lower q suggests larger protein aggregates that are more fractal than the clusters
at smaller length scale. The scattering intensity from (mass) fractal aggregates is
given by [140] S(q) ∝ q−d . The fractal dimension, d , determined from the slopes are
around 1.7 and 1.9 before and after cooling in the q range of (0.5 - 4)·10−3 A˚−1. At
even lower q, after cooling, another Porod region becomes visible and a plateau at
around 2·10−4 A˚ is visible, which indicates that the fractal aggregates can further
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organize in an even larger and more compact structure with a mean size in real
space of D = 2pi/q ≈ 3µm.
SAXS data show additional structural features due to the high resolution in the
high q region. A peak at 0.22 A˚−1 is clearly visible in the SAXS curve (not visible
in SANS) after preparation at 35 ◦C, which can be attributed to the monomer–
monomer correlation within clusters as discussed in our previous work [221]. The
monomer–monomer correlation in the initial state is fitted using a spherical form
factor with a radius of 15 A˚ and a hard sphere structure factor, which gives a vol-
ume fraction of 0.50. The peak completely disappears during the cooling process.
Compared to the SAXS data, the SANS data are shifted towards higher q, mainly
due to the contribution of the hydration shell, to which only SAXS is sensitive [221].
SAXS measurements of the whey protein microgel obtained by thermal treatment
also reveal a hierarchical and fractal structures [123,166]. Interestingly, it also shows
a structural feature at ∼0.07 A˚−1, which has been explained by the close neighbor
effect of the denatured whey protein monomers within the microgel.
Figure 6.4: FTIR spectra of protein samples with a BLG concentration of
67 mg/mL: (Black) without salt and prepared at room temperature; (Green) with
15 mM YCl3 and prepared at room temperature; (Red) with 15 mM YCl3 and
prepared and equilibrated at 35-38 ◦C for 1 h; (Blue) with 15 mM YCl3, prepared
at 35 ◦C and quenched and stored at 5 ◦C for a day.
We emphasize that the observed protein condensation is not caused by a change
of the protein structure induced by YCl3 and further treatments. Figure 6.4 shows
FTIR spectra for a sample with a BLG concentration of 67 mg/mL and 15 mM
YCl3 at room temperature and at 35-38
◦C (measurements for 12-14 mM can be
found in the supporting information, Figure D.2). For comparison, the spectrum
of a protein solution with the same protein concentration but without added salt
is also shown. As one can see, in all cases, the amide I and amide II bands are
in the same shape and ratio of intensity. These measurements confirm that there
is no significant change on the secondary structure of protein neither caused by
addition of YCl3 nor by temperature change. Moreover, the successful growth of
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high-quality crystals and fine structural analysis confirm that the proteins are still
in their native state [158,227].
6.3.2 Structural Evolution Followed by Time-Resolved
SAXS
(a) (b)
(c)
Figure 6.5: (a) Real-time SAXS profiles of 67 mg/mL BLG with 15 mM YCl3 at
different times during a temperature ramp from 37 to 10 ◦C. Insets show the zoom-
in of the monomer–monomer correlation peak (up-right) and a typical SAXS data
curve with a two-level Beaucage fit (bottom-left). (b) Modified SAXS curves from
a) by dividing by the first curve. (c) Two-state analysis of the structural evolution
kinetics using Equation 6.8. Left: plots of F (t) and 1−F (t) as a function of time.
Right: example SAXS curve 102 min after the preparation (black) with obtained
fit (cyan) along with the initial and final curve (shifted up and down for better
visibility).
Optical microscope observations indicate that the protein aggregates formed af-
ter sample preparation can further relax into a liquid-like network within hours [158].
Later crystallization occurs mainly at its interface. The hierarchical structure at
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different temperature presented in the previous section indicates the local struc-
ture change with time and temperature. In the following, the real-time SAXS
data are further analyzed in order to understand the transition kinetics.
The real-time SAXS data including 58 scans in steps of 5 min during a temper-
ature ramp from 37 to 10 ◦C are presented in Figure 6.5a. In general, during the
temperature ramp, the overall scattering profile is preserved, which is consistent
with the SANS measurements in Figure 6.2. However, local structure changes are
clearly visible. For example, the intensity for q below 0.025 A˚−1 increases with
time (or decreasing temperature), whereas the intensity decreases with time in
the q range between 0.025 A˚−1 and 0.075 A˚−1, resulting an isosbestic point. Fur-
thermore, the monomer–monomer correlation peak reduces with time and finally
disappears. These changes are better presented in Figure 6.5b, where the SAXS
data were divided by the first curve (about 11 min after sample preparation). This
figure therefore displays the changes in this process. At 0.025 A˚−1 and 0.075 A˚−1,
respectively, the intensity remains constant upon temperature change and time,
characterizing isosbestic points. At adjacent lower q, the intensity is decreasing,
and increasing on the other side. The existence of an isosbestic point suggests an
equilibrium of two populations of aggregates with one growing in number at the
cost of the other one [135].
Isosbestic (or iso-scattering) points can occur if a system transforms from one
state to the other and the scattering intensity for both states stays constant at
(at least) one given q [135]. Therefore, the curve can be described as the sum of
two constituents [135]:
I(q) = F (t) · Istart(q) + [1− F (t)] · Ifinal(q) (6.8)
F (t) = (I − Ifinal)/(Istart − Ifinal), (6.9)
A two-state analysis was performed using Equation 6.8 to fit the SAXS curves
measured at different times with Istart(q) the first curve in time and Ifinal(q) the
last one. F (t) describes the variation of the scattering intensity. The obtained
F (t) and 1 − F (t) are plotted in Figure 6.5c left. Using the respective F , all the
intermediate SAXS curves can be modeled with a high precision. The right part of
Figure 6.5c shows an example for the curve 102 min after the preparation together
with the obtained fit. The coefficient of determination R2 (0 for no correlation, 1
for perfect correlation) was between 0.99977 and 0.99999 for different curves. This
analysis provides further evidence that the internal structural evolution within the
metastable protein aggregates is formed via a simple two-state process. It is worth
noting that in our previous work [221], a similar sample has been measured using
SAXS and Bragg peaks were observed after two cycles of a temperature ramp
from 25 to 10 ◦C. The SAXS profiles in the present study are very similar, but no
crystals are observed after the measurements. The exact reasons are unknown,
but the different thermal history may be one of them.
As we have pointed out, the temperature dependent monomer–monomer cor-
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relation peak may be related to the flexibility of proteins within clusters and
aggregates. We have further analyzed the monomer–monomer correlation peak
by fitting it using a Gaussian function (after subtraction of a linear background).
The Gaussian was integrated in q and the area was plotted as a function of time
(or temperature, respectively) (see Figure 6.6a). The value of the area (also the
shape of the correlation peak) is nearly constant before it starts to decrease at ap-
proximately 22 ◦C. Below ca. 13 ◦C (after 70 min), this correlation peak disappears
completely.
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Figure 6.6: (a) Area of the monomer–monomer correlation peak (blue data
points) fitted by a Gaussian. The red solid line shows how the temperature was
changed with time. (b) Radius of gyration and absolute value of the exponent
for the cluster shoulder of the Beaucage fits. The dashed line marks where the
monomer–monomer correlation becomes invisible.
Further, the Beaucage model [16,17] was also used to fit the real-time SAXS data
(bottom-left in Figure 6.6a). The considered curves show two levels of a Guinier
and a Porod region corresponding to the dimer and cluster contribution as also
shown in the SANS data. Therefore, two radii of gyration and two exponents are
obtained for every measurement run. Detailed fitting results are shown in the
supporting material (Table D.2). The radius of gyration of a dimer, Rg(Dimer) is
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23.5 A˚ and nearly constant. The radius of gyration of a cluster, Rg(Cluster), grows
significantly in size until approximately 175 min (Figure 6.6b, left axis). Then a
slower increase is visible. Rg(Cluster) is 125 A˚ at the beginning and 170 A˚ at the
end. The Porod exponent for the cluster contribution in dependence of time can
also be found in Figure 6.6 (right axis). After an initial decrease, the exponent
from the scattering of clusters becomes approximately constant. This coincides
with the disappearance of the monomer–monomer correlation peak and therefore
most likely represents the same structural change in the protein solutions with
temperature decrease and time.
6.4 Conclusions
A hierarchy of structures of protein aggregates in aqueous solution of BLG and
YCl3 which may serve as the intermediate for protein crystallization has been
characterized using (V)SANS and SAXS. Structural features at different length
scales including monomer–monomer correlation, the scattering of dimers, compact
clusters and a fractal structure in µm length scales have been identified.
When prepared at 35 ◦C, the monomer–monomer correlation is visible in the
SAXS curves. After cooling to 5-10 ◦C, the dimer acts as elemental building
block and the monomer–monomer correlation peak disappears. It is interesting
to see that a cluster–cluster correlation peak becomes visible with increasing salt
concentration. These rather compact protein clusters might be formed by the
balance between the bridging effect of metal ions and the electrostatic repulsion
due to the accumulated net charges. The appearance of the isosbestic points in
the real-time SAXS data indicates a two-phase process for the internal structure
change within the metastable protein aggregates, which is further demonstrated
using a two-state analysis for the SAXS data.
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Chapter 7
Complementary Study: On the
Universality of Inducing Protein
Crystallization by RC
Most of the results presented in this thesis were obtained with BLG in the presence
of three different multivalent metal salts (YCl3, ZnCl2, and CdCl2). Other systems
with trivalent salts that show RC behavior were found in our group [80,151,220,222,223,226],
whereof HSA in the presence of YCl3 was observed to crystallize
[223]. This chap-
ter addresses the question how universal these observations are and if RC could
be used as a method to crystallize a large number of proteins. It also contains
results obtained by S. Da Vela and O. Matsarskaia. While the proteins tested
in Section 7.1 are commercially available and well-studied, Section 7.2 presents a
recently isolated enzyme (see G. Zocher 2012 [229]).
The divalent salts CdCl2 and ZnCl2 can, as shown in the publications A-C,
also induce RC and crystallization in BLG, but only a first boundary and no
crystallization can be observed in both HSA and BSA. With CoCl2·6H2O and
SrCl2, not even c* could be induced in BLG and BSA; however, a charge inversion
still can be observed. In the following, we focus on trivalent lanthanide salts.
7.1 Toolbox for Tuning Phase Behavior in
Protein Solutions Using Trivalent Salts
A systematic study of the effects that rare earth element salts have on several glob-
ular, acidic proteins was performed. We especially focused on RC and the ability
of the salts to induce crystallization. One of the advantages of rare earth element
salts is their highly positive charge (+3), which is an important prerequisite for
inducing charge inversion. Monovalent salts do not interact strong enough with
proteins [220] and our observations with BLG in the presence of the divalent CdCl2
and ZnCl2 are probably no universal property. Another important advantage of
these salts is the fact that they have, in contrast to several other, more common
elements such as iron or aluminum, no strong effect on the pH of the solutions
due to autoprotolysis and formation of aqua-complexes [115,151]. Gd is additionally
interesting due to the paramagnetic properties of Gd(III) complexes [115,150].
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7.1.1 Phase Behavior Under Variation of the Cation
The radii of the five ions La3+, Ce3+, Gd3+, Y3+, and Yb3+ decrease continu-
ously (see Table 7.1). The larger the ions are, the smaller is their charge density.
We therefore assume the strength of the ions in terms of inducing RC to be
Y b3+ > Y 3+ > Gd3+ > Ce3+ > La3+. Table 7.1 shows the effect of the trivalent
salts LaCl3, CeCl3, GdCl3, YCl3, and YbCl3 on the negatively charged proteins
BLG, HSA, BSA, OVA, and pepsin. Conditions marked by two green checkmarks
mean a complete reentrant condensation behavior with a first critical salt concen-
tration c* and a second critical salt concentration c**. Systems marked by one
orange checkmark showed only a first critical salt concentration c*. A first critical
boundary was found in all of the systems tested, a second boundary in most cases.
However, pepsin shows no normal c** with all salts tested. Re-clearing was found
for some of the salts at very high salt concentrations, for example with 92 mM
YCl3 at a pepsin concentration of 5 mg/mL. For comparison: in other systems
with 5 mg/mL protein, c** was usually found between 1.5 and 3 mM salt. We
assume that the high salt concentration at which the system re-clarifies has other
causes than usual RC (see below where the influence of the pH value is discussed).
Only in OVA, a cation-dependent difference is observable: LaCl3, GdCl3 and YCl3
cause a second boundary c**, while the “strongest” salt judged by the charge den-
sity, YbCl3, does not. However, protein material falls out of OVA solutions above
c** after some time: these third regimes are not stable.
Table 7.1: Protein-salt systems tested for RC. Radii are the effective ionic radii
from Ref. [176]. Systems with c* and c** are marked by two green checkmarks,
systems with only a first boundary by one orange checkmark. 1re-clearing at very
high salt concentrations. 2not investigated.
LaCl3 CeCl3 GdCl3 YCl3 YbCl3
La3+ Ce3+ Gd3+ Y3+ Yb3+
(r=103 pm) (r=101 pm) (r=94 pm) (r=90 pm) (r=87 pm)
BLG XX XX XX XX XX
HSA XX XX XX XX XX
BSA XX XX XX XX XX
OVA XX 2 XX XX X
Pepsin X1 2 X1 X1 X
A linear dependence of c* on the protein concentration is found (with a cer-
tain deviation at low protein concentrations), in accordance with earlier experi-
ments [226]. c* has been fitted linearly for different protein-salt systems. The slopes
of the fits (Table 7.2) increase from LaCl3 to GdCl3 to YCl3 for pepsin and BLG.
However, for HSA and BSA, the inverse behavior is observable. YbCl3, the small-
est of the cations tested, deviates from these trends. Other effects such as orbital
occupancy might play a decisive role here.
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Table 7.2: Slopes b from linear fits y = a+b∗c(Protein) of c* in various systems.
The slope increases from LaCl3 to GdCl3 to YCl3 (decreasing cation size) for
pepsin and BLG. However, for HSA and BSA, the inverse behavior is observable.
BLG Pepsin HSA BSA
LaCl3 0.035±0.001 0.041±0.004 0.08±0.01 0.100±0.002
GdCl3 0.063±0.002 0.050±0.001 0.06±0.005 0.098±0.002
YCl3 0.069±0.002 0.063±0.001 0.05±0.002 0.076±0.012
YbCl3 0.025±8·10−4 0.061±0.002 0.08±4·10−4 0.075±4·10−4
7.1.2 Phase Behavior Under Variation of the Anion
The influence of the anion was investigated, too. Tables 7.3 and 7.4 show the
effect on BLG, HSA, BSA, and pepsin induced by yttrium and ytterbium salts
with varying anions. Again, a first critical boundary was found in all systems
tested.
Table 7.3: Y-salt systems tested for RC. Systems with c* and c** are marked by
two green checkmarks, systems with only a first boundary by one orange check-
mark. 1re-clearing at very high salt concentrations.
YCl3 Y(NO3)3 Y2(SO4)3
BLG XX XX XX2
HSA XX X X
BSA XX X X
Pepsin X1 X1 X
Table 7.4: Yb-salt systems tested for RC. Systems with c* and c** are marked
by two green checkmarks, systems with only a first boundary by one orange check-
mark. 1re-clearing at very high salt concentrations. 2Only partial re-clearing.
YbCl3 Yb(NO3)3 Yb2(SO4)3
BLG XX XX XX
HSA XX X X
BSA XX X X2
Pepsin X X1 X1
The binding of rare earth elements (REE) in complexes to proteins is domi-
nated by electrostatic rather than covalent forces. The complexes are either inner
sphere (no intervening solvent molecules) or outer sphere (solvent-separated ion
pairs) [217]. While the opinion is divided whether at 25◦C in aqueous solutions,
SO2−4 and NO
−
3 complexes with REE are inner or outer sphere, Cl
− forms pre-
dominantly outer-sphere complexes [217]. Chloride and nitrate complexes of rare
earth elements are very weak and chloride complexes are the weakest [217]. Our
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first assumption therefore was that the strength of the effect of the anions used
on the proteins tested follows the inverse order of their complex strength with
rare earth elements: Cl− > NO− > SO2−4 . This classification is confirmed by
the observations on BSA and HSA with yttrium and ytterbium salts (Table 7.3
and 7.4): the strong chloride salts, YCl3 and YbCl3, cause a complete reentrant
behavior while the weaker nitrate and sulfate salts only cause a first border in
both HSA and BSA. The BSA+Yb2(SO4) system only shows a partial re-clearing
at higher salt concentrations, reminiscent of pseudo-c** in systems of BLG and
divalent salts (see publications A-C).
In BLG, a complete RC behavior could be induced with all salts tested. Pepsin
samples show no normal reentrant effect. While c* and c** cannot be induced by
a simple pH change in BSA, HSA, and BLG, both condensation and re-clearing
are found in pepsin when HCl is added without salts. The transition to turbidity
takes place before the isoelectric point is reached but close to it. We therefore
assume that the transitions to clear samples at high trivalent salt concentration
in pepsin are at least partially caused by the pH change.
7.1.3 Zeta Potential Measurements and Charge Inversion
Zeta potentials of multiple protein–salt systems were measured in order to confirm
that charge inversion occurs at high salt concentrations. The zeta potential of
systems with a second boundary c** showed typically a dependence on the salt
concentration similar to the example of BLG in the presence of Yb2(SO4)3 that is
shown in Figure 7.1a. The charge inversion is clearly visible. The zeta potentials of
systems with no second border or a second border at very high salt concentrations
tend to saturate at negative values. However, at much higher salt concentrations,
positive zeta potentials are found. Figure 7.1b shows zeta potential measurements
of pepsin with YCl3 as an example. Further plots of other systems can be found
in the Appendix E.
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Figure 7.1: Zeta potential as a function of salt concentration. (a) BLG with
Yb2(SO4)3; (b) pepsin with YCl3. The error bars show the standard deviation of
five measurements.
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For pepsin, very high c** values were observed with YCl3 and Y(NO3)3 (92
and 80 mM at a pepsin concentration of 5 mg/mL - because of its much smaller
solubility, no result for Y2(SO4)3 could be obtained). They coincide with the even-
tually positive zeta potentials at high salt concentration. This could be partially
due to protonation. However, the pH values of all samples are above the very low
isoelectric point of pepsin of 2.2-2.8 [178]. The lowest pH value (3.69) was measured
for 5 mg/mL pepsin with 80 mM Y(NO3)3.
7.1.4 Protein Stability
A possible reason for missing second critical borders could be the unfolding and
denaturing of the proteins with increasing salt concentrations. Therefore, the sta-
bility of the secondary structure of the proteins under the experimental conditions
was monitored by FTIR and CD. FTIR and CD measurements of BSA and HSA
in the presence of YCl3 were performed by our group before and no significant
changes were found [226]. Likewise, no indications for structural changes are visi-
ble in most of the new systems with the following exceptions: The FTIR results
show that BSA (20 mg/mL) stays stable from 0 to 10 mM Yb2(SO4)3 but decays
heavily at 45 mM. Comparing this result to Table 7.4, we see that this system
has a first critical border c* and becomes partially clear without reaching the
completely clear state again at high salt concentrations. This behavior is prob-
ably caused by unfolding of the protein. CD measurements on this system show
no dramatic changes, probably due to the much lower salt concentrations. With
Y(NO3)3 (and in weaker occurrence with Yb(NO3)3), a structural change in BSA
and HSA is probable. Finally, the plots for BLG indicate that the protein has the
same structure in the first and third regimes with all salts tested. However, in the
second regime, the samples tested show less molar ellipticity than in the first and
third. This could be caused by a lower protein concentration due to precipitation
and by reversible partial unfolding in the second regime. Plots of FTIR and CD
measurements can be found in the Appendix E.
7.1.5 Effective Protein-Protein Interactions Determined
by SAXS
In order to further complement our findings about effective interactions in protein
solutions tuned by different trivalent salts, SAXS measurements were performed.
Figure 7.2 shows measurement curves with 5 mg/mL BSA in the presence of YbCl3
and Yb(NO3)3. In the case of YbCl3, the effective interactions first change from
repulsive to attractive with increasing salt concentration, indicated by the upturn
at low q. In the third regime (10 mM YbCl3), the strength of attraction decreases
again. In the case of Yb(NO3)3, the intensity at low q continuously increases.
Further measurements are necessary for a better understanding of the salt effects.
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Figure 7.2: SAXS measurements of 5 mg/mL BSA in the presence of (a) YbCl3,
(b) Yb(NO3)3.
7.1.6 Crystallization and Structure Determination
One of the central applications of RC in protein systems is tuning the effective
interactions between proteins towards crystallization. Applying the experience
from the crystallization of BLG with YCl3, ZnCl2 and CdCl2, samples of the
systems presented above were prepared with protein and salt concentrations close
to the boundaries, especially c*, which was found in all systems tested. The
samples were stored at 5 and at 21◦C. In fact, a large number of the systems
tested could be successfully crystallized. Especially crystals of BLG and HSA were
found in the presence of various salts: BLG could be crystallized with all salts
tested and HSA with all but the three ytterbium salts, including both Y(NO3)3
and Y2(SO4)3, which did not induce a second boundary in HSA. In seldom cases,
crystals of BSA and OVA were found; however, the reproducibility is poor and
ideal conditions are still to be determined. As an example, Figure 7.3a shows a
picture of crystals grown at 21◦C from a solution with 40 mg/mL HSA and 4 mM
LaCl3 (close to c**) and Figure 7.3b shows a picture of crystals grown at 5
◦C from
(a) (b)
Figure 7.3: (a) Crystals grown from a solution with 40 mg/mL HSA and 4 mM
LaCl3 at 21
◦C. (b) Crystals grown from a solution with 20 mg/mL BLG and
1.3 mM Y(NO3)3 at 5
◦C.
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a solution with 20 mg/mL BLG and 1.3 mM Y(NO3)3 (close to c*).
The structure determination by X-ray diffraction is ongoing. Up to now, struc-
tural information was collected from BLG in the presence of various salts and
of HSA in the presence of YCl3 and GdCl3. In all of them, crystal contacts
are mediated by ion bridging. BLG in the presence of Y(NO3)3, Yb2(SO4)3 and
GdCl3 (and possibly also in the presence of Y2(SO4)3, where one lattice angle
only slightly deviates from 90◦) forms, as well as in the already published case of
YCl3
[227], orthorhombic crystals. Table 7.5 summarizes the benchmark data. A
detailed discussion of the commonalities and differences in these structures with
varying salt type will be subject of future work.
Table 7.5: Structural information of BLG and HSA crystals determined by X-
ray diffraction (work of M. Oelker, S. Da Vela and Dr. G. Zocher). Type and
concentration of the protein and the salt, the space group, the cell parameters
(lengths a-c and angles α-γ) and the resolution are listed.
prot. cprotein salt csalt space cell res.
[mg/mL] [mM] group parameters [A˚]
BLG 50 Y2(SO4)3 1 P21 a=64.24, b=40.31, c=134.45,
α=γ=90◦, β=89.72◦
2.97
BLG 5 Y(NO3)3 3 P212121 a=39.42, b=59.94, c=136.68,
α=β=γ=90◦
2.11
BLG 10 Yb2(SO4)3 0.3 P212121 a=39.47, b=60.21, c=136.30,
α=β=γ=90◦
2.35
BLG 20 GdCl3 2 P212121 a=39.67, b=59.97, c=137.21,
α=β=γ=90◦
2.70
HSA 31 YCl3 2 P212121 a=55.68, b=71.84, c=180.58,
α=β=γ=90◦
2.11
HSA 30 GdCl3 1.1 P212121 a=55.06, b=71.31, c=180.1,
α=β=γ=90◦
3.19
7.2 EpzP - a “Real-World System”
While our research on RC was performed so far on proteins that can be pur-
chased in large amounts, the aim is rather to apply it to the crystallization of
proteins of unknown structure which are subject of current biochemical research.
The first attempt to induce RC in a not commercially available system involves
Phenazine prenyl transferase (EpzP), an enzyme described by Seeger in 2011 and
Zocher in 2012 [175,229]. It was chosen because it can be produced in relatively high
yields and, moreover, its DNA construct is available which allows performing site-
directed mutagenesis. We aim to modify its surface towards more acidic residues
in order to allow or optimize its crystallization properties using metal salts. Wild
type EpzP (27.3 mg/mL) was titrated with YCl3 and both c* and c** were found.
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(a) (b)
(c)
Figure 7.4: Zeta potential measurements on 5 mg/mL EpzP in dependence on
the YCl3 concentration. (a) with (b) without 5 mM HEPES buffer (pH 7.0).
(c) Size exclusion chromatography results obtained by an analytical column (AG
Stehle). The error bars show the standard deviation of five measurements.
Zeta potential measurements on EpzP with YCl3 in water clearly show a charge
inversion, see Figure 7.4a. However, it turned out that EpzP does not remain sta-
ble if diluted in pure water. The size exclusion chromatography results presented
in Figure 7.4c show a clear shift to aggregates, whereas it stays in its monomeric
form if diluted in 5 mM HEPES buffer (pH 7.0). The use of buffer seems to be
necessary for this protein. Measurements on the zeta potential on EpzP with YCl3
in 5 mM HEPES are shown in Figure 7.4b and have an unusual trend, but still
indicate charge inversion.
So far, it was not possible to crystallize the wild type using YCl3. However, the
design of the mutant with a tetrahedral acidic patch is ongoing. In the future, it is
planned to produce it in larger amounts and to characterize the modified protein.
It is planned to crystallize it and compare it to the wild type.
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7.3 Discussion
We tested a series of protein–salt systems with regards to cation and anion effects
on RC, charge inversion, and RC-induced crystallization. A lower boundary was
found in all systems tested.
Variation of the cation has a rather small (and protein dependent) effect, al-
though the effective ion radii are quite different. While BLG, BSA and HSA show
a complete RC phase behavior with a second boundary c** in the presence of
all the chloride salts tested, pepsin only shows the lower critical boundary in all
systems tested. Variation of the anion, however, has a stronger effect: in both
HSA and BSA, an upper boundary can only be induced by the chloride salts but
not by sulfates and nitrates. In OVA, no second critical boundary was found in
the presence of YbCl3 but with other cations. The mechanisms behind this ion-
dependence and observations such as the inverse behavior of the slopes of c* shown
in Table 7.2 are not yet understood. Various effects that have not been taken into
account up to now, such as Hofmeister effects, differences in the solvent accessible
surface of pepsin or BLG and HSA or BSA, the pKa values of the substances and
more should be considered for further interpretation.
One of the central applications of RC in protein systems is tuning the effec-
tive interactions between proteins towards crystallization. Indeed, several of the
systems tested could be successfully crystallized. Especially crystals of BLG and
HSA were found in the presence of various salts.
Earlier expectations were that RC could occur in nearly half of all proteins (that
is the negatively charged ones at neutral pH) in the presence of multivalent metal
salts [226]. The recent experiments confirm that especially the first boundary c* is
very common among negatively charged globular proteins. A second boundary,
however, is not found in all systems tested. Best results were obtained with
chloride salts, in accordance with former experiments with FeCl3 and AlCl3
[226].
The induction of crystallization was not successful either in all the systems tested
but is still a promising approach which could be even further improved with the
increasing understanding of the underlying mechanisms. The good crystallization
conditions close to the boundaries that were observed in BLG in Chapter A-C and
Ref. [227] with various salts were confirmed in additional systems.
Another approach is the targeted modification of proteins towards a better
suitability for the crystallization by RC. Proteins with a known structure but
poor single crystal diffraction data provide information about the present surface-
residues but still have undesirably low resolution. By mutation of the surface-
residues, we could design better-diffracting crystals. A first step towards this
method is done by the aforementioned experiments with EpzP.
132 Chapter 7: On the Universality of Inducing Protein Crystallization
Part III
Conclusions & Outlook

Chapter 8
Summary & Conclusions
In the following, the main findings of this thesis are discussed. Its two main
topics are the determination of proper conditions for the nucleation of high quality
crystals which is a main challenge for structure biology and to study the early stage
of crystallization, including the pathways it follows and its possible precursors. It
has been shown that sign and strength of the interactions between negatively
charged globular proteins can be modified by salt effects [86,151]. RC could provide
a method to promote crystallization in a large number of proteins. In the case
of HSA in the presence of YCl3, crystallization was found in both the dilute and
the dense liquid phase after LLPS and in solutions between c* and the LLPS
region [215,216,223]. The main protein used for the work in this thesis was BLG from
cow milk.
Earlier experiments with BLG in the presence of YCl3 suggested that the best
conditions for high quality crystals can be found close to the boundaries [227]. This
could be confirmed in the systems of BLG in the presence of ZnCl2 (Chapter 3,
publication A) and CdCl2 (Chapter 4 and 5, publications B and C). The divalent
salts ZnCl2 and CdCl2 cause a normal first boundary c* in BLG. At high salt
concentrations, however, only a partial clearing is found at a concentration we
denote as pseudo-c**, which is in contrast to systems with trivalent salts, where
a complete reclearing was observed. A charge-inversion occurs in both cases.
Using SAXS, we could show that the effective interactions become less repulsive
approaching c* and finally become attractive. Repulsion is not reached again in
the third regime. While crystallization of BLG also takes place deep in the second
regime, the quality of the crystals is not sufficient for structure determination.
This can be explained by too strong attractive interactions (in accordance with
our SAXS measurements) that lead to the formation of stable, noncrystalline
aggregates. The metal ions are an integral part of the lattice and the cations
form new contacts by ion bridging. While Cd2+ and Y3+ only bind to acidic side
chains, Zn2+ also binds to histidine. Crystals grown in the presence of CdCl2
under various tested conditions always have a twinning problem (the structure
including the twinning problem has already been reported by A. Green and R.
Aschaffenburg in 1959 [68]) However, the BLG structures obtained with YCl3 and
ZnCl2 are of high quality and were deposited in the protein data bank.
Which pathways of crystallization are followed is an often discussed question,
mainly because energetically favored processes could exist under certain condi-
tions. If these conditions are known, easier ways to obtain crystals can be found.
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In Figure 5.1 (page 93), three possible scenarios were presented. In the “classical”
pathway, one Gibbs free energy barrier has to be overcome for the formation of a
critical nucleus. Nonclassical pathways involve an intermediate phase metastable
with respect to the crystalline state. It either can be also metastable with respect
to the initial fluid phase (resulting in microscopic clusters) or more stable (en-
abling the formation of a macroscopic dense liquid phase). However, the presence
of an additional phase other than the initial fluid and the crystalline solid does not
necessarily imply that these protein clusters or dense liquid phases act as precur-
sors for crystal nucleation. A further distinction has to be drawn into the parallel
formation of the additional phase (possibly acting as agent for heterogeneous nu-
cleation and/or as protein reservoir for growing crystals) and the scenario where
the crystal nucleation occurs within this precursor. These two cases were shown
in Figure 4.1 (page 79), too. We refer to both of them as “nonclassical” and to the
latter one as “two-step” or “multistep” (nucleation).
It is likely that close to c*, crystallization in BLG with all three salts tested
occurs via a classical one-step process, although the possibility of nucleation from
small clusters cannot be ruled out. Close to (pseudo-)c**, additional phases other
than the initial solution and the final crystal were observed. This is consistent
with findings in literature that specific interactions (patchy interaction) may be
important for the formation of a precursor [76,213]. By altering independently the
nonspecific and specific interactions, one can influence which crystallization path-
way is followed. In the case of our system, this could be selected by variation
of the salt concentration: close to c* the nonspecific interactions might domi-
nate. Increasing the specific interaction mediated by ion-bridges by increase of
the salt concentration possibly leads to the non-classical pathways observed in
BLG with YCl3, ZnCl2 or CdCl2. In Chapter 3 (publication A), the systems of
BLG in the presence of YCl3 and ZnCl2 were studied. The solutions are clear
(YCl3) / relatively clear (ZnCl2) and apparently in the third regime above a tran-
sition temperature Ttr and do not crystallize. Below Ttr, two different nonclassical
pathways with an additional phase are observed: close to Ttr, the additional phase
consists of protein clusters or small aggregates. Well below Ttr, larger aggregates
are found directly after sample preparation which relax into a dense liquid phase
within 1-2 h. The initially fine network of dense liquid then coarsens with time.
This behavior is known in literature as a special case of LLPS and called vis-
coelastic phase separation. The phenomenon was described for polymers and for
lysozyme [93,191,192]. Crystallization occurs at the interface of this dense and the
surrounding dilute liquid phase. However, the observations by optical microscopy
are not sufficient to answer the question whether nucleation takes place in two
steps in which the dense phase is a direct precursor of the crystal or if it takes
place heterogeneously from the dilute phase at the droplet interface (“parallel”
pathway).
While it was not possible to decide which one of these nonclassical pathways
was followed in the systems discussed in Chapter 3 (publication A), the results
shown in Chapters 4-5 (publications B and C) provide evidence for a multistep
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process. From observation of the crystallization kinetics, we propose the formation
of metastable aggregates with a certain noncrystalline ordering in a first step
followed by the nucleation of crystals within this intermediate phase. In the
beginning, numerous new crystals appear while their growth is slow which can
be explained by a low mobility in the aggregates. After some time (depending on
the salt concentration), crystal growth becomes faster, possibly due to contact to
the dilute phase after the consumption of enough surrounding aggregates. The
dilute phase enables faster diffusion and therefore could explain the faster crystal
growth in spite of the lower density. The slower dynamics in the denser phase
may be sufficient for crystals to nucleate since less molecules are involved. The
observed kinetics can be reproduced well by a rate equation model based on these
assumptions. Further experiments on BLG with CdCl2 suggest that increasing
the salt concentration in the transition zone pseudo-c** leads to fewer or finer
distributed aggregates, as well as to fewer (but due the larger amount of available
material per crystal larger) crystals.
The system of BLG in the presence of YCl3 has been further studied under
variation of the temperature using a combination of SAXS, SANS and VSANS
(very small angle neutron scattering). The considered samples are clear at the
preparation temperature of 35◦C and are cooled well below their transition tem-
peratures. The scattering data show a hierarchy of structures from monomer to
large clusters that changes with decreasing temperature. Real-time SAXS data
show isosbestic points, indicating a transformation from one state to another, pur-
suing equilibrium. The SAXS data can be modeled well by two-state analysis fits.
These results could prove to be useful for the understanding of the metastable
intermediate phase in this system.
In the end, we want to generalize our work and judge if our findings can be
transferred to other systems. A systematic study with various proteins and triva-
lent salts was performed. In all of these systems, a first boundary could be induced
and in most cases also a second one. In HSA and BSA, an upper boundary only
can be induced by the chloride salts but not by sulfates and nitrates. The cation
also has a certain effect: in OVA, no second boundary was found in the presence
of YbCl3, but with other chloride salts. The reasons behind these effects, however,
are not completely understood yet. BLG and HSA could be crystallized in the
presence of many different trivalent metal salts. The structure determination by
X-ray diffraction has successfully been performed for some of the systems and is
ongoing in others. The induction of RC by multivalent salts thus is a promising
approach for the crystallization of protein systems. Protein and salt concentra-
tions close to the boundaries are especially suitable for the growth of high quality
single crystals. In all determined structures, crystal contacts are mediated by ion
bridging. The aimed modification of proteins towards a better suitability for our
crystallization method offers the possibility to design better-diffracting crystals.
A first step towards this aim is done by our experiments with EpzP.
Concluding, it can be stated that the tuning of protein–protein interactions by
the addition of multivalent metal salts provides a promising method for the growth
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of high-quality crystals. Our real-time studies provide a noninvasive method to
follow the kinetics of crystallization and comprehend the underlying nucleation
mechanisms.
Chapter 9
Remarks, Problems, and Outlook
on Future Work
In this thesis, several studies of aggregation and especially crystallization of globu-
lar proteins have been presented and the possible pathways of nucleation and
growth have been discussed. Collating the results of the individual chapters, a
consistent picture could be established. Naturally, there is still some improvement
possible. In this chapter, open questions and experimental difficulties will be
addressed and future perspectives discussed.
The analysis of the visible area of crystals by optical microscopy is limited by
the resolution and — especially for increasing automation — raises the problem
of blurred crystals from other layers being taken into account. The SAXS analysis
is hindered by crystals or dense liquid phase falling out of or inside the beam
due to gravity. This hindered closer investigations of the crystallization pathway
of BLG in the presence of ZnCl2 via a liquid network: the denser material sinks
to the bottom of the SAXS capillary before crystallization starts. In the system
with CdCl2, especially within the pseudo-c** zone, samples are fortunately rather
viscous and stabilize the crystals at their positions. Only at the end of the growth
process, probably partially due to the consumption of the viscous material and
partially due to the increasing weight of the crystals, the crystals sediment. For
the future, a possibility could be the preparation in a hydrogel, as performed e.g.
by Finet et al. [48]. However, this probably also will change the phase behavior. As
shown in Chapter 5 (publication C), the Bragg peaks are very pronounced in SANS
measurements in D2O, too. All features relevant for our analysis can be measured
at the smaller sample-to-detector position (1.5 m) where the experiment can be
performed fast enough to enable real-time measurements of the crystallization
process with a temporal resolution similar to the one applied with SAXS in Chap-
ters 4-5 (publications B and C). Real-time SANS could eliminate two problems of
the SAXS measurements: possible beam-damage by too long exposure time and,
due to the larger beam size of SANS, difficulties in collecting data for samples
at higher salt concentrations, where the number of crystals decreases significantly
(see also Chapter 5 / publication C).
The effect of the vial surface should not be disregarded. In the system of BLG
and ZnCl2, similar networks of dense liquid form at the bottom of hanging drops
(sample–air interface) as well as on the walls of glass capillaries. Therefore it
can be concluded that they are not due to wetting on the glass–liquid interface.
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However, in other systems, an influence of the vial material could be observed:
for the crystallization of BLG in the presence of CdCl2 followed by optical mi-
croscopy, usually hydrophobically coated glass slides were used. Exchanging them
by normal glass, noticeably more crystals are formed and the different growth
speeds (the “kink” in the average length in Figure 4.4g, page 83) is not observable
anymore. This could be connected to enhanced heterogeneous nucleation at the
glass interface. The impact is even more drastic in e.g. the system of HSA in
the presence of YCl3, where crystallization could be observed in glass and plastic
tubes and quartz cuvettes only, but not on hydrophobically coated glass slides or
likewise hydrophobically coated (plastic) sitting drop plates. Furthermore, the in-
fluence of the solvent (H2O or D2O) changes the phase behavior differently strong
in different systems. While Braun et al. observe that the occurrence of LLPS
depends on whether H2O or D2O are used as a solvent
[25], in the work for this
thesis, no crystallization of BLG in the presence of YCl3 was found in D2O. With
CdCl2 and ZnCl2, however, the crystallization ability of BLG was as good as in
H2O. The reasons behind these solvent dependencies are not fully understood yet
and might be connected to the weakened strength of hydrogen bonds in heavy
water.
While with ZnCl2 and YCl3, BLG was observed to form a dense liquid network
at certain temperatures and concentrations, no LLPS was found in the presence of
CdCl2. The reason of this salt-dependent difference is unknown, too. Naturally,
a LLPS region outside the investigated phase diagram region is possible.
The real-time studies presented in this thesis can be extended to other systems
in the future. Promising systems are HSA crystallizing in the presence of LaCl3 or
CeCl3. These systems crystallize within hours in contrast to several other tested
systems that crystallize much slower, in the order of days. Slower crystallizing
samples, however, could be potentially measured at a X-ray home-source. On the
strength of experience, it is more probable to observe a two-step nucleation process
close to the upper RC boundary. Future research can potentially elucidate the
question whether the multistep pathway of crystal nucleation that was observed
for BLG in the presence of CdCl2 is a frequent property in protein systems or
rather an exception. Based on the findings in this field during the last years, it
seems to be possible that different two-step or multistep pathways exist depending
on the systems and sample conditions. While in Section 1.2, a two-step pathway
proposed by ten Wolde, Vekilov and others is presented that suggests a density
change followed by a structure change, we observe a rather structural development:
the aggregates in our solutions of BLG and CdCl2 form very early and are visible
already in the first microscope pictures. We did not follow their formation up
to now. In our SAXS study, we observe the subsequent formation of a — not
yet crystalline — precursor structure that we assume to be connected to typical
length scales inside the aggregates. This precursor subsequently transforms into
the crystalline state. In order to gain a deeper understanding of this mechanism,
it would be useful to find suitable methods to study the morphology of the MIP
more closely. Within pseudo-c**, the SAXS curves follow a power law with an
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exponent slightly below 2 at low q and deviate strongly from the form factor of
BLG. Therefore one can conclude that structures larger than the accessible q-range
are dominating, which is consistent with the observation of large protein clusters
under the optical microscope. The power law indicates a fractal structure. Further
information is needed in order to judge how these aggregates further develop and
where the typical length that shows in the SAXS curves as a broad peak is located.
Pursuing the first experiments with EpzP, proteins could be modified in order
to grow better-diffracting crystals in the future.
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Publication A
Figure A.1 shows a hanging drop experiment with top droplet-glass and the bottom
droplet-air interface in focus. Only insular dense liquid spots and later crystals
are visible on the upper glass surface while a liquid network forms at the bottom
of the droplets.
(a) (b)
(c) (d)
Figure A.1: Hanging drop experiment of a sample with 6.5 mg/mL BLG and
10 mM ZnCl2 with top droplet-glass (a&b) and the bottom droplet-air interface of
the same droplet (c&d) in focus. Only insular dense liquid spots and later crystals
are visible on the upper glass surface while a liquid network forms at the bottom
of the droplets. a&c: 2 h after preparation, b&d: 23.5 h after preparation
In Figure A.2, the crystallization process via dense liquid network followed by
optical microscope is shown for a sample with 65 mg/mL BLG and 13 mM YCl3
at 293 K.
Table A.1 shows the fitting parameters obtained for 3.3 mg/mL BLG with vary-
ing ZnCl2 concentrations, fitted by an elliptic form factor. The scattering length
density (SLD) of the ellipsoid was fixed to the calculated value.
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(a) (b)
(c) (d)
Figure A.2: Crystal growth at 293 K and a protein concentration of 65 mg/mL
with 13 mM YCl3. The hanging drop method was applied without prior centrifug-
ing. (a) 1 h, (b) 17 h, (c) 45 h and (d) 144 h after preparation.
Table A.1: Fitting parameters of the SAXS analysis with a BLG concentration
of 3.3 mg/mL.
c(ZnCl2) scale a (rotation axis) b
[mM] [10−4] [A˚] [A˚]
0.1 2.4 37.6 19.2
0.3 2.5 42.6 19.7
20.0 2.8 18.0 55.8
50.0 2.8 18.5 57.4
Figure A.3 shows SAXS data for 65 mg/mL BLG in the first (a) and in the third
regime (b) as well as the respective fit curves.
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Figure A.3: Fitted combination of form and structure factors for 65 mg/mL BLG
in the first (a) and in the third regime (b). Deviations of the fit from the data at
high q values are caused by deviations of the ellipsoid used as form factor from
the true form of the BLG dimer.
SAXS data in Regime I were fitted using an elliptic form factor with screened
Coulomb structure factor which was developed by Hayter and Penfold [73,77]:
USC(r) =
{
Z2e2
(1+κDR)2
exp(−κD(r−2R))
r
r > 2R
∞ r ≤ 2R (A.1)
with Z the protein surface charge, e the electronic charge, and  the dielectric
constant of the solvent. κD is the inverse of the Debye screening length, determined
by the ionic strength of the solution and R the effective sphere radius of the
ellipsoid with the axes a, b, b. First the data obtained with 0.5 mM ZnCl2 were
fitted and the values of the axes a, b fixed to the obtained values for the fits for
higher salt concentrations.
In the third regime, an elliptic form factor with a sticky hard sphere structure
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factor was used. The sticky hard sphere potential is defined by [15]
USHS(r) =

∞ r < σ
−u σ < r < σ + ∆
0 r > σ + ∆.
(A.2)
The stickiness parameter τ is defined as
τ =
1
12∆
exp(−u/kT ) (A.3)
with the preturbation parameter ∆
∆ = ∆/(σ + ∆) (A.4)
(fixed to 0.01). As visible by the increase of τ with increasing salt concentration,
the interaction strength becomes weaker.
σ is the hard sphere diameter (σ=2R), ∆ is the width of the square well, and
u is the depth [90]. The obtained volume fractions are close to the calculated
value of 0.0488, using the specific volume of BLG of 0.751 l/kg [118]. The dielectric
constant was fixed to 81 and the temperature to 298. In all fits, the scattering
length density (SLD) of the ellipsoid was fixed to the calculated SLD of BLG for
X-rays with the wavelength used. For the SLD of the solvent, always a value
between 1.14 10−5 A˚−2 and 1.15 10−5 A˚−2 (124600 eV) or between 1.12 10−5 A˚−2
and 1.13 10−5 A˚−2 (16000 eV) was obtained.
All fitting parameters obtained from Figure A.3 for 65 mg/mL BLG are listed
in Table A.2
Table A.2: Fitting parameters of the SAXS analysis with a BLG concentration
of 65 mg/mL.
c(ZnCl2) vol. fract. a b charge τ
[mM] [A˚] [A˚]
0.5 0.050 75.5 18.7 9.8 -
1 0.045 75.5 18.7 9.5 -
2 0.045 75.5 18.7 6.1 -
3 0.045 75.5 18.7 3.5 -
30 0.040 19.0 116.0 - 0.19
40 0.055 20.1 80.8 - 0.27
60 0.055 21.2 72.9 - 0.35
70 0.040 21.8 66.6 - 0.33
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Figure A.4: Additional Zn binding site at H146 in BLG-Zn-2. This binding
site is occupied concentration dependently and was refined to possess an occu-
pancy of 30% for BLG-Zn-2 and 75% for BLG-Zn-20, respectively. Density maps
were calculated with FFT [195]. The (2Fobs-Fcalc)-electron density map (gray) and
anomalous difference map (orange) are contoured at σ = 1.0 and σ = 4.0, respec-
tively.
Table A.3: Data collection statistics. Values in parentheses are for the highest
resolution shell.
BLG + 2 mM ZnCl2 BLG + 20 mM ZnCl2
Beamline SLS X06DA PETRA III P13
Detector PILATUS 2M-F PILATUS 6M-F
Wavelength [A˚] 1.0000 1.2380
Space group P3221 P3221
Unit cell [A˚] a = b = 92.83, c = 42.31 a = b = 89.82, c = 40.75
Matthews coefficient [A˚3/Da] 2.88 2.59
Solvent content [%] 57.23 44.21
Molecules/ASU 1 1
Resolution range [A˚] 19.73 - 2.40 38.89 - 2.44
(2.46 - 2.40) (2.50 - 2.44)
No. reflections
Measured 180247 (11948) 114034 (7284)
Unique 15959 (1211) 13636 (939)
Rmeas [%] 4.5 (103.0) 4.8 (14.3)
Completeness [%] 99.8 (99.5) 99.4 (93.9)
Redundancy 11.3 (9.9) 8.4 (7.8)
<I>/<σ(I)> 29.62 (3.05) 30.57 (14.86)
Wilson B-factor [A˚2] 71.0 59.8
Mosaicity [◦] 0.16 0.20
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Table A.4: Refinement statistics.
BLG + 2 mM ZnCl2 BLG + 20 mM ZnCl2
Resolution range [A˚] 19.73 - 2.40 38.89 - 2.44
Rcryst 0.1960 0.2037
Rfree (test set of 12 %) 0.2315 0.2332
No. of non-H atoms
Protein 1261 1263
Metal ions 2 3
Water 4 10
Average isotropic B-factor [A˚2]
Main chain 71.9 53.4
Side chain 78.1 57.9
Metal ions 70.3 63.6
Water 63.0 54.1
rmsd bond lengths [A˚] 0.004 0.004
rmsd bond angles [◦] 0.898 0.871
Ramachandran regions
Most favorable [%] 96.8 95.5
Allowed [%] 1.3 3.3
Outliers [%] 1.9 1.3
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Video on crystallization
The crystal growth and the number of crystals observed by optical microscopy in
a time series can also be followed in the video movie.mpg attached as separate
file.
FTIR and Zeta-potential data on protein stability
Fourier transform infrared spectroscopy (FTIR) measurements in D2O and circular
dichroism (CD) measurements in H2O were performed to prove that BLG stays
in its native state when increasing concentrations of CdCl2 were added (main
manuscript). Here, in Figure B.1a, we show FTIR measurements over a time span
of 85 min for the sample condition mainly used in this work (20 mg/mL BLG,
15 mM CdCl2) to demonstrate that there are also no time-dependent changes in
protein stability. Circular dichroism requires low protein concentrations at which
no turbidity in regime II is visible. To confirm that the complete charge inversion
takes place in the investigated CdCl2 range, zeta potential measurements were
performed (Figure B.1b).
Additional SAXS measurements and analysis
In Figure B.2, the position of the minimum intensity and the exponent of the
intensity as a function of q, I(q) ∝ qα, in the low q region are plotted as a
function of time. The q values at the minimum intensity decrease slightly before
crystallization, followed by an increase after 30 min, which is also the moment at
which Bragg peaks become detectable as illustrated by the dashed black line in
Figure B.2. The slope of the scattering intensity in low q changes from q−2.0 to
q−2.7, indicating the formation of more compact structures.
Figures B.3-B.5 show additional real-time SAXS data and analysis for a different
sample within the region of pseudo-c** (33 mg/mL BLG with 17 mM CdCl2).
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(a) (b)
Figure B.1: (a) Time-resolved FTIR spectra for a BLG concentration of
20 mg/mL and a CdCl2 concentrations of 15 mM covering the time span of the
SAXS experiments in time steps of 5 min. Curves are shifted in intensity for
better visibility. (b) Zeta potential measurements for samples used for the CD
experiments.
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Figure B.2: Position of scattering minimum of intermediate structure in
I(q)/I0(q) and absolute value of exponent at low q for 20 mg/mL BLG with 15 mM
CdCl2.
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Figure B.3: 3D-plot 33 mg/mL BLG + 17 mM CdCl2.
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Figure B.5: Time-dependent development of I(q)/I0(q) in 33 mg/mL BLG with
17 mM CdCl2. (a) Red spheres (left axis) show Ainterm(t), the integral of the
broad Gaussian function connected to the intermediate. Green stars (left axis)
show ABragg(t), the integral of the two Bragg peaks in this area. For clarity and
better statistics, always three data points of Ainterm(t) and ABragg(t) were merged
into one. The blue dashed line (right axis) shows the time derivative of ABragg(t),
the crystallization rate. (b) Position of minimum of intermediate structure and
absolute value of exponent at low q. For clarity, only every third (minimum
position) or second (exponent) data point is shown.
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The electrophoretic mobility was used to determine the zeta potential of proteins
as a function of the salt concentration. By this method, charge inversion was
verified. The measurements were done using a Zetasizer Nano ZS from Malvern
Instruments Ltd with a 633 nm laser. Although the reentrant effect for BLG so-
lutions in the presence of CdCl2 is not complete, a charge inversion with increas-
ing divalent salt concentration is observed, see Fig. C.1. Compared to previous
work [227], the charge inversion of BLG is weaker and occurs at higher salt concen-
trations than with the trivalent salt YCl3
[158,227]. The phase boundaries are shifted
towards higher salt concentrations, too. This relative weak charge inversion may
explain the phase behavior observed, i.e. a pseudo− c** or a transition zone and
the sample solutions in the third regime are still a bit turbid.
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Figure C.1: Zeta potential measurements on 2 mg/mL BLG with increasing
CdCl2 concentrations. The dotted red line is a guide to the eye, the dashed black
line marks a charge of 0.
Protein crystallization followed by real-time SAXS measurements. Samples con-
tain 33 mg/mL BLG with 15 - 20 mM CdCl2 in the transition zone of pseudo-c**.
Fig. C.2 shows additional SAXS data for 33 mg/mL BLG with 15 and 18.5 mM
CdCl2.
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Figure C.2: Real-time SAXS curves for 15 mM CdCl2 (a) and 18.5 mM (b).
Fig. C.3 shows the kinetic evolution for a two-step process as modeled by rate
equations with parameters reproducing the experimental findings from Figure 8b
in the main manuscript.
The number of crystals in solutions with 33 mg/mL BLG and different CdCl2
concentrations around pseudo− c** observed by microscopy can also be followed
in the videos listed in the following:
• The first video shows the crystallization in presence of 17 mM CdCl2 (file is
attached in electronic supporting information). The crystals are numerous
and small.
• The second one shows the crystallization in presence of 20 mM CdCl2 (file is
attached in electronic supporting information). Compared to the previous
video, significantly fewer and larger crystals can be observed.
Another animation provided with this publication shows the fitting performed
for evaluation of the amount of MIP and crystalline phase for a sample with 17 mM
CdCl2 (file is attached in electronic supporting information). Both the broad peak
and the Bragg peaks have been fitted by scaled Gaussians and their enclosed areas
evaluated.
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Figure C.3: Kinetic evolution for a two-step process as modeled by rate equa-
tions. The following parameter values were used to show the good qualitative
agreement of the model with the data set: ke = 0.15 min
−1, L0 = 0.2, αI = 0.2,
kgL = 0.6 min
−1 (same as for Figure 9c in the main manuscript), kI = 0.003 min−1,
kn = 0.002 min
−1, kgI = 0.02 min−1.
.
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Table D.1: Parameters for conventional fitting of involved structures at different
length scales in samples with 67 mg/ml BLG and YCl3 concentrations from 12
to 15 mM (first measurement curve at 35◦C and last measurement curve at 5◦C).
The SLD of the sample was fixed to 1.68·10−6A˚−2, the calculated value for BLG
for neutrons of the used wavelength. The applied form factors were spheres. For
the dimer, a hard sphere structure factor was used with a spherical form factor
(radius fixed to 15 A˚). In case of the cluster, elliptical form factors were assumed.
The curve for 12 mM YCl3 was fitted by a sticky hard sphere structure factor
(perturbation parameter fixed to 0.01), the curve for 13 mM with a hard sphere
structure factor and the curves for 14 and 15 mM YCl3 with a screened Coulombic
potential. Ionic strength, temperature and dielectric constant were fixed.
12 mM 13 mM 14 mM 15 mM
Dimer 35◦C HS HS HS HS
volume fraction 0.229 0.225 0.224 0.222
Cluster 35◦C SHS HS SC SC
rotation axis [A˚] 35.8 32.9 32.6 30.1
non-rotation axis [A˚] 93.4 86.4 89.4 90.9
volume fraction 0.054 0.038 0.069 0.095
stickiness 0.2 - - -
charge - - 0.12 4.95
Cluster 5◦C SHS HS SC SC
rotation axis [A˚] 50.1 44.1 44.8 42.6
non-rotation axis [A˚] 97.4 98.5 105.6 106.9
volume fraction 0.025 0.101 0.132 0.175
stickiness 0.2 - - -
charge - - 0.18 4.94
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Figure D.1: Complete set of measurements for Figure 2.
.
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(a) (b)
(c) (d)
Figure D.2: FTIR measurements of protein samples with a BLG concentration
of 67 mg/mL without salt at room temperature (black) and with (a) 12 mM, (b)
13 mM, (c) 14 mM, and (d) 15 mM YCl3 at room temperature (green), after prepa-
ration and 1 h equilibration time at 35-38 ◦C (red), and red marked sample after
one day at 5 ◦C (blue).
Table D.2: Fitting parameters obtained by a two level Beaucage fit for the
first (noncryst-1) and the last measurement run of the deeply quenched sample
(noncryst-2) as well as the first (cryst-2) and the final curve of the weakly quenched
samples from Ref. [221] (cryst-2). The scaling factor was 0.36-0.38 for the measure-
ments of the deep quench and 0.39 (start) and 0.40 (end) for the crystallizing
sample, the background was taken into account with 1.2-2.4·10−3cm−1.
noncryst-1 noncryst-2 cryst-1 cryst-2
Level 1
Rg [A˚] 130.22 167.03 134.10 138.09
Power 2.67 2.44 2.57 2.51
Level 2
Rg [A˚] 25.5 23.7 24.8 26.8
Power 3.31 3.03 3.79 3.27
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Figure E.1: Zeta potential measurements of different protein–salt systems.
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Figure E.3: FTIR measurements of different protein–salt systems. (I)
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Figure E.3: FTIR measurements of different protein–salt systems. (II)
.
Symbols and Abbreviations
2θ scattering angle
A area
A scattering amplitude
A2 second virial coefficient
a pressure resulting from interactions between particles of a gas
a˜ molar a
b excluded volume contribution in a van der Waals gas
b˜ molar b
bj scattering length
c concentration
c* first boundary concentration in RC systems
c** second boundary concentration in RC systems
D size in real space
d sample thickness
d fractal dimension (Porod exponent)
dσ/dΩ differential scattering cross section
∆G change in Gibbs free energy
∆µ change in chemical potential
∆ρ difference in scattering length density
∆Ω solid angle
 extinction coefficient
F (Helmholtz) free energy
G free enthalpy or Gibbs free energy
g(~r) pair correlation function
γ interfacial free energy density
H enthalpy
h; k; l Miller indices
I intensity
J classical homogeneous nucleation rate
j flux
K kinetic prefactor
kB Boltzmann constant
~kin incoming wave vector
~kout outgoing scattered wave vector
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ksp equilibrium molecular solubility product
L length
λ wavelength
µ chemical potential
N number
P pressure
P (~q) form factor
pseudo-c** second boundary concentration in BLG with divalent salts
Φ volume fraction
~q momentum transfer
R ideal gas constant
Rg radius of gyration
r radius
r* critical cluster size (radius)
ρ density
S entropy
S(~q) structure factor
s relative supersaturation
σ (hard sphere) diameter
T temperature
T transmission
Tc critical temperature
Ttr transition temperature
t time
U internal energy
u internal energy per unit mass or volume
V volume
V˜ molar volume
BLG β-lactoglobulin
CD circular dichroism
CdCl2 cadmium chloride
CeCl3 cerium chloride
CNT classical nucleation theory
DLS dynamic light scattering
FTIR Fourier transform infrared
GdCl3 gadolinium chloride
LaCl3 lanthanum chloride
LLPS liquid–liquid phase separation
MIP metastable intermediate phase
NMR nuclear magnetic resonance
169
PDB protein data bank
pI isoelectric point
RC reentrant condensation
SANS small angle neutron scattering
SAXS small angle X-ray scattering
SEC size exclusion chromatography
SLS static light scattering
UV-Vis ultraviolet-visible
VSANS very small angle neutron scattering
YbCl3 ytterbium chloride
Yb(NO3)3 ytterbium nitrate
Yb2(SO4)3 ytterbium sulfate
YCl3 yttrium chloride
Y(NO3)3 yttrium nitrate
Y2(SO4)3 yttrium sulfate
ZnCl2 zinc chloride
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